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BENJAMIN MICHAEL SIEMSEN. Prelimbic cortical synaptic and structural 
plasticity following cocaine self-administration and abstinence in rats: Role of 
glutamatergic pathway specificity. (Under the direction of JACQUELINE F. 
MCGINTY) 
Abstract 
The primary goal of this dissertation is to further examine the role of the prelimbic 
(PrL) subdivision of the rodent medial prefrontal cortex in relapse to cocaine 
seeking following abstinence, and to extend our understanding of pathway-specific 
adaptations in the PrL cortex projection to the nucleus accumbens (NAc) core that 
drives relapse. Previous findings indicate that the PrL cortex shows a biphasic 
response to abstinence from cocaine exposure. Specifically, early withdrawal (two 
hours after the final self-administration session) results in dephosphorylation of 
glutamate NMDA receptors and glutamate signaling regulators including 
extracellular signal-regulated kinase and the downstream transcription factor 
cAMP response-element binding protein (CREB). One week of abstinence 
enhances p-CREB and AMPA receptor subunit GluA1 phosphorylation in the PrL 
cortex, and Synapsin I in the NAc core. Interventions that act to normalize 
glutamate transmission in the PrL cortex during early withdrawal provide an 
enduring suppression of drug-seeking by normalizing activity in the PrL-NAc core 
pathway. Using a combination of biochemical and behavioral pharmacology 
techniques, we have found that the cocaine-induced activation of STriatal-
Enriched protein tyrosine Phosphatase in the PrL cortex during early withdrawal 
plays a role in subsequent cocaine seeking by dephosphorylating extra-cellular
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signal-regulated kinase. We also show that chemogenetic-mediated activation of 
the PrL cortex, or PrL-NAc core neurons, immediately after self-administration 
transiently reduces drug seeking which is not sustained. Finally, using an array of 
immunohistochemistry, pathway-specific viral vectors, and high-resolution 
confocal microscopy techniques, we provide evidence that PrL-NAc core neurons 
show reduced immunoreactivity of the activity markers Fos and p-CREB, reduced 
dendritic spine head diameter, and reduced GluA1/2 expression in subsets of 
dendritic spines during early withdrawal. The opposite effect was found after one 
week of abstinence. At this timepoint, PrL-NAc core neurons showed heightened 
nuclear p-CREB, spine head diameter, and GluA1/2 expression in dendritic spines. 
These findings suggest that the PrL cortex, and specifically PrL-NAc core neurons, 
undergoes an abstinence duration-dependent transformation in glutamate 




Chapter 1: General Introduction 
The role of the prefrontal cortex in drug-seeking behavior: Findings from 
clinical studies 
 
Illicit drug use in general is a major societal concern and in 2007 alone was 
estimated to cost the United States economy 193 billion dollars annually in costs 
related to crime, health, and productivity. For comparison, costs related to 
treatment and management of diabetes in the United States was 173 billion dollars 
in 2007 (NDIC, 2011). In 2011, approximately half of all emergency department 
visits were related to illicit drug misuse. Importantly, cocaine misuse in particular 
was responsible for approximately 40% of the emergency department visits related 
to illicit drug misuse (SAMHSA, 2011). From the perspective of an addicted patient, 
illicit drug abuse not only produces great external society harm, but also produces 
internal harm by increasing the risk of developing a Substance Use Disorder 
(SUD). Globally, of the total percentage of individuals initially experimenting with 
illicit drug use, approximately 20% will meet criteria for diagnosis of a SUD 
(Degenhardt and Hall, 2012).  
A major clinical issue in the treatment of SUDs is the relatively high 
propensity for relapse, even after prolonged periods of abstinence (Sinha, 2011). 
In a metanalysis examining relapse rates of treatment-engaged patients, it was 
found that following 50 days of discharge from a treatment center, less than half of 
cocaine-addicted patients remain abstinent. Remarkably, after one year only 
approximately 12.5% of patients remained abstinent (Sinha, 2011). Thus, a major 
goal of drug addiction research is determining neural mechanisms underlying 
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relapse and finding pharmacological targets to prevent relapse. Craving, a 
necessary precursor to relapse, can result from exposure of an addict to drug-
associated contexts or cues, invigorating the unmanageable desire to seek and 
ultimately use drugs (Kalivas, 2009). In clinical studies, the prefrontal cortex has 
emerged as a critical regulator of relapse behavior (Goldstein and Volkow, 2011) 
which is attributed to its downstream innervation of limbic-motor regions implicated 
in the execution of motivated behavior, such as the ventral striatum (Kalivas and 
Volkow, 2011). Furthermore, human addicts observing cocaine-related videos 
show hyperactivation of the prefrontal cortex in response to cues (i.e. 
paraphernalia), which positively correlates with self-reported craving (Robbins et 
al., 1999; Garavan et al., 2000).  
Interestingly, similar prefrontal cortical regions show reduced glucose 
metabolism using Positron-Emission Tomography (PET) following several weeks 
of abstinence from cocaine use (Volkow et al., 1992) a phenomena termed 
‘hypofrontality’. This decreased activity is likely important for relapse because 
repetitive transcranial magnetic stimulation (rTMS), a technique to elevate 
neuronal activity in defined brain regions, of the dorsolateral prefrontal cortex 
during abstinence appears to reduce cocaine use as well as craving (Terraneo et 
al., 2016).  Additionally, hypoactivity of the medial prefrontal cortex (mPFC) during 
a cognitive challenge task correlates with propensity for relapse (Brewer et al., 
2008).  
Structurally, grey matter volume is reduced in the mPFC in cocaine abusing 
patients relative to healthy controls (Ersche et al., 2011), and grey matter volume 
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negatively correlates with years of use (Ide et al., 2014). However, grey matter 
volume normalizes after 6 months of abstinence (Parvaz et al., 2017).  Collectively, 
these findings indicate that cocaine use produces maladaptive structural and 
functional alterations in prefrontal regions, which may serve as biomarkers for 
relapse propensity. However, these cocaine-induced structural adaptations appear 
to be plastic such that the recovery process during abstinence involves 
reorganization of these regions involved in behavioral control, which may be 
important for successful relapse prevention. Although neuroimaging and clinical 
neuropsychological measurements of addicted patients are critical for the 
development of pharmacological treatments for preventing relapse, preclinical 
models have provided a wealth of knowledge pertaining to neurotransmitters and 
circuitry involved in relapse-like events. Accordingly, animal models of addiction 
remain essential for furthering our understanding of drug-induced adaptations and 
how contexts and cues associated with drug reward gain salience to drive craving 
and ultimately relapse (Garcia Pardo et al., 2017).  
Role of the prefrontal cortex in relapse to cocaine seeking: Findings from 
preclinical studies 
 
Several decades of work have led to the conclusion that cocaine-induced 
elevations in extracellular dopamine (Everitt and Wolf, 2002) within limbic-reward 
regions are critical for not only the rewarding characteristics of acute cocaine, but 
also the reinforcement learning that occurs between contexts, cues, and the 
interoceptive state induced by cocaine (Wise et al., 2008; Volkow et al., 2017). 
Chronic elevations in dopamine lead to increased transcription of genes involved 
in reinforcement learning, facilitating the encoding of the association between the 
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rewarding characteristics of drugs of abuse and contexts or cues 
(Pulipparacharuvil et al., 2008; Taniguchi et al., 2017). Ultimately, this produces 
heightened sensitivity to glutamatergic inputs, as discussed in detail below. 
Preclinical models of addiction using self-administration (SA), followed by 
extinction and reinstatement, in rodents have revealed a critical role for dopamine 
release in the prelimbic (PrL) cortex (McGlinchey et al., 2016; James et al., 2018) 
and the nucleus accumbens core (NAc core) (Shen et al., 2014a) in reinstating 
cocaine seeking. However, the induction of cocaine seeking is dependent on 
elevated PrL glutamate release in the NAc core (Figure 1.1) (Kalivas et al., 2005; 
Kalivas, 2009). Thus, cocaine experience produces profound alterations in 
glutamatergic plasticity, which may be due to chronic dopamine elevations, in both 
the NAc core as well as the upstream PrL cortex, changes which are critical for 
subsequent relapse following presentation of drug-associated stimuli (Kalivas, 
2009).  
Figure 1.1. Dopamine and glutamate pathways within the brain reward circuitry. 
Cocaine-induced adaptations in dopamine transmission in the NAc core and PrL 
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cortex induce alterations in glutamatergic transmission in the NAc core. 
Heightened glutamate release in the NAc core arising from the PrL cortex is highly 
implicated in relapse to cocaine seeking following re-exposure to conditioned 
contexts or cues after abstinence. 
 
These findings suggest that targeting corticostriatal glutamatergic 
dysfunction during abstinence may provide an enduring reduction in relapse 
vulnerability following presentation of cocaine-associated contexts and stimuli. 
Indeed, treatments which normalize corticostriatal glutamate transmission, such 
as N-acetylcysteine (NAC) provide an enduring suppression of relapse in 
preclinical models (Moussawi et al., 2009). However, such treatments have 
provided mixed results in promoting abstinence in clinical populations (McClure et 
al., 2014). Regardless, it is well-accepted that treatment approaches to promote 
abstinence in human populations should be directed towards normalizing 
glutamate transmission between the PFC and NAc core. 
Several lines of evidence implicate heightened glutamatergic transmission 
arising from PrL afferents in the NAc core as a mediator of cocaine-seeking 
behavior. For example, optogenetic-mediated inactivation of the PrL, the NAc core, 
or PrL axon terminals within the NAc core, immediately prior to a cue-induced 
relapse test in rats suppresses cocaine seeking (Stefanik et al., 2013). Additionally, 
glutamate release arising from PrL afferents in the NAc core mediates cocaine 
prime-induced reinstatement, and glutamate levels in the NAc core are suppressed 
following chronic cocaine SA and extinction training (McFarland et al., 2003). 
However, other glutamatergic inputs to the NAc core are critical for cue-induced 
reinstatement, including basolateral amygdala (BLA) afferents within the NAc core 
(Stefanik and Kalivas, 2013).  
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However, in most experiments interrogating cocaine-induced plasticity in 
corticostriatal circuits, interventions have been performed immediately prior to 
relapse testing in rats. This approach has informed our understanding of plasticity 
that mediates relapse occurring at this abstinence timepoint. However, this 
approach may not be beneficial for preventing relapse in clinical populations 
because neuroadaptations involved in relapse in brain reward circuitry have fully 
developed and may be less malleable relative to earlier abstinence timepoints. 
Relatively less is known about how chronic cocaine SA in rats alters excitatory 
transmission between the PrL and the NAc core during early withdrawal, a 
timepoint which may be particularly useful for interventions in clinical populations 
(McGinty et al., 2015). Indeed, the early hours of drug withdrawal have been found 
to be a critical timepoint for relapse prevention in preclinical models. 
Early withdrawal, PrL cortex, and BDNF 
In the last decade our laboratory has vigorously investigated alterations in 
glutamatergic transmission within the PrL cortex during early withdrawal (i.e. two 
hours after the final cocaine SA session). Several lines of evidence have shown 
that this timepoint is critical for relapse prevention. First, we have found that a 
single infusion of brain-derived neurotrophic factor (BDNF) into the PrL cortex 
immediately after the final of 14 daily cocaine SA sessions provides an enduring 
suppression of relapse to contexts, cues, as well as a priming injection of cocaine 
for at least three weeks after the infusion (Berglind et al., 2007). Second, this 
intervention normalizes glutamatergic neurotransmission within the NAc core 
following extinction and prevents the cocaine prime-induced elevation in 
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extracellular glutamate in the NAc core (Berglind et al., 2009). This is associated 
with a normalization of augmented Synapsin phosphorylation, and presumably 
glutamate release probability, in the NAc core during early withdrawal (Sun et al., 
2014a), suggesting BDNF normalizes PrL-NAc core glutamate transmission. 
Third, the suppressive effect of PrL BDNF on cocaine seeking relies on the 
normalization of a cocaine-induced dephosphorylation of several key 
glutamatergic signaling entities in the PrL cortex during early withdrawal; including 
extracellular signal-regulated kinase 2 (ERK2), the downstream transcription factor 
cAMP response-element binding protein (CREB), as well as the N-Methyl-D-
Aspartate (NMDA) receptor subunits, GluN2A and GluN2B (Whitfield et al., 2011; 
Go et al., 2016; Barry and McGinty, 2017). Specifically, preventing BDNF from 
reversing the cocaine-induced dephosphorylation of these signaling molecules 
with selective antagonists and kinase inhibitors prevents intra-PrL BDNF from 
suppressing cocaine seeking  (Go et al., 2016; Barry and McGinty, 2017). 
Interestingly, these dephosphorylation events are transient in nature such that the 
ERK2 dephosphorylation is normalized 24 hours after the final SA session 
(Whitfield et al., 2011). A major question resulting from this body of work is how 
chronic cocaine SA results in these dephosphorylation events, and specifically, 
what phosphatase might be activated in the PrL cortex during this early withdrawal 
timepoint to drive these dephosphorylation events. 
Striatal-enriched protein tyrosine phosphatase as a likely mediator of PrL 
dysfunction during early withdrawal 
 
The STriatal-Enriched protein tyrosine Phosphatase (STEP) has arisen as an 
important regulator of ERK2 (Paul et al., 2003), GluN2B (Braithwaite et al., 2006), 
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and more recently, GluN2A (Tian et al., 2016) tyrosine phosphorylation. 
GluN2AY1325 phosphorylation potentiates NMDA-mediated excitatory currents by 
increasing GluN2A open channel probability (Taniguchi et al., 2009). GluN2BY1472 
phosphorylation inhibits internalization of GluN2B-containing NMDA receptors, 
enhancing synaptic activity (Carreno et al., 2011). Dephosphorylation of these 
NMDA receptor subunits would therefore likely produce a suppression of NMDA-
receptor mediated currents in the PrL cortex during early withdrawal from cocaine 
SA, although this has yet to be shown.  
Previous studies indicate that NMDA or glutamate stimulation in cultured 
neurons leads to a rapid but transient NMDA receptor-dependent elevation in 
ERK2 phosphorylation (Paul et al., 2003). The rapid rise in ERK2 phosphorylation 
is GluN2A-dependent, whereas the subsequent dephosphorylation of ERK2 is 
GluN2B-dependent (Paul and Connor, 2010). Finally, our lab has previously shown 
that cocaine SA leads to STEP dephosphorylation in the PrL cortex during early 
withdrawal, resulting in STEP activation (Sun et al., 2013).   
Apart from its role in regulating glutamatergic neurotransmission, STEP 
also plays a role in actin depolymerization following NMDA receptor stimulation in 
vitro. Specifically, NMDA receptor activation in cultured neurons activates STEP 
and leads to the STEP-dependent dephosphorylation of the actin binding protein, 
SH3 protein interacting with NCK of 90 kD (SPIN90) (Cho et al., 2013). When 
tyrosine is phosphorylated by Src family kinases (SFKs), SPIN90 acts as a potent 
inhibitor of the actin-depolymerizing factor, cofilin, in dendritic spine heads. 
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However, when dephosphorylated by STEP, SPIN90 translocates to the dendritic 
shaft, allowing for cofilin-mediated actin depolymerization in dendritic spine heads.  
Thus, it is possible that the activation of STEP during early withdrawal in the 
PrL cortex may be accompanied by actin depolymerization, leading to shrinkage 
of dendritic spine heads. Moreover, STEP dephosphorylates C-terminal tyrosine 
residues of the GluA2 subunit of AMPA receptors, promoting endocytosis of 
GluA2-containing AMPA receptors (Zhang et al., 2008). Collectively, these findings 
indicate that STEP not only functions to limit excitatory neurotransmission via 
dephosphorylation of key tyrosine residues on both AMPA and NMDA receptors, 
but that STEP activation also facilitates actin depolymerization through interactions 
with actin binding proteins. See Figure 1.2 for a diagram summarizing the 
consequences of increased STEP activity on glutamate signaling. Such alterations 
in actin polymerization may result in changes in the morphology of dendritic spines, 





Figure 1.2 Diagram summarizing consequences of STEP activation on glutamate 
signaling. STEP activation suppresses ERK signaling and promotes endocytosis 
of GluA2-containing AMPA receptors. STEP also interacts with the actin binding 
protein substrate SPIN90 (not shown) to facilitate actin depolymerization leading 
to shrinkage of dendritic spines. 
 
Dendritic spine morphology as an index of neuronal physiology 
Dendritic spines are small protrusions arising from dendrites that are enriched in f-
actin, actin binding proteins, post-synaptic receptors, as well as scaffolding 
proteins linking receptors to effectors and internal Ca2+ stores (Sala and Segal, 
2014). For several decades, it has been suggested that actin polymerization plays 
a critical role in mediating synaptic plasticity (Fifkova and Delay, 1982). Dendritic 
spines exist in various morphological states and are generally classified into four 
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main categories; filopodia, thin, stubby, and mushroom, with the latter forming 
stable and mature synapses (Bellot et al., 2014). In the adult cortex, filopodia, 
which are generally thought to be immature protrusions but are required for initial 
spinogenesis (formation of new spines), are low in density (Zuo et al., 2005). 
Moreover, others have suggested that filopodia are indeed not dendritic spines due 
to their overall lack of a defined spine head (Dailey and Smith, 1996).  
Furthermore, the pruning and formation of new dendritic spines, as well as 
the stabilization of existing spines (i.e. structural plasticity), is thought to underlie 
several components of plasticity mediating learning and memory (Fu and Zuo, 
2011). Indeed, several studies have demonstrated changes in the morphology of 
dendritic spine heads following LTP induction, such as the enlargement of spine 
heads and shortening/widening of the spine neck (Tonnesen et al., 2014), are 
highly correlated with the potentiation of glutamatergic excitatory 
neurotransmission (Kasai et al., 2003). Thus, synaptic plasticity at excitatory 
synapses mediating learning and memory in various brain regions is reflected in 
alterations in dendritic spine morphology, and such changes may be an index of 
the activity state of neurons.  
Role of AMPA receptor subunit conformation and transmission in dendritic 
spine morphology 
 
Ionotropic glutamate receptors subserve the majority of excitatory 
neurotransmission within the brain (Hollmann and Heinemann, 1994). 
Physiologically, NMDA receptor activation produces a rise in intracellular Ca2+ 
which is important for enlargement of dendritic spine heads during the induction of 
long-term potentiation. This series of events is dependent on calmodulin, actin 
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polymerization, and an increase in AMPA receptor-mediated glutamate currents 
(Matsuzaki et al., 2004). Studies in vitro have shown that, in particular, the GluA2 
subunit of AMPA receptors is important for dendritic spine head enlargement 
(Passafaro et al., 2003).  
The GluA1 subunit of AMPA receptors is critical for glutamatergic plasticity, 
and phosphorylation of several key C-terminal residues of GluA1 potentiates 
AMPA receptor-mediated excitatory transmission. Specifically, phosphorylation of 
GluA1S845 through a cAMP-dependent protein kinase A (PKA)-mediated 
mechanism enhances glutamate currents (Roche et al., 1996). Interestingly, 
AMPA receptors are extremely abundant in mature, mushroom-type dendritic 
spines, but display low abundance in thin and filopodia-type dendritic spines, 
subtypes which are thought to be more malleable in response to differential 
excitatory input and may be the site of so-called silent synapses (Matsuzaki et al., 
2001). Collectively, these findings indicate that AMPA receptor phosphorylation, 
and trafficking to synapses, is a critical event mediating synaptic potentiation; 
which requires actin polymerization and enlargement of dendritic spine heads. 
Regarding the effect of short access cocaine SA on AMPA receptor 
phosphorylation in the PrL cortex, our lab has found no such alterations during 
early withdrawal. However, in contrast to early withdrawal, one week of abstinence 
(i.e. early abstinence) results in profound alterations in AMPA receptor 





Prelimbic cortex and early abstinence 
As discussed above, the PrL cortex shows a state of diminished glutamatergic 
neurotransmission during early withdrawal which is reversed by BDNF. However, 
additional data collected in our laboratory suggest that plasticity occurring over one 
week of abstinence renders the PrL cortex hypersensitive to inputs encoding 
cocaine-conditioned stimuli. Specifically, following one week of forced abstinence 
there is enhanced phosphorylation of CREB with no alteration in ERK2 
phosphorylation. Furthermore, the PKA target GluA1S845 is also elevated after one 
week of forced abstinence (Sun et al., 2014b). Importantly, an intra-PrL infusion of 
the PKA inhibitor, Rp-cAMPS, prior to context-induced relapse after abstinence 
normalizes the hyperphosphorylation of GluA1 and CREB, suppressing context-
induced relapse.  
PKA phosphorylation of GluA1S845 has been shown to enhance plasma 
membrane insertion of AMPA receptors, augmenting excitatory neurotransmission 
(Banke et al., 2000; Oh et al., 2006). Apart from the upstream kinase ERK2, PKA 
is also an important regulator of CREB phosphorylation and CREB-mediated gene 
transcription in the cortex (Kelly, 2018). Several experiments have implicated 
dopamine receptor D1-PKA signaling in both the PrL cortex (Boudreau et al., 2009) 
as well as the NAc core (Hope et al., 2005) in neuroplasticity following chronic 
cocaine administration. In a cocaine SA paradigm, infusion of dopamine into the 
NAc core or the PrL cortex is sufficient to induce reinstatement following extinction 
(Cornish and Kalivas, 2000; McFarland and Kalivas, 2001).  
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The finding that the PrL cortex shows a hyperphosphorylation of PKA 
targets, GluA1 and CREB, indicates the potential for hyperactivity within the PrL 
cortex following one week of abstinence. This is not without precedent, as a recent 
experiment showed elevated AMPA:NMDA ratio, an index of synaptic potentiation, 
following withdrawal from cocaine-induced conditioned place preference (Otis and 
Mueller, 2017). Noncontingent cocaine administration has also been shown to 
increase excitability of PrL neurons by inhibiting G protein-gated inwardly rectifying 
K+ (GIRK) channels (Dong et al., 2005; Hearing et al., 2013). Interestingly, a 
deletion of GIRK channel-encoding genes in forebrain neurons of knockout mice 
is sufficient to augment cocaine-induced locomotion, which is associated with 
increased PrL-NAc core glutamate transmission (Marron Fernandez de Velasco et 
al., 2017). Finally, a cocaine-induced behavioral sensitization paradigm augments 
extracellular glutamate levels in the PrL cortex after 7 days of withdrawal, 
suggesting elevated glutamate tone on PrL pyramidal neurons (Williams and 
Steketee, 2004). 
A recent study found that after extinction from cocaine SA, there is an 
increase in intrinsic excitability of PrL neurons (Sepulveda-Orengo et al., 2017). 
This induction of PrL hyperexcitability is likely not an epiphenomenon, as drugs 
that impair cocaine reinstatement show a normalization of this hyperexcitability 
(Sepulveda-Orengo et al., 2017). Recent evidence also indicates a role for 
sensitized PrL D1-PKA signaling following chronic cocaine injections in decreasing 
the threshold for the induction of spike-timing-dependent LTP in layer V pyramidal 
neurons, perhaps priming synapses for potentiation following subsequent cue 
15 
 
exposure (Ruan and Yao, 2017). Moreover, elevated BDNF expression in the PrL 
cortex following 8 days of cocaine withdrawal facilitates LTP induction in layer V 
pyramidal neurons, which mediates locomotor sensitization (Lu et al., 2010). 
Taken together, these findings indicate that the PrL cortex likely transitions 
from a state of glutamatergic hypoactivity to one of glutamatergic hypersensitivity 
as a function of abstinence duration. This hypersensitive state may be dependent 
on elevated sensitivity to dopaminergic inputs, perhaps priming synapses for an 
augmented response to incoming glutamatergic inputs. This is supported by the 
finding that there is increased activation of prefrontal cortical regions following 
presentation of cocaine-conditioned cues in human cocaine abusers 
(Pulipparacharuvil et al., 2008) as well as increased immediate early gene 
expression, a proxy for elevated neuronal activity (Dragunow and Faull, 1989), 
during presentation of cocaine-conditioned cues (James et al., 2018) or contexts 
(Hearing et al., 2008) in rodents. Although it is unclear whether cocaine SA alters 
the electrophysiological properties of PrL neurons after one week of abstinence, 
ex vivo and in vivo electrophysiology have been used to address cocaine-induced 
alterations in such properties of neurons in the PrL cortex and the NAc core at 
other timepoints. 
Cocaine-induced alterations in physiology and structural plasticity in 
cortico-accumbens circuitry 
 
Although several studies have investigated how chronic cocaine exposure alters 
excitatory neurotransmission within the NAc core, fewer experiments have 
investigated alterations in physiology induced by chronic cocaine exposure in the 
PrL cortex. In the NAc core, basal AMPA:NMDA ratio is elevated following 
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extinction from cocaine SA, which is augmented by 15 minutes of cue-induced 
reinstatement, representing a period of transient synaptic potentiation (tSP). The 
elevated AMPA:NMDA ratio is associated with increased dendritic spine head 
diameters following extinction that undergo further potentiation during cue-induced 
reinstatement (Gipson et al., 2013; Smith et al., 2014). Importantly, these transient 
adaptations rely on glutamate release arising from the PrL cortex (Stefanik et al., 
2016). Further, it has been shown that chronic cocaine SA and withdrawal produce 
a marked inability to induce LTP or LTD in NAc core neurons following stimulation 
of the prefrontal cortex in vivo (Moussawi et al., 2009). Moreover, animals 
undergoing 30 days of abstinence from cocaine SA show a higher proportion of 
‘phasically active’ NAc core neurons during resumption of cocaine SA relative to 
one day of abstinence, suggesting prolonged abstinence elevates cocaine-cue 
encoding and responsiveness in NAc core neurons (Hollander and Carelli, 2005). 
Thus, cocaine SA induces dysfunctional glutamatergic transmission in PrL 
afferents within the NAc core, which are likely important for craving and relapse to 
cocaine seeking following re-exposure to cocaine-conditioned stimuli.  
As discussed above, few experiments have investigated cocaine-induced 
alterations in physiology or structural plasticity within the PrL cortex, which is 
surprising given its critical role in behavioral activation and subsequent relapse. A 
key study found that, relative to baseline, the firing rate of mPFC neurons is 
suppressed following cocaine infusions in a SA paradigm. However, this effect was 
normalized after 10 days of SA. Interestingly, this was associated with decreased 
basal firing rate following the first cocaine infusion during each day of SA (Sun and 
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Rebec, 2006). Furthermore, the authors found enhanced burst firing and numbers 
of spikes per burst relative to baseline in cocaine-experienced animals. The 
authors conclude that although cocaine dampens basal PFC firing rates, the 
encoding of cocaine-conditioned stimuli is enhanced following chronic cocaine SA. 
Data from our lab indicate that daily cocaine experience produces a dampening of 
PrL firing rates, with subsequent daily sessions recruiting a larger percentage of 
suppressed neurons (Dennis et al., 2018). Moreover, it has been shown that 30 
days of abstinence from cocaine SA increases the percentage of ‘phasically active’ 
PrL, but not IL, cortical neurons during extinction day 1, relative to one day of 
abstinence (West et al., 2014). A similar effect was shown following resumption of 
cocaine SA after one month of abstinence.  
Following long-access cocaine SA and extinction training, a subset of rats 
who show compulsive cocaine-seeking behavior have decreased intrinsic 
excitability in deep-layer pyramidal neurons of the PrL cortex (Chen et al., 2013). 
Rescuing this hypoexcitability with optogenetic stimulation reduced compulsive 
cocaine seeking (Chen et al., 2013). In concert, these findings indicate that, in 
general, cocaine experience increases the encoding of cocaine-associated stimuli 
by PrL neurons. However, this may be associated with suppressed activity of these 
neurons at baseline. 
Cocaine-induced alterations in PrL structural plasticity 
Although well-documented adaptations in dendritic spine morphology or density 
have been demonstrated in the NAc core, fewer experiments have been done 
investigating such adaptations in the PrL cortex. The few studies that have been 
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performed have provided mixed results regarding the effect of cocaine SA and 
various lengths of abstinence on PrL structural adaptations. This discrepancy 
appears to be due to different techniques to label dendritic spines, different 
abstinence timepoints, different pyramidal neurons (i.e. layer II/III versus V), as 
well as different regions of the dendrite analyzed (basal versus apical). Using Golgi 
staining, experiments have generally reported increased spine density on apical 
dendrites after one month of abstinence (Robinson et al., 2001) and basal 
dendrites after one week of abstinence (Rasakham et al., 2014). This agrees with 
the finding that MDMA behavioral sensitization produces increases in spine density 
of distal apical dendrites of layer V PrL neurons (Ball et al., 2009). However, Golgi 
staining typically uses 2D photomicrographs to trace dendrites, neglecting 
dendritic spines that protrude axially. Additionally, relative to labeling of neurons 
with the lipophilic dye DiI, Golgi staining severely underestimates the number of 
spines, particularly thin spines (Shen et al., 2008). In contrast, more recent 
experiments using advanced techniques have found reduced layer II/III apical 
spine density after two weeks of abstinence (Radley et al., 2015) and reduced layer 
V apical spine density specifically in neurons innervating D1-, but not D2,-
expressing MSN’s in the NAc core after 14 days of withdrawal from daily 
noncontingent cocaine injections (Barrientos et al., 2018).  
Although these experiments have provided valuable insight into how 
cocaine SA alters the structure and function of PrL neurons, only recently have 
they revealed pathway-specific structural adaptations. This is important given the 
heterogeneity of PrL efferents. For example, layer II/III pyramidal neurons project 
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to several downstream structures including the BLA (Gabbott et al., 2005; Little 
and Carter, 2013). This well-defined projection likely contributes to prefrontal 
cortical modulation of cognition as well as emotional drive. However, layer II/III 
pyramidal neurons also project to the contralateral mPFC (Little and Carter, 2013), 
as well as dorsal striatal regions regulating motor control (Gabbott et al., 2005). In 
contrast, layer V pyramidal neurons provide robust innervation of the NAc core 
(Gabbott et al., 2005), a pathway that has been shown to be a key projection in 
cocaine-induced plasticity underlying relapse (discussed in detail above). Layer V 
pyramidal neurons also innervate the dorsomedial striatum, as well as the BLA. 
Additionally, these neurons project to other subcortical structures implicated in 
prefrontal cortical regulation of motivation, such as the lateral hypothalamus 
(Gabbott et al., 2005).  
Thus, experiments investigating PrL structural adaptations resulting from 
cocaine SA should provide additional information regarding how these adaptations 
might occur in a pathway-specific manner. These observations would provide 
critical information regarding projection-defined adaptations. Importantly, no 
studies to date have investigated not only how cocaine SA alters PrL structural 
plasticity during early withdrawal, but also whether this occurs in neurons 
projecting from the PrL cortex to the NAc core. Assuming cocaine-induced 
plasticity is altered in a pathway-specific manner, it is therefore imperative to 
possess tools to interrogate the effect of pathway-specific manipulations of PrL 
neurons on subsequent behavioral responses to cocaine-conditioned stimuli. 
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Designer Receptors Exclusively Activated by Designer Drugs (DREADDs): A         
chemogenetic toolkit for altering neuronal activity in a pathway-specific 
manner 
 
DREADDs are mutated human muscarinic receptors that lack the binding site for 
the endogenous ligand, acetylcholine, but have gained affinity for the exogenous 
ligand clozapine-N-oxide (CNO) (Pei et al., 2008). Specifically, DREADDs take 
advantage of endogenous signaling cascades coupled to Gαi (hM4Di), Gαq 
(hM3Dq), and Gαs (rM3Ds) signaling which decrease, increase, and modulate 
neuronal excitability, respectively (Rogan and Roth, 2011). DREADDs are typically 
introduced into neuronal populations through adeno-associated viral vectors 
containing DNA encoding for DREADD receptors (Smith et al., 2016). Initially, 
DREADD expression was exclusively driven by a cell-type specific promoter (i.e. 
CaMKIIα) or a pan-neuronal promoter (i.e. Synapsin). More recently, the advent of 
intersectional viral approaches has allowed for the manipulation of specific 
neuronal pathways using DREADDs. This requires the use of viral vectors injected 
in terminal regions of interest which show preferential retrograde transport and 
express Cre-recombinase in all neurons projecting to said region (Junyent and 
Kremer, 2015; Tervo et al., 2016). This is combined with infusions of viral vectors 
containing Cre-dependent DNA in given brain regions innervating the area where 
retrograde viruses were infused. Ultimately, this allows for Cre-dependent 
DREADD expression in a defined pathway of interest (Garcia et al., 2017).  
In the last several years, the use of pathway-specific DREADDs has been 
applied to the interrogation of prefrontal cortical efferents implicated in relapse to 
cocaine seeking. For example, Augur and colleagues recently found that 
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chemogenetic activation of the ventromedial prefrontal cortex (vmPFC), including 
the IL cortex, immediately prior to cue-induced reinstatement was sufficient to 
suppress relapse. Moreover, they found that preferentially activating vmPFC 
projections to the NAc shell was sufficient to reproduce this effect (Augur et al., 
2016). This finding suggests that the primary mechanism of action of hM3Dq 
activation of this pathway was to reactivate IL cortical neurons projecting to the 
NAc shell encoding the updated contingency of cocaine availability inherent in 
extinction training.  
Using Gi-coupled DREADDs, Kerstetter and colleagues found that inhibition 
of PrL projections to the NAc core during daily cocaine SA sessions resulted in 
enhanced responding on the formerly active lever during extinction, and increased 
responding on the active lever during cocaine prime-induced reinstatement. 
However, inhibiting this pathway immediately prior to reinstatement was sufficient 
to suppress cocaine prime-induced reinstatement (Kerstetter et al., 2016). This 
finding is consistent with a role for elevated PrL glutamate release in the NAc core 
mediating cocaine prime-induced reinstatement (McFarland et al., 2003). 
Data from our lab indicate that Gi-DREADD inhibition of all PrL outputs 
using a CaMKIIα promoter immediately after the final SA session suppresses 
relapse to contexts, cues, as well as a priming injection of cocaine. Specifically 
inhibiting the PrL projection the NAc core at the same timepoint was without effect 
on relapse behavior. However, the suppressive effect of global PrL Gi-DREADD 
inhibition on relapse behavior was recapitulated when specifically inhibiting the PrL 
projection to the paraventricular nucleus of the thalamus (PVT). One interpretation 
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of these data is that there exist parallel, dichotomous glutamatergic pathways 
arising from the PrL cortex during early withdrawal from cocaine SA.  Thus, PrL-
NAc core may exist in a hypoactive state, whereas PrL-PVT may exist in a 
hyperactive state following cocaine SA. This is not without precedent, as a recent 
study found that these two pathways differentially encode reward-predictive cues 
(Otis et al., 2017). 
Collectively, these findings indicate that pathway-specific DREADD 
modulation of PrL outputs can differentially affect various aspects of relapse to 
cocaine seeking depending on the specific pathway being manipulated.  
Purpose of studies and overall hypothesis 
The data collected in our lab and others clearly show that the PrL cortex undergoes 
profound alterations in glutamatergic plasticity during early withdrawal which, in 
some instances, is opposite relative to one week of abstinence. This chain of 
events has been shown to be critical for subsequent relapse. Because early 
withdrawal represents a critical timepoint for relapse prevention due to the 
dephosphorylation events that occur in the PrL cortex, it was imperative to examine 
whether preventing these dephosphorylation events from occurring through 
targeting STEP activity is sufficient to suppress relapse  (Aim1). Moreover, 
because the dephosphorylation events occurring in the PrL cortex during early 
withdrawal are reflective of a hypoactive glutamatergic state, it is reasonable that 
artificially increasing glutamatergic neuronal activity in the PrL cortex during early 
withdrawal would be sufficient to suppress relapse after abstinence (Aim 2). 
Further, the dephosphorylation events occurring in the PrL during early withdrawal, 
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as well as the hyperphosphorylation of PKA targets after one week of abstinence, 
have previously been shown to be associated with altered AMPA receptor 
transmission and spine morphology. Thus, we hypothesized that spine 
morphology and AMPA receptor immunoreactivity in dendritic spines might also 
be altered in an analogous manner at these various timepoints (Aim 3). Finally, 
because the PrL projection to the NAc core is involved in the suppressive effect of 
BDNF on relapse when infused into the PrL cortex immediately after SA, it is likely 
that elevating neuronal activity preferentially in this pathway is sufficient to 
suppress relapse after abstinence. Additionally, cocaine-induced alterations in 
structural plasticity might be occurring in this pathway, which we hypothesized to 
be bidirectionally regulated during early withdrawal and one week of abstinence.  
Therefore, we investigated whether 1) cocaine SA-induced alterations in the 
PrL cortex during early withdrawal are mediated by the activation of STEP, 
resulting in dysfunctional glutamate transmission in the PrL to NAc core pathway, 
2) artificially elevating corticostriatal glutamatergic transmission during early 
withdrawal would suppress relapse after abstinence, and 3) these 
dephosphorylation events during withdrawal and the hyperphosphorylation of PKA 
targets following one week of abstinence are associated with changes in the 
activation state of PrL-NAc neurons and altered dendritic spine morphology 





Figure 1.3. Hypothesized alterations in glutamate signaling, gene transcription 
regulators, and structural plasticity during early withdrawal and after one week of 













Chapter 2. STEP activation in the PrL cortex mediates 
cocaine-induced ERK dephosphorylation during early 
withdrawal and plays a role in relapse after abstinence 
 
Data presented in Chapter 2 have been published in Addiction Biology (23(1):219-
229, 2018). Minor changes to the original article have been made for appropriate 
integration into this dissertation.  
 
Introduction 
Cocaine SA causes a transient dephosphorylation of critical neuronal plasticity-
related proteins in the PrL cortex of rats that leads to subsequent relapse to 
cocaine seeking, as discussed in detail in Chapter one. The dephosphorylation of 
ERK is a critical component of the cocaine-induced alterations in PrL plasticity 
occurring during early withdrawal. BDNF-mediated inhibition of cocaine seeking 
after abstinence when infused into the PrL cortex immediately after SA is blocked 
by a prior infusion of the mitogen-activated extracellular signal-regulated kinase 
inhibitor U0126 (Whitfield et al., 2011). Thus, the suppressive effect of BDNF on 
relapse is dependent on normalizing ERK dephosphorylation in the PrL cortex 
during early withdrawal. 
  A major question is how cocaine SA causes ERK dephosphorylation in the 
PrL cortex. Of several phosphatases that dephosphorylate ERK, STEP has 
emerged as a fundamental regulator of the ERK cascade in response to dopamine 
and glutamate interactions in the striatum triggered by psychostimulants 
(Lombroso et al., 1993; Valjent et al., 2005). STEP is a CNS-specific tyrosine 
phosphatase localized to dopaminoceptive neurons with high expression in the 
striatum (Lombroso et al., 1993) and moderate expression in the medial prefrontal 
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cortex (Boulanger et al., 1995). Canonically, STEP is activated by Ca2+ influx 
through GluN2B-containing NMDA receptors (Paul et al., 2003), leading to a 
calcineurin-dependent phosphatase cascade that culminates in the 
dephosphorylation and activation of STEP (Boulanger et al., 1995; Paul et al., 
2003; Goebel-Goody et al., 2012). Following activation, STEP dephosphorylates 
regulatory tyrosine residues on various substrates implicated in neuronal plasticity, 
including ERK (Paul et al., 2003; Paul and Connor, 2010), the Src family kinase, 
Fyn (Nguyen et al., 2002), GluN2A (Tian et al., 2016), and GluN2B (Braithwaite et 
al., 2006).  
STEP activity is augmented in several neuropsychiatric and 
neurodegenerative disorders. For example, STEP activity is elevated in human 
postmortem samples and in animal models of Alzheimer’s Disease (AD) (Snyder 
et al., 2005; Kurup et al., 2010), Parkinson’s Disease (Kurup et al., 2015), and 
schizophrenia (Xu et al., 2018). Moreover, inhibition of STEP with systemic 
injections of the novel, relatively selective inhibitor, TC-2153, significantly improves 
memory deficits in a mouse model of AD (Xu et al., 2014) as well as PCP-induced 
hyperlocomotion in mice (Xu et al., 2016). TC-2153 treatment reverses the 
biochemical, electrophysiological, and cognitive deficits in mouse models of 
schizophrenia and in glutamatergic neurons derived from human-induced 
pluripotent stem cells from schizophrenic patients (Xu et al., 2018). As expected, 




Regarding preclinical models of addiction, dephosphorylation events within 
the PrL cortex during early withdrawal from cocaine SA are accompanied by 
decreased phosphorylation, and thus increased activation, of STEP (Sun et al., 
2013), suggesting STEP is a likely mediator of the ERK dephosphorylation in the 
PrL cortex during early withdrawal from cocaine SA. Therefore, we investigated 
whether inhibition of STEP with an intra-PrL microinfusion of TC-2153 immediately 
following the final SA session would prevent ERK dephosphorylation in the PrL 
cortex during early withdrawal and decrease relapse to cocaine seeking. We also 
tested whether systemic injections of TC-2153 at the same time point would reduce 
relapse. Our results indicate that intra-PrL administration of TC-2153 immediately 
following the final SA session suppressed context-induced relapse and cue-, but 
not cocaine prime-, induced reinstatement. Intra-PrL TC-2153 also prevented the 
cocaine-induced ERK dephosphorylation within the PrL cortex during early 
withdrawal. However, systemic TC-2153 injections at the same time point had the 
opposite effects on cocaine-seeking. Overall, our results indicate that the cocaine-
induced activation of STEP is an important regulator of neuroadaptations occurring 
within the PrL cortex during early withdrawal that lead to subsequent cocaine 
seeking. 
Materials and Methods 
Animal subjects and surgery 
Adult male Sprague Dawley rats (n=166) Charles Rivers Laboratories; Wilmington, 
MA) were individually housed on a twelve-hour reverse light/dark cycle (lights on 
at 6AM). Upon arrival, rats were allowed at least 3 days of acclimation to the 
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vivarium. During this time, they were provided standard rat chow (Harlan; 
Indianapolis, IN) and water ad libitum. All animal use protocols were approved by 
the Institutional Animal Care and Use Committee of the Medical University of South 
Carolina and were performed according to the National Institutes of Health Guide 
for the Care and Use of Laboratory Animals (8th ed., 2011). All rats weighed 275-
325g at the time of surgery. On the day of surgery, rats were injected i.p. with a 
ketamine (66 mg/kg) and xylazine (1.33 mg/kg) mixture for anesthesia and 
ketorolac (2.0 mg/kg) for analgesia. Rats that underwent SA were implanted in the 
right jugular vein with chronic indwelling i.v. silastic catheters (Fisher Scientific; 
Hampton, NH). Catheters were attached by subcutaneous tubing to a backmount 
which exited from an incision in the back. Following catheterization, rats were 
either secured in a stereotaxic apparatus (Kopf Instruments, Tujunga, CA) or 
underwent post-operative recovery care (specified below). Following securement 
in the stereotaxic apparatus, 26-gauge bilateral stainless-steel guide cannulae 
(Plastics One, Roanoke, VA) were aimed 1 mm above the PrL cortex (+2.8mm 
anteroposterior, +/- 0.6mm mediolateral, -3.0mm dorsoventral relative to bregma). 
Guide cannulae were fixed to the skull with cranioplastic cement and anchored 
with steel screws. Following surgery, a bilateral 10 mm stylet was inserted into the 
guide cannula to prevent blockage, and rats were infused i.v. with 0.1 ml of 
cefazolin and 0.05 ml of Taurolidine-Citrate Solution (TCS; Access Technologies, 
Skokie, IL). Post-operative care was conducted for 5 days, during which rats were 





Rats were trained to self-administer cocaine on a fixed-ratio 1 schedule of 
reinforcement for 12-14 days (2 hr/day; criterion of ≥ 10 infusions/day), during 
which rats were food restricted to 20g of chow to motivate learning. SA was 
conducted in standard MedPC operant chambers which contained two retractable 
levers (Fairfax, VT), and were housed within sound-attenuating cubicles fitted with 
a fan for airflow and masking noise. Active lever presses elicited a light and tone 
cue complex followed by a 0.2 mg/50 μl infusion of cocaine hydrochloride (NIDA, 
Research Triangle Park, NC), followed by a 20 second timeout period. Yoked-
saline controls received a non-contingent infusion of 0.9% saline (with light and 
tone cues) when their cocaine partner received a contingent cocaine infusion. For 
all experiments, inactive lever presses had no programmed consequence. 
Sucrose SA was conducted in the same manner as cocaine SA experiments, 
except active lever presses were reinforced with a single 45 mg chocolate flavored 
sucrose pellet (BioServe-F07256; Flemington, NJ). 
Intracranial microinfusions  
Prior to intracranial microinfusions, rats were habituated to a different behavioral 
room equipped with an infusion pump (Harvard Apparatus) containing two gas-
tight Hamilton syringes for at least 2 days immediately following their SA sessions. 
The day prior to their microinfusions, a stylet extending 1 mm past the tip of the 
guide cannula was inserted. Immediately following their final SA session, rats were 
infused (0.5 μl/hemisphere, 0.25 μl/minute) with either vehicle (0.01% DMSO in 
filtered 0.1M PBS) or a 1 μM concentration of TC-2153. Injectors (33 gauge) were 
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left in place for 1 minute after infusions to facilitate diffusion. Following 
microinfusions, rats were either returned to the vivarium for 6 days of homecage 
abstinence or were rapidly decapitated two hours later for phospho-protein 
analysis. 
Systemic injections 
TC-2153 (2.0 mg/ml) was dissolved in 18% DMSO/2% Tween-20 in filtered 0.1M 
PBS, and rats were injected (i.p.) 2.5X body weight to achieve a final dose of 5 
mg/kg, immediately after the final SA session. Six and 10 mg/kg have been shown 
to increase p-ERK in mice in vivo (Xu et al., 2014; Xu et al., 2016). However, due 
to solubility restrictions (4 mg/ml did not stay in solution in our hands), we tested 
only 5 mg/kg. Following injections, rats were returned to the vivarium for 6 days of 
homecage abstinence. 
Post-abstinence relapse test, extinction, cue- and cocaine prime-induced 
reinstatement 
 
Following abstinence, rats underwent a post-abstinence (PA) relapse test under 
extinction conditions (active lever presses had no programmed consequence). 
After at least 6 days (no more than 21 days) of further extinction training to a 
criterion of an average of ≤15 presses on the active lever over the last 3 days, rats 
underwent a 2-hour cue-induced reinstatement test. During this test, active lever 
presses elicited the cocaine-associated cue complex, but no infusion. Following 
further extinction, rats underwent a 2-hour cocaine prime-induced reinstatement 
test (10 mg/kg, i.p.) under extinction conditions. Following the cocaine prime test, 





Following decapitation, brains were extracted, rapidly frozen in isopentane, and 
stored at -80°C. Brains were either coronally sectioned (40 μM) with a cryostat and 
Nissl-stained to confirm cannula placements, or a single 3mm wide X 2mm deep 
tissue punch through the dorsomedial PFC (AP +~4.68–2.76) was taken using a 
modified biopsy punch (Braintree Scientific; Braintree, MA), and stored at -80°C 
until processing. Cannula placements were confirmed during dissection. 
Tissue processing 
Tissue processing was performed as previously described (Sun et al. 2013). 
Briefly, 115 μl of ice-cold RIPA buffer (in mM: 50 Tris-HCL, pH 7.4, 150 NaCl, 2 
EDTA, pH 7.4, and 10% Glycerol, 1% Triton X, 1% NP-40, and 1% Sodium 
Deoxycholate) with a complete set of protease and phosphatase inhibitors, was 
added to each punch. Punches were briefly sonicated, incubated in ice-cold buffer 
for 30 minutes, centrifuged at 10,000 x g for 20 minutes at 4°C, and the supernatant 
was used for all analyses. Protein concentrations were determined using a 
standard BCA assay. Lysates were then diluted to 2 μg/μl in 0.1X Sample Buffer 
(Protein Simple; San Jose, CA) and individually aliquoted. 
Wes™ immunoassay 
The Wes™ capillary electrophoresis system (Protein Simple, Bio-Techne, San 
Jose, CA) was used for protein quantification. Aliquots of lysates (2 μg/μl) were 
thawed and further diluted in 0.1X Sample Buffer to 0.8 μg/μl for analysis of p-ERK 
and 0.4 μg/μl for analysis of t-ERK using a combination of ¾ 0.1x Sample Buffer 
and ¼ 4X Master Mix (1:1 mix of 40 mM DTT and 10X Sample Buffer, Protein 
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Simple, San Jose, CA) according to the manufacturer’s instructions. Samples were 
denatured at 95°C for 5 minutes. A rabbit primary antibody against p-ERK1/2 (1:50, 
Cell Signaling Technology-9101S RRID:AB_331646) was multiplexed with a 
primary antibody against calnexin (Enzo life sciences-ADI-SPA-860-F 
RRID:AB_11178981) at a concentration of 1:2000. A rabbit primary antibody 
against t-ERK1/2 (1:100, Cell Signaling Technology-9102S RRID:AB_10695746) 
was multiplexed with 1:1000 calnexin. Supplier anti-rabbit secondary antibodies 
were used as instructed (Protein Simple, San Jose, CA). 
Each plate contained samples from all experimental groups, and both p-
ERK2 and t-ERK2 were analyzed for each sample from the same aliquot. Analysis 
of electropherogram peaks was performed using Compass™ software (Protein 
Simple) using the Gaussian distribution of the Area Under the Curve (AUC) of the 
peak luminol-peroxidase signal in the capillaries. Analysis was done by dividing 
the AUC of p-ERK2 by t-ERK2. Data are expressed as a fold change relative to 
the respective controls.  
Experimental design 
Figure 2.1 shows the timeline for all experimental procedures conducted. 
Experiment 1 was conducted to determine the optimum concentration of TC-2153 
that increased p-ERK when microinfused into the PrL cortex. Rats received a 
single intra-PrL microinfusion of vehicle or TC-2153 (0.5, 1, or 5 μM) and were 
rapidly decapitated two hours later. These concentrations were chosen based on 
previous work showing that treatment of cortical cultures with concentrations of 
TC-2153 ranging from 1-5 μM increased p-ERK (Xu et al., 2014). The time point 
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was chosen because the cocaine-induced dephosphorylation of ERK in the PrL 
cortex occurring two hours after the end of SA is necessary for subsequent cocaine 
seeking because normalizing ERK dephosphorylation with a single intra-PrL BDNF 
infusion suppresses cocaine seeking (Whitfield et al., 2011).  
Experiment 2 was designed to determine whether an intra-PrL 
microinfusion of TC-2153 immediately following the final SA session would 
suppress relapse after abstinence and extinction. Rats were either microinfused 
with vehicle or the optimal concentration of TC-2153 (1 μM) from Experiment 1 
immediately following the final of 12-14 cocaine SA sessions. Following 6 days of 
forced abstinence, rats underwent a PA context-induced relapse test, further 
extinction, a cue-induced reinstatement test, further extinction, and a cocaine 
prime-induced reinstatement test. In Experiment 3, rats either underwent cocaine 
SA or received yoked-saline infusions and received either an intra-PrL 
microinfusion of TC-2153 (1 μM) or vehicle immediately after the final SA session. 
Rats were rapidly decapitated two hours later to determine the effect of TC-2153 
on the cocaine-induced ERK dephosphorylation within the PrL cortex during early 
withdrawal. Experiment 4 was conducted in the same manner as Experiment 2, 
except active lever presses were reinforced with chocolate sucrose pellets instead 
of cocaine infusions and there was no sucrose-primed test. The design of 
Experiment 5 was similar to Experiment 2, except rats received a systemic 





Figure 2.1. Schematic of the experimental timelines for all experiments. Final 
sample sizes: Experiment 1-(0 μM: n=5, 0.5 μM: n=7, 1 μM: n=6, 5 μM: n=7); 
Experiment 2- (TC-2153 (1μM): n=9, vehicle: n=13); Experiment 3- 
(Saline+Vehicle: n=10, Saline+TC-2153: n=7, Cocaine+Vehicle: n=8, 
Cocaine+TC-2153: n=9); Experiment 4- (TC-2153 (1 μM): n=7, Vehicle: n=4); 




All analyses were performed using GraphPad Prism 7 software (La Jolla, CA). All 
behavioral data were analyzed with a mixed-model ANOVA with time 
(SA/extinction versus PA/Cue/cocaine prime test) as the within-subject variable 
and treatment (TC-2153 versus Vehicle) as the between-subject variable. If 
significant main effects or an interaction was observed, Bonferroni-corrected 
pairwise comparisons were used to compare groups during and across time points. 
Grubbs’ test was used to determine statistical outliers and these were removed 
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from final analyses (n=4). Data in Experiment 1 were analyzed with a one-way 
ANOVA followed by Dunnett’s multiple comparison test to compare all TC-2153 
concentrations to the vehicle control group. Data in Experiment 3 were analyzed 
with a two-way ANOVA followed by Student-Neuman-Keuls pairwise comparison 
tests. All data are expressed as the mean +/- SEM, and statistically significant 




Cannula placements for experiments 2 and 4 are shown in Figure 2.2. Circles 
indicate the region of the PrL cortex dissected for subsequent phospho-protein 
analyses in experiments 1 and 3. Cannula placements were deemed suitable if the 
tip of the cannula was located within the ventral tier of the anterior cingulate cortex 
or within the PrL cortex, but not in the infralimbic cortex. Additionally, the most 
ventral portion of the cannula had to be between AP +4.20 – AP +2.76 mm from 
Bregma. As shown in Figure 2.2, most cannula placements were tightly focused 
























Figure 2.2. Map of coronal sections through the PFC showing all cannula 
placements for experiments 2 and 4. The circled regions correspond to areas 
where tissue punches were taken for experiments 1 and 3 (AP ~+4.68mm-
+2.76mm relative to bregma). 
 
Experiment 1. Intra-PrL microinfusion of TC-2153 increased p-ERK in naïve 
rats 
 
Naïve rats (n=32; n=8/group) received a bilateral intra-PrL microinfusion of vehicle 
or one of three concentrations of TC-2153 (0.5, 1, or 5 μM). Rats were rapidly 
decapitated two hours after the infusion to determine the optimal concentration of 
TC-2153 that increased p-ERK in the PrL cortex in vivo. Of the 32 rats initially 
used, 2 died after surgery and 4 brain samples were incorrectly punched. One 
sample was not analyzed due to lysate discoloration. 
A one-way ANOVA indicated a significant effect of intra-PrL TC-2153 on p-
ERK (F(3,21)=3.21, p<0.05). Dunnett’s multiple comparison test indicated that only 
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the 1 μM concentration of TC-2153 significantly increased p-ERK relative to vehicle 
controls (p=0.04; Fig. 2.3A,C). There was no effect of TC-2153 on t-ERK 
normalized to calnexin (F(3,21)=0.08, p>0.05; Fig. 2.3B,D). Thus, for all future 




Figure 2.3. A single intra-PrL microinfusion of TC-2153 (1 μM) increased p-ERK 
in naïve rats. Rats were infused with vehicle (0) or 0.5, 1, or 5 μM of TC-2153 and 
rapidly decapitated two hours later to determine the optimal concentration of TC-
2153 that increased p-ERK when microinfused into the PrL cortex. A. Only 1 μM 
TC-2153 increased p-ERK relative to vehicle-infused rats (*p<0.05). B. There was 
no difference in t-ERK/calnexin. Representative chemiluminescent peaks for p-







Experiment 2. Intra-PrL microinfusion of TC-2153 suppressed context-
induced relapse and cue-, but not cocaine prime-, induced reinstatement. 
 
We next investigated the effect of a bilateral intra-PrL microinfusion of TC-2153 (1 
μM) immediately following SA on context-induced relapse following abstinence, 
cue-, and cocaine prime-, induced reinstatement following extinction. Two rats died 
during surgery, 5 rats died before finishing SA, 11 rats were removed from the final 
analysis due to cannula placements outside of the PrL cortex, and 2 rats were 
outliers according to Grubbs’ test during the cue and cocaine prime test in the TC-
2153 and vehicle group, respectively. Final group sizes were: n=13 (vehicle) and 
n=9 (TC-2153). Figure 2.4A shows SA data for both groups. When analyzing active 
lever presses during the final 10 days of SA, results revealed a significant main 
effect of time (F(9,180)=2.37, p<0.05). However, there was no significant main effect 
of treatment (F(1,20)=0.46, p>0.05) nor a significant treatment by time interaction 
(F(9,180)=0.74, p>0.05). When analyzing inactive lever presses, results revealed 
there was no significant main effect of time (F(9,180)=0.69, p>0.05), treatment 
(F(1,20)=0.00008, p>0.05), nor a significant treatment by time interaction 
(F(9,180)=1.35, p>0.05). When analyzing infusions, results revealed a significant 
main effect of time (F(9,180)=4.48 p<0.0001), but no significant main effect of 
treatment (F(9,180)=2.78, p>0.05), nor a significant treatment by time interaction 
(F(9,180)=0.39, p>0.05). Thus, there was no difference between groups regarding 
active lever presses, inactive lever presses, or infusions during the final 10 days 
of SA. However, both groups showed elevated responding on the active, but not 
inactive, lever as well as increased infusions earned over the course of SA.   
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After their respective intracranial infusions, rats were exposed to 6 days of 
abstinence followed by a PA test. Results revealed a significant main effect of time 
(F(1,20)=6.09,  p<0.05) and treatment (F(1,20)=8.53, p<0.01), but no treatment by time 
interaction (F(1,20)=3.30, p>0.05) for active lever presses. Bonferroni-corrected 
pairwise comparisons indicated that active lever presses were similar between 
groups during the last 3 days of SA before microinfusions (p>0.05). Rats infused 
with vehicle (p<0.01), but not TC-2153 (p>0.05), pressed the active lever 
significantly more during the PA test than during the last 3 days of SA and rats 
infused with TC-2153 pressed the active lever during the PA test significantly less 
than vehicle-infused controls (p<0.01; Fig. 2.4B). For inactive lever presses, there 
was a significant main effect of time (F(1,20)=23.17, p<0.0001), but no significant 
main effect of treatment (F(1,20)=3.62, p>0.05), nor a significant treatment by time 
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interaction (F(1,20)=1.77, p>0.05). Thus, both groups showed elevated inactive lever 
pressing during the PA test relative to the last 3 days of SA. 
Figure 2.4. A single intra-PrL TC-2153 microinfusion immediately following the 
final SA session suppressed cocaine seeking following abstinence and extinction 
training. Rats were either infused in the PrL cortex with TC-2153 (1 μM) or vehicle 
immediately following the final SA session. A. SA data for rats in experiment 2. B-
D. TC-2153 suppressed active lever pressing during (B) the PA test following 
abstinence as well as (C) during the cue-induced reinstatement test after 
extinction, but not (D) the cocaine prime-induced reinstatement test (++p<0.01, 
++++p<0.0001 compared to the last 3 days of SA/extinction; **p<0.01, ***p<0.001 
compared to vehicle). 
 
After completion of extinction, rats underwent a cue-induced reinstatement 
test. For active lever presses, there was a significant main effect of time 
(F(1,20)=88.67, p<0.0001) and treatment (F(1,20)=8.82, p<0.01), as well as a 
significant treatment by time interaction (F(1,20)=9.80, p<0.01; Fig. 2.4C). 
Bonferroni-corrected pairwise comparisons indicated that active lever pressing 
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over the last 3 days of extinction did not differ between groups (p>0.05). Both 
vehicle- (p<0.0001) and TC-2153- (p<0.01) infused rats pressed the active lever 
significantly more during the cue test than during the last 3 days of extinction and 
rats infused with TC -2153 pressed the active lever significantly less than vehicle-
infused rats (p<0.001). For inactive lever presses, there was no significant main 
effect of treatment (F(1,20)=1.56, p>0.05), time (F(1,20)=1.47, p>0.05), not a 
significant treatment by time interaction (F(1,20)=0.007, p>0.05).  
Following re-extinction to criterion, rats underwent a cocaine prime-induced 
reinstatement test (Fig. 2.4D). One rat removed its headcap prior to the cocaine 
prime test and was excluded from the analysis. For active lever presses, there was 
a significant main effect of time (F(1,19)=54.86, p<0.0001), indicating that both 
groups had increased active lever pressing during the cocaine prime-induced 
reinstatement test relative to the last 3 days of extinction. However there was no 
significant main effect of treatment (F(1,19)=1.857, p>0.05) or a significant treatment 
by time interaction (F(1,19)=0.33, p>0.05). For inactive lever presses, there was no 
significant main effect of treatment (F(1,19)=2.20, p>0.05), time (F(1,19)=0.51, 
p>0.05), nor a significant treatment by time interaction (F(1,19)=0.16, p>0.05). These 
results show that a single intra-PrL microinfusion of TC-2153 immediately following 
SA suppresses cocaine seeking in the PA and cue-, but not cocaine prime-, 







Experiment 3. Intra-PrL microinfusion of TC-2153 prevented the cocaine-
induced ERK dephosphorylation within the PrL cortex during early 
withdrawal 
 
To determine the effect of STEP inhibition on the cocaine-induced ERK 
dephosphorylation within the PrL cortex during early withdrawal, rats (n=48) were 
randomly assigned to either cocaine SA or yoked-saline groups following surgery. 
One rat was removed prior to the end of SA after a catheter failure. Immediately 
following the final of 12-14 cocaine/yoked saline SA sessions, the PrL cortex of 
rats was microinfused bilaterally with TC-2153 or vehicle and rapidly decapitated 
two hours after the infusion. Of the remaining 47 rats, 13 were excluded from 
analyses for the following reasons: cannula placements that were outside of the 
PrL cortex (n=6), catheter failure on the final day of SA (n=1), or tissue samples 
were punched incorrectly (n=6). Following exclusion, final group sizes were as 
follows: Saline+Vehicle (n=10), Saline+TC-2153 (n=7), Cocaine+Vehicle (n=8), 
Cocaine+TC-2153 (n=9). 
Figure 2.5A shows the SA data for cocaine self-administering rats and 
yoked saline controls. A two-way repeated measures ANOVA revealed a 
significant main effect of SA (cocaine versus yoked saline) for active lever presses 
(F(1,32)=92.34, p<0.05). Bonferroni-corrected pairwise comparison test indicates 
that cocaine self-administering animals pressed the active lever significantly more 
than yoked saline controls during sessions 1-10 (p<0.0001). Moreover, cocaine 
SA rats receiving vehicle microinfusions were not significantly different than 
cocaine SA rats receiving TC-2153 microinfusions when analyzing average active 
lever presses during the last 3 days of SA (t(15)=0.006, p>0.05) or average infusions 
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earned over the last 3 days of SA (t(15)=0.11, p>0.05; Fig. 2.5B). A two-way ANOVA 
revealed a significant main effect of treatment (TC-2153 versus vehicle) as well as 
SA (cocaine versus saline) on p-ERK (Treatment: F(1,30)=14.84, p<0.001, SA: 
F(1,30)=10.28, p<0.01), but no significant treatment by SA interaction (F(1,30)=0.08, 
p>0.05). Student-Neuman-Keuls tests revealed that p-ERK levels were 
significantly lower in the cocaine + vehicle group versus the yoked-saline + vehicle 
group. TC-2153 significantly increased p-ERK in yoked-saline rats (p<0.05; Fig. 
2.5C,E) and prevented the cocaine SA-induced decrease. There was no effect of 
treatment, SA, or a significant treatment by SA interaction on t-ERK/calnexin 
(Treatment: F(1,30)=2.28, p>0.05, SA: F(1,30)=2.43, p>0.05, treatment by SA: 
F(1,30)=3.12, p>0.05; Fig. 2.5D,F). These results indicate that intra-PrL TC-2153 
infused immediately following the final SA session prevented the cocaine-induced 













Figure 2.5. Intra-PrL TC-2153 normalizes the cocaine-induced decrease in p-
ERK2 within the PrL cortex during early withdrawal. A. SA data for cocaine (n=17) 
and yoked saline (n=17) rats. Cocaine SA rats pressed the active lever significantly 
more than yoked saline controls (^^^^p<0.0001) B. Cocaine self-administering rats 
infused with vehicle or TC-2153 were equal regarding active lever presses over 
the last 3 days of SA as well as average infusions earned.  C. Rats microinfused 
with vehicle immediately following the final cocaine SA session show decreased 
p-ERK relative to yoked-saline rats infused with vehicle. This decrease is 
prevented in rats that received a TC-2153 microinfusion immediately following 
cocaine SA. Additionally, yoked-saline rats microinfused with TC-2153 showed 
augmented p-ERK compared to saline-vehicle rats (*p<0.05 compared to Saline-
Vehicle, +p<0.05 compared to Cocaine-Vehicle). D. There were no differences 
between groups in t-ERK/calnexin. E-F. Representative chemiluminescent peaks 




Experiment 4. Intra-PrL microinfusion of TC-2153 did not affect context-
induced relapse or cue-induced reinstatement of sucrose seeking 
 
To determine whether the suppressive effect of intra-PrL infusion of TC-2153 on 
relapse was cocaine-specific, rats (n=16) underwent 12-14 days of sucrose SA 
and were microinfused with either TC-2153 or vehicle immediately following the 
final SA session. One rat died after surgery and 3 rats removed their headcaps 
prior to the PA test. Of the remaining 12 rats, one was removed from analysis 
because its cannula placement was outside of the PrL cortex. Figure 2.6A shows 
sucrose SA data for all final rats included in this experiment. When active lever 
presses were analyzed, a two-way repeated-measures ANOVA revealed a 
significant main effect of time (F(9,81)=4.26, p<0.0001), but no significant main effect 
of treatment (F(1,9)=0.63, p>0.05), nor a significant treatment by time interaction 
(F(9,81)=0.89, p>0.05). For pellets earned, a two-way repeated-measures ANOVA 
indicated a significant main effect of time (F(9,81)=6.24, p<0.05), but no significant 
main effect of treatment (F(1,9)=0.99, p>0.05) nor a significant treatment by time 
interaction (F(9,81)=0.89, p>0.05). Following infusions, rats underwent 6 days of 
forced abstinence followed by a PA test. For active lever presses, a two-way 
ANOVA revealed a significant main effect of time (F(1,9)=35.69, p<0.001; Fig. 2.6B), 
but no main effect of treatment (F(1,9)=0.00005, p>0.05) or a significant treatment 
by time interaction (F(1,9)=0.01, p>0.05), indicating that both groups had reduced 
active lever pressing during the PA test relative to the last 3 days of sucrose SA. 
For inactive lever presses, there was no significant main effect of treatment 
(F(1,9)=1.09, p>0.05), time (F(1,9)=1.14, p>0.05), nor a significant treatment by time 
interaction (F(1,9)=2.44, p>0.05). Following further extinction to criterion, rats 
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underwent a cue-induced reinstatement test. When analyzing active lever presses, 
results indicated a significant main effect of time (F(1,9)=37.79, p<0.001; Fig. 2.6C), 
but not treatment (F(1,9)=0.31, p>0.05) or a significant treatment by time interaction 
(F(1,9)=1.08, p>0.05). For inactive lever presses, there was no significant main 
effect of treatment (F(1,9)=0.79, p>0.05), time (F(1,9)=0.51, p>0.05), nor a significant 
treatment by time interaction (F(1,9)=0.47, p>0.05).  These data indicate that both 
groups had increased active lever pressing during the cue-induced reinstatement 
test relative to the last 3 days of extinction, which was not altered by a prior TC-
2153 microinfusion.  
Figure 2.6. A single intra-PrL microinfusion of TC-2153 fails to suppress sucrose 
seeking after abstinence and extinction. A. Sucrose SA data for all rats in 
experiment 4. B-C, Animals microinfused with TC-2153 or vehicle show equal 
responding on the active lever during the PA test (B) as well as (C) during the cue-
induced reinstatement test, but both groups had reduced responding during the 
PA test relative to the last 3 days of SA and increased responding during the cue 
test relative to the last 3 days of extinction (***p<0.001 compared to the last 3 days 
of SA or extinction, two-way ANOVA). 
 
Experiment 5. A systemic injection of TC-2153 preferentially suppressed 
cocaine prime-induced reinstatement 
 
Previous findings indicate systemic TC-2153 is able to alter ERK2 phosphorylation 
in the mPFC in vivo (Xu et al., 2014). To test the ability of TC-2153 to induce p-
ERK2 in the PrL cortex two hours after injection, naïve rats were either injected 
with vehicle or TC-2153 (5 mg/kg, i.p., n=4/group) and rapidly decapitated two 
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hours later. A two-tailed t-test showed that rats injected with TC-2153 had 
significantly higher p-ERK2 relative to tERK2 in the PrL cortex two hours after 
injection (t(6)=2.81, p<0.05, Fig. 2.7A). There was no difference in tERK2 
normalized to Calnexin between groups (t(6)=0.62, p>0.05, Fig. 2.7B).  To 
determine the effect of systemic administration of TC-2153 on relapse, rats (n=28) 
underwent cocaine SA for 12-14 days as above. Three rats became ill and were 
euthanized prior to the end of SA. Two rats were removed for catheter failure prior 
to finishing SA. One rat per group was an outlier according to Grubbs’ test in the 
cocaine prime test and was removed from all analyses. The remaining rats were 
injected i.p. with TC-2153 (5 mg/kg, n=10) or vehicle (n=11) immediately following 
the last of 12-14 cocaine SA sessions. Figure 2.7C shows SA data for all rats in 
this experiment. When comparing active lever presses between vehicle versus TC-
2153 injected rats, a two-way repeated-measures ANOVA indicated there was no 
significant main effect of time (F(9,171)=1.27, p>0.05), treatment (F(1,19)=0.33, 
p>0.05), nor a significant treatment by time interaction (F(9,171)=1.61, p>0.05). For 
inactive lever presses, there was no significant main effect of time (F(9,171)=0.92, 
p>0.05), treatment (F(1,19)=3.75, p>0.05), nor a significant treatment by time 
interaction (F(9,171)=0.82, p>0.05). For infusions, there was a significant main effect 
of time (F(9,171)=7.64, p<0.0001), but not treatment (F(1,19)=0.13, p>0.05), nor a 
significant treatment by time interaction (F(9,11)=1.41, p>0.05). Thus, there was no 
difference between groups for active lever presses, inactive lever presses, nor 
infusions earned during SA. However, both groups had increased infusions as a 
function of SA time.  Following 6 days of abstinence, rats were returned to their SA 
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chambers for the PA test. For active lever presses, a two-way ANOVA revealed a 
significant main effect of time (F(1,19)=23.10, p<0.001; Fig. 2.7D), indicating that 
both groups had increased active lever pressing in the PA test relative to the last 
3 days of SA, but there was no significant main effect of treatment (F(1,19)=0.18, 
p>0.05) or a significant treatment by time interaction (F(1,19)=0.003, p>0.05). There 
was a significant main effect of time (F(1,19)=51.78, p<0.05), but no significant main 
effect of treatment (F(1,19)=3.82, p>0.05), nor a significant treatment by time 
interaction (F(1,19)=2.15, p>0.05) when analyzing inactive lever presses. 
Following completion of extinction, rats underwent a cue-induced 
reinstatement test. For active lever presses, results showed a significant main 
effect of time (F(1,19)=110.50, p<0.0001; Fig. 2.7E), indicating that both groups 
pressed the active lever significantly more during the cue-induced reinstatement 
test compared to the last 3 days of extinction, but there was no main effect of 
treatment (F(1,19)=2.50, p=0.13) or a treatment by time interaction (F(1,19)=2.38, 
p>0.05). When analyzing inactive lever presses, there was no significant main 
effect of treatment (F(1,19)=2.21, p>0.05), time (F(1,19)=1.59, p>0.05), nor a 
significant treatment by time interaction (F(1,19)=0.11, p>0.05). 
Following re-extinction to criterion, rats underwent a cocaine prime-induced 
reinstatement test. When analyzing active lever presses, there were significant 
main effects of time (F(1,19)=42.66, p<0.0001), treatment (F(1,19)=7.065, p<0.05), as 
well as a significant treatment by time interaction (F(1,19)=8.26, p<0.01; Fig. 2.7F). 
Bonferroni-corrected pairwise comparisons indicated that active lever presses 
were equal between groups over the last 3 days of extinction (p>0.05), but rats 
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injected with TC-2153 pressed the active lever significantly less than vehicle-
injected rats during the cocaine prime test (p<0.001). For inactive lever presses, 
there was no significant main effect of time (F(1,19)=0.0005, p>0.05), treatment 
(F(1,19)=0.74, p>0.05), nor a significant treatment by time interaction (F(1,19)=3.22, 
p>0.05).  Collectively, these data indicate that injections of TC-2153 immediately 










Figure 2.7. Systemic injection of TC-2153 suppressed cocaine prime-induced 
reinstatement but not post-abstinence context-induced relapse or cue-induced 
reinstatement. A-B. A single systemic injection of TC-2153 (5 mg/kg, i.p.) 
increased PrL cortical p-ERK2 (A) two hours after injection in naïve rats, without 
affecting tERK2 (B) (n=4/group). C. SA data for all rats in experiment 5. D-F. Rats 
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were either injected with TC-2153 (5 mg/kg, i.p.) or vehicle immediately following 
the final cocaine SA session. Both groups had increased active lever pressing 
during (D) the PA test following 6 days of forced abstinence as well as (E) during 
the cue-induced reinstatement test following extinction. There was no effect of TC-
2153 on active lever pressing in either test. However, TC-2153 injections 
suppressed (F) cocaine prime-induced reinstatement (++++p<0.0001, 
+++p<0.001, +p<0.05 compared to the last 3 days of SA/extinction, *p<0.05, 
***p<0.001 compared to vehicle). 
 
Discussion 
Summary of findings 
The results of the current experiments are the first to show that the cocaine-
induced activation of STEP in the PrL cortex during early withdrawal from cocaine 
SA (Sun et al., 2013) plays a significant role in relapse. Interestingly, we found that 
an intra-PrL TC-2153 microinfusion immediately after SA suppressed context-
induced relapse and cue-, but not cocaine prime-, induced reinstatement. 
However, systemic TC-2153 injections had the opposite effect. Additionally, intra-
PrL TC-2153 prevented the cocaine-induced ERK dephosphorylation in the PrL 
cortex during early withdrawal. These results corroborate previous findings that 
early withdrawal from cocaine SA is a critical time point whereby an intervention, 
like an infusion of BDNF or TC-2153, that normalizes ERK and/or GluN2 signaling 
in the PrL cortex produces an enduring suppression of relapse (Whitfield et al., 
2011; Go et al., 2016). This finding coupled with the finding that BDNF does not 
alter food seeking (Berglind et al., 2007), and TC-2153 does not alter sucrose 
seeking, indicates that intra-PrL interventions during early withdrawal selectively 





Differential effect of systemic vs. intra-PrL TC-2153 on cocaine seeking  
Recent studies indicate that systemic delivery of TC-2153 normalizes 
cognitive/behavioral dysfunction in animal models of disorders with augmented 
STEP activity (Xu et al., 2014; Xu et al., 2016; Xu et al., 2018). However, our 
experiments are the first to microinfuse TC-2153 and we found that systemic 
versus intra-PrL TC-2153 differentially suppressed cocaine seeking. Several 
potential explanations exist for these observed differences.  
The lack of effect of systemic TC-2153 on context-induced relapse and cue-
induced reinstatement could be due to the inability of 5 mg/kg TC-2153 to prevent 
the dephosphorylation of ERK within the PrL cortex during early withdrawal from 
cocaine SA. However, this is unlikely because 5 mg/kg TC-2153 increased p-ERK 
within the PrL cortex two hours after an injection in naïve rats. STEP is heavily-
enriched in other regions, such as the striatum and hippocampus (Boulanger et 
al., 1995) thus it is likely that systemic TC-2153 also increases p-ERK in these 
regions, as previously reported for the hippocampus (Xu et al., 2014). Furthermore, 
intra-PrL TC-2153 also increased p-ERK acutely in naïve rats, but, unlike systemic 
TC-2153, prevented context-induced relapse as well as cue-induced reinstatement 
after extinction when infused immediately after SA. Thus, we hypothesize that the 
inability of systemic TC-2153 to suppress context- and cue-induced cocaine 
seeking is likely due to the inhibition of STEP in other brain regions, in addition to 
the PrL cortex, during early withdrawal, and that one or more of these regions may 
underlie the preferential inhibition of cocaine prime-induced reinstatement. 
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The striatum, including the NAc core, is heavily-enriched in both major 
isoforms of STEP, STEP46 and STEP61 (Lombroso et al., 1993; Sharma et al., 
1995). However, only STEP61 is expressed in the PFC. Furthermore, STEP46 has 
greater enzymatic activity than STEP61 (Boulanger et al., 1995), and TC-2153 has 
~1.75 higher affinity for STEP46 than STEP61 (Xu et al., 2014). Acute cocaine has 
been shown to increase p-ERK in the NAc core by inactivating STEP46, which 
requires concomitant activation of dopamine D1 and NMDA receptors (Paul et al., 
2000; Valjent et al., 2005; Girault et al., 2007). By extension, cocaine prime-
induced reinstatement is thought to require the integration of dopamine and 
glutamate inputs in the NAc core from the VTA and PrL cortex, respectively (Shen 
et al., 2014a), and is associated with increased extracellular dopamine and 
glutamate in the NAc core (McFarland et al., 2003), suggesting that a priming 
injection of cocaine likely increases p-ERK by inactivating STEP46 in the NAc core. 
The differential expression pattern and function of STEP46 and STEP61 in the PrL 
cortex and NAc core, and the role of dopamine and glutamate interactions in the 
NAc core in regulating STEP and cocaine prime-induced reinstatement, suggest 
that systemic TC-2153 may preferentially suppress cocaine prime-induced 
reinstatement by inhibiting STEP in the NAc core during early withdrawal, which 
future experiments should investigate. 
Intra-PrL TC-2153 prevented the cocaine-induced ERK dephosphorylation 
during early withdrawal 
 
The results of the current study agree with previous studies indicating that cocaine 
SA decreases p-ERK in the PrL cortex during early withdrawal (Whitfield et al., 
2011; Go et al., 2016). Consistent with our hypothesis, we show here that this 
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effect was prevented by intra-PrL microinfusions of TC-2153. ERK is central to 
neuroadaptations occurring within neural circuits that mediate drug seeking (Lu et 
al., 2006; Zhai et al., 2008). Therefore, it is not surprising that time-course 
experiments indicate that p-ERK changes dynamically within the PFC during 
various stages of abstinence from cocaine SA (Whitfield et al., 2011; Miszkiel et 
al., 2014). For example, cocaine-mediated decreases in p-ERK in the PrL cortex 
two hours after SA normalize by 22 hours and remain unaltered after six days of 
abstinence (Whitfield et al., 2011). Importantly, intra-PrL infusion of BDNF is 
unable to suppress relapse when microinfused after six days of forced abstinence 
(Berglind et al., 2007). However, the suppressive effect of BDNF on cocaine 
seeking when it is microinfused immediately after SA depends on normalizing p-
ERK during early withdrawal (Whitfield et al., 2011).  
Potential mechanism of STEP activation during early withdrawal 
STEP has been shown to be dephosphorylated and activated by Ca2+ influx 
through GluN2B-containing NMDA receptors via a PP2B-PP1 dependent 
mechanism in corticostriatal cultures (Paul et al., 2003). Moreover, extrasynaptic 
NMDA receptor stimulation inactivates ERK in cultured hippocampal and cortical 
neurons (Kim et al., 2005; Ivanov et al., 2006; Leveille et al., 2008) whereas 
synaptic NMDA receptor stimulation leads to STEP ubiquitination, facilitating 
sustained ERK activation (Hardingham et al., 2001; Hardingham et al., 2002; Xu 
et al., 2009). Thus, an attractive hypothesis is that a hyperglutamatergic tone 
arises in the PrL cortex after chronic SA which facilitates extrasynaptic NMDA 
receptor stimulation, and subsequent activation of STEP, inhibiting NMDA function 
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and associated ERK signaling during early withdrawal. In support, not only does 
cocaine SA lead to the dephosphorylation of ERK and CREB, but also GluN2AY1325 
and GluN2BY1472 (Go et al., 2016), and STEP dephosphorylates GluN2BY1472 
(Braithwaite et al., 2006).  
TC-2153 also enhances GluN2A pan-tyrosine phosphorylation in 
hippocampal cultures. Interestingly, STEP-/- mice have increased GluN2A pan-
tyrosine, but not GluN2AY1325, phosphorylation (Tian et al., 2016) suggesting a 
different tyrosine site in GluN2A may be dephosphorylated by STEP. However, 
STEP may indirectly dephosphorylate GluN2AY1325 via dephosphorylation and 
inactivation of Fyn as demonstrated in vitro (Nguyen et al., 2002). Thus, future 
experiments should investigate whether TC-2153 prevents the cocaine-induced 
GluN2A/B dephosphorylation. Furthermore, an intra-PrL microinfusion of Ro-25-
6981, a selective GluN2B antagonist, immediately after SA does not reduce 
relapse (Go et al., 2016). However, treatment of cortical cultures with memantine, 
a non-selective NMDA antagonist, preferentially blocks extrasynaptic NMDA 
receptors (Leveille et al., 2008), suggesting that preferential inhibition of 
extrasynaptic GluN2B-containing NMDA receptors may prevent the cocaine-
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induced activation of STEP, ERK dephosphorylation, and subsequent cocaine 
seeking (Figure 2.8).  
 
Figure 2.8 Cocaine SA-induced activation of STEP in the PrL cortex during early 
withdrawal may rely on increased activation of extrasynaptic NMDA receptors due 
to glutamate overflow. 
 
Conclusions  
ERK dephosphorylation in the PrL cortex during early withdrawal represents a 
critical neuroadaptation that promotes relapse. Normalizing p-ERK with a single 
intra-PrL BDNF (Whitfield et al., 2011) or TC-2153 microinfusion immediately after 
cocaine SA suppresses cocaine seeking. Although BDNF and TC-2153 have a 
similar effect on cocaine seeking, they are likely producing this effect in different 
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ways. Intra-PrL BDNF immediately after SA is likely acting upstream of STEP by 
directly increasing activity of MEK signaling during early withdrawal (Whitfield et 
al., 2011), as well as potentially inducing the degradation of STEP (Saavedra et 
al., 2016). However, TC-2153 acts only at the level of STEP to prevent the catalytic 
activity of STEP following activation (Xu et al., 2014). Both interventions culminate 
in normalized p-ERK, highlighting the importance of ERK dephosphorylation as a 
neuroadaptation occurring in the PrL cortex during early withdrawal that leads to 
cocaine seeking. In conclusion, our results reveal a key role of STEP activation in 
the PrL cortex in regulating cocaine seeking, as well as associated adaptations in 


























Chapter 3: The effect of chemogenetic activation of the 
PrL cortex and PrL-NAc core pathway on relapse to 




Relapse is thought to arise from dysfunctional medial prefrontal cortex-dependent 
regulation of subcortical basal ganglia structures (Quintero, 2013). Specifically, 
cocaine-induced alterations in the glutamatergic projection arising from the PrL 
cortex innervating the NAc core has been implicated in the initiation of drug 
seeking following presentation of cocaine-conditioned contexts, cues, or a priming 
injection after abstinence or extinction (Kalivas, 2009). Moreover, the development 
of cocaine addiction is thought to occur through distinct stages of altered 
neuroplasticity, which are differentially regulated by drug-taking, abstinence, and 
re-exposure to cocaine-conditioned stimuli (Kalivas and O'Brien, 2008). Thus, 
pharmacological agents targeting specific adaptations mediating relapse may be 
beneficial at one stage of addiction relative to other stages.  
Previous work from our lab indicates that the suppressive effect of PrL 
cortical BDNF on cocaine seeking when infused immediately after SA can be 
blocked by antagonizing GluN2A/B-containing NMDA receptors prior to BDNF. 
Thus, preventing BDNF-TrkB signaling from elevating glutamatergic 
neurotransmission by antagonizing NMDA receptors prior to BDNF during early 
withdrawal prevents the long-term suppressive effect of BDNF on cocaine seeking 
(Go et al., 2016). These findings indicate that BDNF is likely augmenting glutamate 
transmission in the PrL-NAc core pathway during early withdrawal. Although intra-
PrL BDNF likely exerts its effects by normalizing corticostriatal glutamate 
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transmission through increased synaptic activity during early withdrawal, it is 
unknown whether simply elevating synaptic activity in the PrL cortex during early 
withdrawal is sufficient to suppress cocaine seeking after abstinence and extinction 
training. 
A plethora of literature indicates that the PrL-NAc core pathway is the 
primary glutamatergic projection mediating the initiation of cocaine seeking 
(McFarland et al., 2003; Reissner et al., 2015; McGlinchey et al., 2016). However, 
recent data indicate that divergent pathways arising from the PrL cortex 
differentially encode reward-predictive cues. PrL-NAc, relative to PrL-PVT, 
neurons differentially encode cue-elicited reinforcement learning of appetitive 
behaviors, and their coordinated activity permits plasticity relevant for cue-
encoding (Otis et al., 2017). Moreover, during the acquisition of cocaine SA, some 
PrL cortical neurons show decreased activity relative to baseline (i.e. prior to 
beginning daily SA sessions), with a larger percentage showing hypoactivity on the 
last day of SA relative to the first. However, a certain percentage of pyramidal 
neurons show elevated firing rates relative to baseline, although the percentage 
does not change from the first to the last day of SA (Dennis et al., 2018). Therefore, 
it could be postulated that these neurons may differentially encode cocaine cue 
salience through divergent outputs during the critical early withdrawal period. With 
the advent of optogenetics and chemogenetics, it has only recently been possible 
to definitively show the relationship between the PrL cortex and its downstream 
targets in drug seeking following various periods of abstinence. 
59 
 
Apart from transiently elevating the firing rates of neurons, Gq-coupled 
DREADDs also engage cell-signaling pathways associated with Gq-signaling, 
including the MAPK pathway (Bellocchio et al., 2016). In the last decade, 
DREADDs have been used extensively to probe the role of the medial prefrontal 
cortex in working memory (Liu et al., 2014), fear memory prediction (Yau and 
McNally, 2015), as well as behavioral activation elicited by cocaine conditioned 
cue exposure (Augur et al., 2016), among other prefrontal-dependent behaviors. 
Apart from being utilized as a tool to potentiate, or inhibit, general populations of 
neurons in various brain regions, DREADDs have also been combined with 
intersectional viral approaches which allow for modulation of specific PrL cortical 
projections (Garcia et al., 2017). These experiments rely on injections of 
retrograde-transported viruses, such as canine-adeno virus type 2 (CAV2) or 
AAVrg, which express Cre-recombinase (Junyent and Kremer, 2015; Tervo et al., 
2016) in combination with Cre-dependent viral vectors expressing DREADDs. 
Using this intersectional viral approach, Kerstetter and colleagues found 
that suppressing PrL-NAc core neurons during progressive ratio (PR) cocaine SA 
augments responding on the formerly active lever during the first extinction 
session, as well as cocaine prime-induced reinstatement. However, inhibition of 
PrL-NAc core neurons immediately prior to drug-prime reinstatement suppressed 
drug seeking (Kerstetter et al., 2016). This is consistent with optogenetic evidence 
that inhibiting PrL-NAc core neurons prior to reinstatement prevented cocaine 
seeking (Stefanik et al., 2013). Thus, PrL-NAc core manipulations have opposing 
effects depending on the timepoint of intervention. Moreover, augmenting activity 
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in the IL-NAc shell pathway prior to reinstatement following extinction training 
suppresses cocaine seeking (Augur et al., 2016). Thus, intersectional viral 
approaches can be utilized to gain a better understanding of corticostriatal 
pathways that mediate, or suppress, cocaine seeking. However, to date, no studies 
have applied this technique to alter PrL cortical activity, specifically that of NAc 
core efferents, immediately after cocaine SA. 
The data discussed above suggest that BDNF elevates synaptic activity in 
the PrL cortex during early withdrawal, which may provide a long-term 
normalization of corticostriatal glutamate transmission. We therefore hypothesized 
that chemogenetic-mediated activation of the PrL cortex immediately after the final 
SA session would suppress relapse after abstinence, an effect mediated by PrL-
NAc core activation. To investigate this hypothesis, we used either CaMKIIα-driven 
hM3Dq, or hSyn-DIO-hM3Dq, DREADDs in combination with NAc core CAV2-Cre-
eGFP or rgAAV-pmSyn1-Cre-eBFP viral vectors to activate PrL cortical 
glutamatergic neurons, or preferentially activate the PrL-NAc core output, 
respectively. Although we did not find any effects that persisted during an entire 
two-hour relapse test in either experiment, we did see trends in some of the relapse 
tests as well as specific timepoints during relapse wherein hM3Dq activation was 
effective. Thus, global chemogenetic activation of the PrL cortex as well as the 
PrL-NAc core pathway is insufficient to suppress relapse to the same degree as 
BDNF during early withdrawal. This difference may be due to the transient nature 




Materials and Methods 
Animal subjects 
Sixty-seven adult male Sprague Dawley rats were used for this study (Charles 
Rivers Laboratories, Wilmington, MA). Rats were maintained in the vivarium under 
the same conditions as experiments described in Chapter two. 
Surgery 
Rats were anesthetized, and chronic indwelling catheters were implanted into the 
jugular vein as described in Chapter two. All viral procedures and constructs used 
in this study were approved by the Medical University of South Carolina 
Institutional Biosafety Committee. For intra-cranial viral microinjections, rats were 
fixed into a stereotaxic apparatus and glass micropipettes were used to inject 
either an AAV5-CaMKIIα-hM3Dq-mCherry (UNC vector core, Chapel Hill, NC or 
Addgene, Cambridge, MA), AAV5-CaMKIIα-mCherry (UNC vector core, Chapel 
Hill, NC or Addgene, Cambridge, MA), AAV5-CaMKIIα-eGFP (UNC vector core), 
AAV5-hSyn-DIO-hM3Dq-mCherry (Addgene), or AAV5-hSyn-DIO-mCherry 
(Addgene) into the PrL cortex (AP +2.8 mm, ML +/- 0.6 mm, DV -3.8mm from 
bregma). All viruses injected into the PrL cortex had a titer of ~3 X 1012 viral 
genomes/ml and 0.75 μl/hemisphere was injected. In Experiment 3, rats also 
received microinjections of either CAV2 vector expressing a Cre-eGFP fusion 
protein under control of a CMV promoter (CAV2-Cre-eGFP; 3.6 X 1012 viral 
genomes/ml, Montpellier vector core, 0.75 ul/hem) or AAVrg pmSyn1-EBFP-Cre 
(~3 X 1012 viral genomes/ml Addgene, 0.75 ul/hem) into the NAc core (+ 1.6 mm 
AP, +/- 2.8 mm ML, - 7.1 mm DV from bregma, 10º angle). These viruses are 
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retrogradely transported, expressing Cre-recombinase in neurons expressing Cre-
dependent viral vectors that innervate the injected brain region (Junyent and 
Kremer, 2015; Tervo et al., 2016). All microinjections were delivered over a course 
of 5 minutes and glass micropipettes were left in place for 10 minutes to facilitate 
diffusion away from the injection site.  
Behavior 
Cocaine SA was performed identical to that which was used in Chapter two. Rats 
received 10-14 days of SA.  Immediately following the final cocaine SA session, 
all rats were injected with CNO (3 mg/kg i.p., NIDA chemical synthesis and drug 
supply program). Subsequent forced abstinence (i.e. 6 days), post-abstinence 
context-induced relapse, extinction, cue-induced reinstatement, extinction, and 
cocaine prime-induced reinstatement were performed identical to Chapter two. 
 Approximately one week following the cocaine prime test, rats received 
another injection of CNO (3 mg/kg, i.p.), were anesthetized (ketamine/xylazine), 
then transcardially perfused with 150 ml of 0.1M phosphate-buffered saline (PBS) 
followed by 200 ml of 4% paraformaldehyde (PFA, pH 7.4) two hours after the 
injection because this timepoint has been shown to be when maximal Fos 
induction occurs following acute cocaine (Graybiel et al., 1990). Brains were 
immersed in the same fixative for 1 hour and were then processed for 
immunohistochemical detection of the mCherry or eGFP tag/reporter and the 






Fifty μm sections containing the medial prefrontal cortex (mPFC) and NAc core 
were sliced on a cryostat (Leica Biosystems, Mannheim, Germany). The collected 
sections were stored in 0.1 M PBS containing 0.2% sodium azide and stored at 
4oC until immunohistochemical processing.  
Three to four sections from AP +2.76 to AP +4.2 mm from bregma were 
used for mCherry and Fos detection. First, sections were blocked in PBS with 0.3% 
Triton X-100 (PBST) and 2% normal goat serum (NGS) for two hours.  Next, tissue 
was incubated at 4oC in PBST containing primary antisera with NGS (2%) 
overnight. Primary antisera consisted of a chicken anti-mCherry (1:2000; LS 
Biosciences #LS-C204825, Seattle, WA RRID:AB_2716246), chicken anti-GFP 
(1:1000; Abcam #ab13970, Cambridge, MA RRID:AB_300798) and either rabbit 
anti-cFos (1:250, Santa Cruz Biotechnology, sc-52 RRID:AB_2106783) or mouse 
anti-cFos (1:100, Santa Cruz Biotechnology, sc-166940). Sections were then 
rinsed in PBST (3 X 10 minutes), then incubated in species-specific secondary 
antisera conjugated to either Alexa Fluor®594 (1:1,000; Abcam #ab150172) for 
mCherry detection or Alexa Fluor®647 (1:1,000; Abcam #ab150115) for detection 
of Fos. In experiment 2, mCherry/eGFP and Fos colocalization was not performed 
due to diffuse virus expression when hM3Dq was driven by a CaMKIIα promoter. 
Thus, sections were immunoprocessed for only Fos (1:250, Santa Cruz 
Biotechnology, sc-52 RRID:AB_2106783) followed by Alexa Fluor®594-
conjugated secondary antisera (1:1,000; Cell-signaling technologies, #8889). 
Sections were incubated in secondary antisera for two hours at room temperature 
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protected from light. Sections were then rinsed in PBST (3 X 10 minutes), then 
mounted on superfrost-plus glass slides using ProLong gold anti-fade (Thermo 
Fisher Scientific; Waltham, MA). Slides were stored at 4ºC until imaging was 
performed. 
Epifluorescent and confocal imaging 
Epifluorescent photomicrographs of mCherry and eGFP expression in the PrL 
cortex and NAc core, respectively, were acquired using a 2.5X air objective with 
an Olympus brightfield microscope equipped with appropriate wavelength filters. 
These images were used for verification of virus placement in the PrL cortex and 
NAc core. Animals were excluded from analyses if significant virus expression was 
observed in the infralimbic cortex (see results) or if virus expression was 
significantly different between hemispheres. ImageJ was used to manually draw 
regions of interest for Cg1, IL, and PrL cortex on each photomicrograph. The 
percent of total integrated density in each region was calculated for each section. 
Three to four sections were analyzed per animal, and then averaged to obtain a 
single integrated density data point for each region for each animal. In Experiment 
2, Fos immunoreactivity was detected using a Leica SP5 laser-scanning confocal 
microscope. Images were acquired with a He-Ne 543 laser line, 10X air objective, 
a 1024x1024 frame size, and a 1 μm Z-step size. In experiment 3, a Leica SP5 
laser-scanning confocal microscope was used. Images were acquired with a 20X 
air objective with 1024x1024 frame size and a 1 μm Z-step size. Alexa Fluor® 594 
(mCherry) was detected using a He-Ne 543 laser line and Alexa Fluor® 647 (Fos) 
was detected using a He-NE 633 laser line. In some instances, a Leica SP8 laser-
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scanning confocal microscope was used, but imaging parameters were similar. 
Laser power, pinhole size, and gain was initially optimized and then held constant 
for the remainder of the experiment.  
 In Experiment 2, FIJI (NIH) was used to quantify the extent of Fos 
expression in acquired images. Un-deconvolved Z-stacks were exported to FIJI 
and automatic thresholds were applied. In experiment 3, un-deconvolved confocal 
Z-stacks (~35 μm) were exported to Imaris software (Bitplane, Zurich, Switzerland) 
for analysis. First, background was subtracted from images. Next, the spots 
module was used to identify mCherry+ soma and Fos+ nuclei. Spot-detection size 
was held constant throughout the experiment. However, in instances where Imaris 
did not detect clear mCherry+ soma or Fos+ nuclei, these were manually added. 
Finally, the number of mCherry+ somas expressing Fos+ nuclei was normalized to 
the total number of mCherry+ soma and compared between mCherry- and hM3Dq-
expressing rats. 
Tissue processing and Wes™ immunoassay 
Tissue processing and the Wes™ immunoassay were performed in an identical 
manner as in Chapter 2. However, in this experiment we observed subtle, albeit 
significant, differences in the AUC of calnexin multi-plexed with p-ERK2 between 
groups. Thus, p-ERK2 AUC was normalized to calnexin, which was then 
normalized to the ratio of the AUC of tERK2/calnexin. Like Chapter 2, samples 






All behavioral data were analyzed with a mixed-model two-way ANOVA utilizing 
Bonferroni-corrected pairwise comparison tests when comparing two or more 
timepoints between groups. When comparing several bins to the first bin for each 
virus group independently, Dunnett’s multiple comparison test was used. Fos data 
and neurochemical data were analyzed with a two-tailed t-test with or without 
Welch’s correction when appropriate. Statistical outliers were detected using 
Grubbs’ test (extreme studentized deviate method) and were excluded from all 
analyses. All data are expressed as the mean +/- standard error of the mean 
(SEM). 
Results 
Experiment 1. CNO increased p-ERK2 two hours after injection in naïve rats 
 
Figure 3.1A shows the timeline for Experiment 1. Experiment 1 was designed to 
determine whether acute activation of CaMKIIα-hM3Dq with CNO (3 mg/kg, i.p.) 
increased ERK2 phosphorylation (p-ERK2) in the PrL cortex two hours after 
injection, similar to the effect of BDNF (Whitfield et al., 2011) or STEP inhibition 
(Chapter 2). Naïve rats (n=9) were either injected with CNO (n=5, 3 mg/kg, i.p.) or 
vehicle (n=4, 5% DMSO in sterile saline) and rapidly decapitated two hours after 
the injection. Using a Wes™-based immunoassay, results showed a significant 
elevation in p-ERK2/tERK2 in hM3Dq rats injected with CNO relative to vehicle 
(t(7)=2.38, p<0.05, Fig. 3.1B). There was no difference in tERK2/calnexin (t(7)=0.51, 
p>0.05, Fig. 3.1C). Representative chemiluminescent peaks of p-ERK2 for CNO-
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Figure 3.1. CNO (3 mg/kg, i.p.) acutely elevates p-ERK2 in CaMKIIα-hM3Dq-
expressing rats. A. Experimental timeline. B. Naïve rats infused with AAV5-
CaMKIIα-hM3Dq injected with CNO (3 mg/kg, i.p.) show elevated ERK2 
phosphorylation in the PrL cortex two hours after the injection relative to vehicle- 
injected controls. C. There was no difference in ERK2 between groups. D. 
Representative chemiluminescent peaks for CNO-injected rats (blue) and vehicle- 
injected rats (green) *p<0.05 compared to vehicle. 
 
Experiment 2. The effect of hM3Dq activation of the PrL cortex immediately 
after SA on post-abstinence context-induced relapse, cue-, and cocaine 
prime-, induced reinstatement after extinction 
 
Of the initial 13 rats infused with the eGFP control virus, 3 were removed. One rat 
was removed for significant virus expression in the IL cortex. One rat was removed 
for lack of reinstatement in all three tests, and one rat never acquired SA. Of the 
13 rats initially infused with hM3Dq virus, 3 were removed. One rat never acquired 
SA, and two rats were removed for having significant virus expression in the IL 
cortex. Figure 3.2A shows the experimental timeline for experiment 2. 
Representative virus expression for CaMKIIα-hM3Dq-expressing rats is shown in 
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Figure 3.2B. The quantitation of virus expression in three regions of the mPFC is 
shown in Figure 3.2C. Figure 3.2D shows the last 10 days of SA for eGFP (blue) 
and hM3Dq (black) rats. Active lever presses (ALP), inactive lever presses (ILP), 
and infusions were analyzed with a mixed-model two-way ANOVA with virus as 
the between-subjects factor and SA session as the within-subjects factor. For 
active lever presses, analyses revealed there was no significant virus by SA 
session interaction (F(9,162)=0.36, p>0.5), main effect of virus (F(1,18)=0.08, p>0.05), 
nor a significant main effect of SA session (F(9,162)=0.58, p>0.05). Thus, there was 
no difference between groups in active lever presses over the last 10 days of SA 
and both groups showed stable responding on the active lever during this time. 
For inactive lever presses, there was no significant virus by SA session interaction 
(F(9,162)=0.58, p>0.05), main effect of virus (F(1,18)=0.74, p>0.05), or main effect of 
SA session (F(9,162)=1.24, p>0.05). Thus, there was no difference between groups 
regarding inactive lever presses. For infusions, there was no significant virus by 
SA session interaction (F(9,162)=0.23, p>0.05), nor a main effect of virus 
(F(1,18)=0.33, p>0.05). However, there was a main effect of SA session 
(F(9,162)=4.98, p<0.0001). Thus, there was no difference between groups for 
infusions earned over the last 10 days of SA, but both groups increased infusions 









Figure 3.2. PrL cortical CaMKIIα-hM3Dq-mCherry virus expression quantitation 
and SA data. A. Experimental timeline. B. Representative virus expression for 
hM3Dq-expressing rats. C. Quantitation of the extent of virus expression in eGFP 
(left) and hM3Dq (right) rats. The percentage of total virus expression (as shown 
by fluorescent integrated density) is shown for Cg1 (grey), IL (red), and PrL (black) 
cortex. D. SA data comparing active lever presses (ALP), inactive lever presses 
(ILP), and infusions between groups over the last 10 days of SA. 
 
hM3Dq activation of the PrL cortex immediately after SA did not suppress 
context-induced relapse after abstinence  
 
Immediately following the final SA session, all rats were injected with CNO (3 
mg/kg, i.p.) and returned to the vivarium for one week of forced home-cage 
abstinence. Rats then underwent a single two-hour post-abstinence context-
induced relapse test under extinction conditions. Figure 3.3A shows the results of 
the post-abstinence relapse test. A mixed-model two-way ANOVA revealed there 
was no significant virus by timepoint interaction (F(1,18)=2.70, p>0.05), nor a 
significant main effect of virus (F(1,18)=3.99, p>0.05), but there was a significant 
main effect of timepoint (F(1,18)=47.33, p<0.0001). Thus, there was no difference 
between groups regarding active lever presses during both the last 3 days of SA 
and the PA test. However, both groups showed elevated responding on the 
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formerly active lever during the PA test relative to the last 3 days of SA. For inactive 
lever presses, there was no significant virus by timepoint interaction (F(1,18)=0.17, 
p>0.05), nor a significant main effect of virus (F(1,18)=0.22, p>0.05), but there was 
a significant main effect of time (F(1,18)=35.81, p<0.0001). Thus, there was no 
difference between groups regarding inactive lever presses during the last 3 days 
of SA or during the PA test. However, both groups showed elevated responding 
on the formerly inactive lever during the PA test relative to the last 3 days of SA.  
 Because the results revealed a trend towards reduced active lever pressing 
in hM3Dq-expressing rats when the entire two-hour PA test data set was analyzed, 
we performed a follow-up analysis investigating individual timepoints during the PA 
test in 10-minute bins using a two-way RM ANOVA (Fig. 3.3B). There was no 
significant virus by time point interaction (F(11,198)=1.49, p>0.05) nor a significant 
main effect of virus (F(1,18)=3.67, p>0.05). However, there was a significant main 
effect of time (F(11,198)=9.54, p<0.0001). Thus, akin to the entire two-hour test, there 
was no significant difference between groups when examining individual 
timepoints within the PA test, but both groups reduced their responding during the 
PA test. 
hM3Dq activation of the PrL cortex immediately after SA reduced active lever 
pressing only during the first 10 minutes of cue-induced reinstatement  
 
Following the PA test, rats underwent further extinction training until they reached 
criterion, then underwent a cue-induced reinstatement test. Figure 3.3C shows the 
results of the entire two hours of cue-induced reinstatement. For active lever 
presses, a two-way mixed model ANOVA revealed that there was no significant 
virus by time point interaction (F(1,18)=1.53, p>0.05), nor a significant main effect of 
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virus (F(1,18)=1.58, p>0.05). However, there was a significant main effect of time 
(F(1,18)=78.14, p<0.0001). Thus, there was no overall effect of hM3Dq activation of 
the PrL cortex immediately after SA on cue-induced reinstatement. However, both 
groups increased their responding on the formerly active lever during cue-induced 
reinstatement relative to the last 3 days of SA, as expected. For inactive lever 
presses, there was no significant virus by timepoint interaction (F(1,18)=0.1, p>0.05) 
nor a significant main effect of virus (F(1,18)=0.01, p>0.05). However, there was a 
significant main effect of time (F(1,18)=6.09, p<0.05). Thus, there was no difference 
between groups during the last 3 days of extinction or during the entire two-hour 
duration of the cue-induced reinstatement test. However, both groups showed 
elevated active and inactive lever pressing during reinstatement relative to the last 
3 days of extinction.  
 As in the PA test, we also analyzed individual 10-minute bins during the 
cue-induced reinstatement test using a two-way RM ANOVA, as shown in Figure 
3.3D. In contrast to the PA test, a two-way ANOVA revealed a significant virus by 
timepoint interaction (F(11,198)=2.01, p<0.05). There was also a significant main 
effect of timepoint (F(11,198)=3.86, p<0.0001), but no significant main effect of virus 
(F(1,18)=0.57, p>0.05). Bonferroni-corrected pairwise comparison tests indicated 
that hM3Dq rats had significantly lower active lever presses during the first 10 
minutes of cue-induced reinstatement relative to eGFP rats (p<0.05). Moreover, 
when comparing each 10-minute bin to the first 10-minute bin in eGFP rats with a 
Dunnett’s multiple comparison test, each timepoint was significantly lower than the 
first 10 minutes (all p<0.05), except when comparing 20-30 minutes to 0-10 
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minutes (p>0.05). However, when comparing each 10-minute bin to the first 10-
minute bin in hM3Dq rats, there was no timepoint that was significantly different 
from the first 10-minute bin. Thus, there was no significant difference between 
groups when analyzing active or inactive lever presses during the entire two-hour 
reinstatement test. However, hM3Dq activation of the PrL cortex immediately after 
SA suppressed active lever pressing during the first 10 minutes of reinstatement, 
when lever pressing was highest in eGFP rats.  
hM3Dq activation of the PrL cortex immediately after SA did not suppress 
cocaine prime-induced reinstatement after extinction 
 
Following the cue-induced reinstatement test, rats were re-extinguished until 
criterion. Rats then underwent a two-hour cocaine prime-induced reinstatement 
test under extinction conditions (Fig. 3.3E). When analyzing active lever presses, 
a two-way mixed model ANOVA revealed that there was no significant virus by 
timepoint interaction (F(1,18)=0.54, p>0.05), nor a significant main effect of virus 
(F(1,18)=1.39, p>0.05). However, there was a significant main effect of time 
(F(1,18)=103.8, p<0.0001). For inactive lever presses, there was no significant virus 
by timepoint interaction (F(1,18)=0.21, p>0.05), main effect of virus (F(1,18)=2.08, 
p>0.05), or main effect of time (F(1,18)=0.02, p>0.05). Thus, there was no effect of 
hM3Dq activation of the PrL cortex immediately after SA on active or inactive lever 
presses during the entire two-hour cocaine prime-induced reinstatement following 
extinction.  
 As for the PA test and cue-induced reinstatement test, we also extended 
this analysis to the individual 10-minute bins within the cocaine prime-induced 
reinstatement test (Fig. 3.3F). A two-way RM ANOVA revealed that there was no 
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significant virus by timepoint interaction (F(11,198)=0.57, p>0.05), nor a significant 
main effect of virus (F(1,18)=1.0, p>0.05). However, there was a significant main 
effect of time (F(11,198)=15.74, p<0.0001). Thus, there was no difference between 
groups regarding active lever pressing during individual timepoints within the 
cocaine prime-induced reinstatement test, and both groups showed reduced active 




Figure 3.3. Global chemogenetic activation of PrL cortical neurons immediately 
after SA is without an overall effect on post-abstinence context-induced relapse 
and cue- and cocaine prime- induced reinstatement after extinction during the two-
hour tests but did selectively reduce lever pressing during the first 10 minutes of 
cue-induced reinstatement. A. hM3Dq-mediated activation of the PrL cortex 
immediately after SA failed to suppress post-abstinence context-induced relapse 
after abstinence. B. There was no effect of hM3Dq activation immediately after SA 
at any timepoint analyzed during the PA test. C. There was also no effect of hM3Dq 
activation of the PrL cortex on cue-induced reinstatement after extinction when 
analyzing the entire two-hour session. D. There was a specific reduction in lever 
pressing during the first 10 minutes of cue-induced reinstatement when lever 
pressing was highest in eGFP control rats. E. There was no effect of hM3Dq 
activation on cocaine prime-induced reinstatement. F. There was no effect of 
hM3Dq activation immediately after SA at any timepoint analyzed during the 
cocaine prime-induced reinstatement test. White bars indicate inactive lever 
presses, and colored bars indicate active lever presses. ****p<0.0001 compared 
to last 3 days of SA (ALP), +p<0.05, ++++p<0.0001 compared to last 3 days of SA 
(ILP), ^p<0.05 compared to eGFP, @p<0.05 compared to first 10-minute bin. 
 
CNO increased Fos expression in the PrL cortex of hM3Dq rats  
 
Following the cocaine prime-induced reinstatement test, all rats were returned to 
the vivarium for ~one week. A subset of rats was then given a challenge injection 
of CNO (3 mg/kg, i.p.) and transcardially perfused two hours later for Fos analysis 
(Fig. 3.4). A Welch’s-corrected t-test showed that hM3Dq-expressing rats showed 
robust Fos activation relative to eGFP controls (t(6.05)=2.92, p<0.05, Fig. 3.4A). 
Representative Fos induction is shown for eGFP- (Fig. 3.4B), and hM3Dq-
expressing (Fig. 3.4C) rats.  
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Figure 3.4. Post-experiment CNO challenge increased Fos immunoreactivity in 
hM3Dq-expressing rats. A. Fos+ cells were significantly higher in hM3Dq rats 
relative to eGFP controls two hours after CNO injection. B. Representative Fos 
(red) immunoreactivity in eGFP rats. C. Representative Fos immunoreactivity in 
hM3Dq rats. *p<0.05 compared to eGFP. 
 
Experiment 3. The effect of hM3Dq activation of PrL cortical neurons 
projecting to the NAc core immediately after SA on post-abstinence context-
induced relapse, cue-, and cocaine prime-, induced reinstatement after 
extinction 
 
Of the 16 mCherry rats, 4 were removed. One rat was removed for lack of SA 
acquisition, one rat was removed as a statistical outlier during cue-induced 
reinstatement, and two rats were removed for virus expression outside of the PrL 
cortex. Of the 16 hM3Dq rats, 5 were removed. Three rats were removed for 
significant virus expression outside of the PrL cortex. One rat never acquired SA, 
and one rat became ill and was removed from the study. Figure 3.5A shows the 
experimental timeline including surgery, behavioral experiments, time of CNO 
injections as well as post-experiment CNO-induced Fos quantitation in mCherry- 
and hM3Dq-expressing rats. Figure 3.5B shows a schematic for dual-viral 
injections which result in preferential infection of PrL cortical neurons projecting to 
the NAc core. Figure 3.5C shows representative Cre-dependent expression of the 
mCherry tag in the hM3Dq construct. Note that virus expression was largely 
confined to the PrL cortex, particularly layer V. Figure 3.5D shows representative 
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CAV2-Cre-eGFP expression in the NAc core. Figure 3.5E shows SA data for 
mCherry and hM3Dq rats. For statistical purposes, only the last 10 days of SA are 
shown. However, all rats received a minimum of 10 days and a maximum of 14 
days of SA.  
  For active lever presses, a two-way RM ANOVA showed no significant virus 
by SA session interaction (F(9,189) = 0.8266, p>0.05) nor significant main effects of 
SA session (F(9,189)=0.8858, p>0.05) or virus (F(1,21)=1.51, p>0.05). For inactive 
lever presses, there was no significant virus by SA session interaction 
(F(9,189)=1.35, p>0.05) or main effect of virus (F(1,21)=1.78, p>0.05). However, there 
was a significant main effect of time (F(9,189)=2.58, p<0.05). For infusions earned, 
a two-way RM ANOVA showed no significant virus by SA session interaction 
(F(9,189)=1.47, p>0.05) nor a significant main effect of SA session (F(9,189)=1.40, 
p>0.05) or virus (F(1,21)=1.08, p>0.05). Collectively, these results indicate that there 
was no difference between mCherry and hM3Dq rats regarding active lever 
presses, inactive lever presses, or infusions over the last 10 days of SA. 
Immediately following the last SA session, all rats received a single injection of 





Figure 3.5. Experimental timeline, virus expression, and SA data for experiment 
3. A. Experimental timeline. B. Schematic illustrating use of intersectional viral 
approach for preferential infection of PrL-NAc core neurons. C. Representative 
AAV5-hSyn-DIO-hM3Dq-mCherry expression in the PrL cortex. Note the majority 
of virus expression is contained within the PrL cortex, specifically in layer V 
neurons. D. Representative CAV2-Cre-eGFP expression in the NAc core. Circled 
region denotes anterior commissure (ac), and dotted line indicates NAc core. Inset 
corresponds to high-magnification view of boxed region. E. SA data for experiment 
3 showing active lever presses (ALP), inactive lever presses (ILP), and infusions 
for both groups over the last 10 days of SA. 
 
hM3Dq activation of PrL-NAc core neurons reduced lever pressing only 
during the first 10 minutes of post abstinence relapse testing  
 
Figure 3.6A shows the average active lever presses for the last 3 days of SA (left) 
for mCherry (blue) and hM3Dq-expressing (black) rats. A two-way mixed model 
ANOVA indicated a non-significant virus by timepoint interaction (F(1,21)=0.58, 
p>0.05), but significant main effects of virus (F(1,21)=4.78, p<0.05) and time 
(F(1,21)=16.15, p<0.001). There was no significant virus by timepoint interaction 
(F(1,21)=1.88, p>0.05) nor main effect of virus (F(1,21)=1.78, p>0.05) on inactive lever 
presses. However, there was a main effect of time (F(1,21)=27.39, p<0.0001). Thus, 
both groups showed elevated active and inactive lever pressing following one 
week of forced abstinence, and hM3Dq rats showed reduced active lever pressing 
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relative to mCherry controls. Bonferroni-corrected pairwise comparison tests 
indicated that there was no difference between groups over the last 3 days of SA 
(p>0.05), but there was a strong trend towards reduced active lever pressing 
during the PA test in hM3Dq rats (p=0.08).  
Because we found a strong trend towards reduced active lever pressing in 
the overall two-hour PA test, we investigated individual timepoints within the PA 
test by analyzing lever pressing during 10-minute bins. Figure 3.6B shows the 
effect of hM3Dq activation immediately after SA on active lever pressing during 
10-minute bins. A two-way RM ANOVA showed a significant virus by time 
interaction (F(11,231)=2.03, p<0.05) as well as a significant main effect of time 
(F(11,231)=11.55, p<0.0001), but not virus (F(1,21)=2.06, p>0.05). Bonferroni-
corrected multiple comparison tests indicated that hM3Dq rats showed reduced 
active lever pressing during the first 10 minutes of the PA test (p<0.001) relative to 
mCherry controls. Additional analyses comparing each timepoint to this first 10-
minute bin only in mCherry control rats indicated that the first 10 minutes of active 
lever pressing were significantly higher relative to every other 10-minute bin 
(p<0.01 0-10 vs. 10-20, p<0.001 0-10 vs. 20-30, p<0.0001 0-10 vs. 30-40 and 
above). Interestingly, only 90-100 minutes was different than 0-10 minutes in 
hM3Dq rats (p<0.05). Thus, hM3Dq activation of PrL-NAc core neurons 
immediately after SA suppresses relapse during the first 10 minutes of testing, 





hM3Dq activation of PrL-NAc core neurons failed to suppress cue-induced 
reinstatement after extinction 
 
Figure 3.6C shows the average last 3 days of extinction active lever pressing for 
mCherry and hM3Dq rats as well as active and inactive lever pressing during cue-
induced reinstatement. A two-way mixed model ANOVA indicated a non-significant 
virus by time point interaction (F(1,21)=2.92, p>0.05) as well as a non-significant 
main effect of virus (F(1,21)=3.14, p>0.05). However, there was a significant main 
effect of timepoint (F(1,21)=102.9, p<0.0001). There was a no virus by time point 
interaction (F(1,21)=0.23, p>0.05), main effect of treatment (F(1,21)=0.27, p>0.05), or 
main effect of time (F(1,21)=1.54, p>0.05) on inactive lever presses. Thus, both 
groups showed elevated active, but not inactive, lever pressing during cue-induced 
reinstatement relative to the last 3 days of extinction but there was no difference 
between groups on active lever presses during extinction or cue-induced 
reinstatement.  
When analyzing 10-minute bins (Fig. 3.6D), a two-way RM ANOVA 
indicated no virus by time interaction (F(11,31)=1.054, p>0.05) or a main effect of 
virus (F(1,21)=3.065, p>0.05). However, there was a significant main effect of time 
(F(1,21)=3.283, p<0.001). Thus, both groups showed reduced active lever pressing 
as a function of time during cue-induced reinstatement but there was no effect of 
hM3Dq activation on any timepoint.  
hM3Dq activation of PrL-NAc neurons after SA failed to suppress cocaine 
prime-induced reinstatement after extinction  
 
Figure 3.6E shows the average last 3 days of extinction (left) for mCherry and 
hM3Dq rats. When analyzing active lever presses, a two-way mixed-model 
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ANOVA revealed there was no significant virus by timepoint interaction 
(F(1,21)=2.68, p>0.05), nor main effect of virus (F(1,21)=2.86, p>0.05). However, there 
was a significant main effect of time (F(1,21)=37.86, p<0.0001). There was no 
significant virus by timepoint interaction (F(1,21)=2.65, p>0.05), main effect of virus 
(F(1,21)=0.91, p>0.05), or a main effect of time (F(1,21)=3.40, p>0.05) on inactive 
lever presses. Thus, both groups showed elevated active, but not inactive, lever 
pressing during cocaine prime-induced reinstatement relative to the last 3 days of 
extinction, and hM3Dq activation was without an effect on cocaine prime-induced 
reinstatement during the 2-hour test. Further analysis of individual 10-minute 
binned data with a two-way RM ANOVA indicated that there was no significant 
virus by time interaction (F(11,231)=0.849, p>0.05) or main effect of virus 
(F(1,21)=2.893, p>0.05) but there was a significant main effect of time (F(11,231)=6.57, 
p<0.0001). In this analysis, both hM3Dq-activated and control groups showed 
reduced active lever pressing as a function of time during cocaine prime-induced 
reinstatement but there was no effect of hM3Dq activation per se on active lever 



















Figure 3.6. Activation of PrL-NAc core neurons immediately after SA failed to 
suppress post-abstinence context-induced relapse or cue- and cocaine prime- 
induced reinstatement after extinction during two-hour tests but did reduce lever 
pressing selectively during the first 10 minutes of post-abstinence context-induced 
relapse. A. PrL-NAc core activation immediately after SA had no effect on lever 
pressing during two-hour post-abstinence relapse testing. B. PrL-NAc core 
activation suppresses active lever pressing during the first 10 minutes of relapse 
testing, when mCherry lever pressing was highest. C. PrL-NAc core activation was 
without an effect during two-hour cue-induced reinstatement testing. D. There was 
no effect of PrL-NAc core activation during any timepoint during cue-induced 
reinstatement. E. There was no effect of PrL-NAc core activation on cocaine prime-
induced reinstatement. F. There was no effect of PrL-NAc core activation during 
any timepoint during cocaine prime-induced reinstatement. *** p<0.001, **** 
p<0.0001 compared to last 3 days of SA or extinction (ALP), ++++ p<0.0001 
compared to last 3 days of SA (ILP), ̂ ^^ p<0.001 compared to mCherry, @ p<0.05, 




Post-experimental CNO challenge induced robust Fos expression in 
mCherry neurons preferentially in hM3Dq rats  
 
Approximately one week following the cocaine prime-induced reinstatement test, 
a subset of rats received another single injection of CNO (3 mg/kg, i.p.) and were 
perfused two hours later for Fos immunohistochemistry. Figure 3.7A shows that 
CNO induced robust Fos activation in mCherry neurons in hM3Dq rats relative to 
mCherry as shown by Welch’s-corrected t-test (t(10.69)=13.83, p<0.0001). 
Representative Fos immunoreactivity in mCherry rats is shown in Figure 3.7B. 
Representative Fos immunoreactivity in hM3Dq rats is shown in Figure 3.7C. 
Figure 3.7. Post-experiment CNO challenge increased Fos immunoreactivity in 
mCherry+ neurons preferentially in hM3Dq-rats. A. Approximately 75% of 
mCherry+ neurons showed robust Fos immunoreactivity in hM3Dq-expressing rats 
compared to mCherry controls. B. Representative Fos immunoreactivity in 
mCherry control rats. C. Representative Fos immunoreactivity in hM3Dq-
expressing rats. Blue arrow: Fos+mCherry- soma. White arrow: Fos+mCherry+ 











Summary of findings 
Here we provide data showing an overall lack of support for the hypothesis that 
augmenting PrL cortical, and specifically PrL-NAc core, neuronal activity during 
early withdrawal is sufficient to suppress relapse after abstinence. Although we 
found that hM3Dq activation increased p-ERK2 two hours after injection in naïve 
rats (Experiment 1), we did not find an overall behavioral effect of hM3Dq activation 
of the PrL cortex (Experiment 2), or PrL-NAc core neurons (Experiment 3), 
immediately after SA. However, we did observe several trends when overall two-
hour testing was analyzed. Subsequent analyses of the within-session 
timecourses indicated that activation of all PrL cortical outputs immediately after 
SA transiently suppressed cue-induced reinstatement after extinction (i.e. first 10 
minutes) when control lever pressing was highest. However, we did not see such 
an effect during post-abstinence context-induced relapse or cocaine prime-
induced reinstatement after extinction. Moreover, when specifically activating PrL-
NAc core neurons immediately after SA, there was a transient inhibition of cocaine 
seeking during the post-abstinence context-induced relapse test, but not during 
cue- or cocaine prime-induced reinstatement after extinction, again, when control 
lever pressing was invigorated. 
Relevance of early timepoints in relapse testing 
Although our previous experiments have typically examined data during the entire 
two-hour test (Whitfield et al., 2011; Barry and McGinty, 2017), there is precedent 
for examining early portions of relapse testing. Although context-induced 
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reinstatement after extinction and context-induced relapse after abstinence are 
mediated by distinct brain regions (Fuchs et al., 2006), the cocaine-conditioned 
context represents a shared stimulus which elicits cocaine seeking. Context 
(Stankeviciute et al., 2014)- and cue (Gipson et al., 2013)-induced reinstatement 
potentiate dendritic spine head diameter, which tightly correlates with lever 
pressing behavior, in NAc core medium spiny neurons (MSNs) during the first 15 
minutes of reinstatement. During cue-induced reinstatement, this transient 
synaptic potentiation is associated with an augmented AMPA:NMDA ratio and is 
dependent on glutamate release from the PrL cortex, which likely holds true for 
context-induced reinstatement. Moreover, after 45 minutes of reinstatement, spine 
head size and AMPA:NMDA ratios normalize. At this time lever pressing is 
diminished, presumably due to within-session extinction learning.  
Although we did not see any significant differences when examining overall 
lever pressing during the two-hour session, the finding that lever pressing was 
suppressed during early parts of post-abstinence context-induced relapse 
(Experiment 3) and cue-induced reinstatement (Experiment 2) is likely an 
important, albeit subtle, effect of hM3Dq activation of PrL cortex, and PrL-NAc 
core, immediately after SA. Moreover, the overall lack of effect suggests that there 
are distinct mechanisms in the suppressive effect of BDNF relative to hM3Dq, 
which could be due to differential signaling and duration of effects induced by these 





BDNF-TrkB signaling vs. Gq-DREADD signaling: Similarities and differences 
Previous data indicate that intra-PrL BDNF suppresses cocaine seeking by 
normalizing glutamate transmission in the PrL cortex during early withdrawal, 
leading to a long-term stabilization of glutamate release in the NAc core (Berglind 
et al., 2007; Berglind et al., 2009; Go et al., 2016). Moreover, there is evidence 
that intra-PrL BDNF alters neuronal signaling in the NAc core as early as two hours 
after the infusion (Berglind et al., 2007; Sun et al., 2014a). BDNF is typically 
recognized as a neurotrophic factor that induces neuronal activity by linking TrkB 
activation with NMDA receptor tyrosine phosphorylation and glutamate release 
(Huang and McNamara, 2010; Zhang et al., 2013). Ultimately, this facilitates 
CREB-mediated gene transcription (Mao et al., 2015) via ERK-MAPK signaling 
(Tao et al., 1998).  
However, there is also a clear role for BDNF acting in a homeostatic manner 
depending on the activity state of neurons (Rutherford et al., 1998). At the synaptic 
level, it has been suggested that BDNF may preferentially alter transmission 
differentially at individual synapses depending on the state of potentiation or 
depression at these synapses (Nagappan and Lu, 2005). This may be critical for 
the sustained induction of ERK activity. For example, sequential stimulation of only 
seven spatially-dispersed dendritic spines by glutamate uncaging in vitro is 
sufficient to induce sustained ERK, and ultimately CREB, activation in the nucleus, 
effects largely due to NMDA receptor-mediated elevations in intracellular Ca2+ 
(Zhai et al., 2013).  In contrast, DREADDs are thought to integrate with 
endogenous Gq-coupled signaling cascades (Alexander et al., 2009), presumably 
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lacking specificity regarding the spatial location of their mode of action, specifically 
at sites of internal Ca2+ stores. This is important considering the functional 
heterogeneity that exits between various internal Ca2+ stores (Blaustein and 
Golovina, 2001). Thus, DREADDs are likely promiscuous regarding their 
engagement of Gq-coupled signaling cascades to induce neuronal firing. 
Interestingly, muscarinic type-1 acetylcholine receptor activation facilitates 
the activation of STEP through the release of Ca2+ from intracellular stores (Tian 
et al., 2016), opposing the Src-mediated phosphorylation of GluN2A-containing 
NMDA receptors. Thus, the activation of Gq-coupled DREADDs with CNO may 
induce STEP activation, which would likely be dependent on the dose of CNO 
used. However, because we found elevated p-ERK2 two hours after CNO (3 
mg/kg, i.p.) injection in naïve rats, and because STEP is a major regulator of the 
magnitude of ERK signaling (Paul et al., 2003), it is unlikely that the dose of CNO 
used in our experiments activates STEP two hours after injection.  
Furthermore, BDNF super-activates (i.e. above and beyond baseline) ERK 
signaling in the PrL cortex during early withdrawal (Whitfield et al., 2011; Barry and 
McGinty, 2017), driving CREB phosphorylation and presumably CREB-mediated 
gene transcription of plasticity-regulating genes (Whitfield et al., 2011). Although 
we did not test whether hM3Dq activation is able to normalize the cocaine-induced 
dephosphorylation of ERK2 or CREB in the PrL cortex during early withdrawal, we 
hypothesize that hM3Dq activation likely does not elevate ERK2 or CREB 
phosphorylation to the same degree as BDNF. Moreover, BDNF leads to sustained 
ERK2 phosphorylation with maximal effects seen at two hours, returning to 
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baseline by six hours, but CREB phosphorylation remains elevated six hours after 
a single BDNF infusion in naïve rats (Whitfield et al., 2011). Previous experiments 
have shown that treatment of striatal cultures with high concentrations of CNO (50 
μM) only transiently activates ERK2 phosphorylation, which returns to baseline 
levels two hours after treatment (Bellocchio et al., 2016). Moreover, activation of 
striatal projection neurons in mice with CNO (1 mg/kg, i.p.) elevates pERK within 
30 minutes which returns to baseline by 140 minutes (Alcacer et al., 2017). One 
caveat of the latter finding was that this experiment was performed in dopamine 
denervated mice. These findings are consistent with the hypothesis that hM3Dq 
activation may not elevate ERK2 and CREB phosphorylation in the PrL cortex for 
the entire two hours after the end of cocaine SA due to the transient effects of 
CNO.  
BDNF-TrkB signaling elevates ERK-MAPK signaling not only through 
autophosphorylation of TrkB (Atwal et al., 2000), but also by BDNF-TrkB-GluN2B-
mediated activation of ERK (Krapivinsky et al., 2003). Moreover, blockade of 
NMDA receptors prior to BDNF prevents the suppressive effect of BDNF as well 
as BDNF-mediated elevations in ERK2 phosphorylation in the PrL cortex during 
early withdrawal (Go et al., 2016). These findings suggest that the activation of 
ERK by BDNF is dependent on the source of Ras-MAPK activity (i.e. downstream 
of TrkB or directly at the level of TrkB). Such fine-tuned regulation of ERK signaling 
likely does not occur with hM3Dq activation, as previous findings indicate that Gq-
DREADDs activate ERK exclusively through a PKC-dependent mechanism, at 
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least in vitro (Kaufmann et al., 2013), and there is no evidence for NMDA-induced 
elevations in Ca2+ following hM3Dq activation. 
Considerations for experimental approach 
Recent evidence indicates that CNO is back-metabolized to clozapine, which is 
the direct agonist for DREADD receptors (Gomez et al., 2017). Clozapine shows 
high-affinity for dopamine D2 receptors, α adrenergic receptors, as well as several 
serotonin receptor subtypes. Specifically, acute treatment with clozapine (10 
mg/kg, i.p.) reduces binding affinity of the 5-HT2A serotonin receptor (Wilmot and 
Szczepanik, 1989). Moreover, a subthreshold dose of clozapine (0.1 mg/kg, i.p.) 
alters striatal-dependent locomotor activity in hM4Di-expressing mice, which is 
comparable in magnitude to 10 mg/kg, i.p. CNO (Gomez et al., 2017). Thus, we 
cannot exclude the effects of clozapine in our experiments. However, because all 
animals were injected with CNO at a relatively low dose (3 mg/kg, i.p.), which did 
not affect the ability of control animals to reinstate, we suggest that off-target 
effects of clozapine are likely not present. Thus, any effect (or lack thereof) is likely 
due to clozapine binding to DREADD receptors as opposed to the well-
documented actions of clozapine at various other receptors when delivered acutely 
(Wilmot and Szczepanik, 1989). Moreover, others have suggested that 10 mg/kg, 
i.p. CNO may be required for sustained activity of DREADD receptors over a two-
hour window (Mahler and Aston-Jones, 2018). Because 0.1 mg/kg clozapine is a 
subthreshold dose for altering behavior in animals that do not express DREADDs, 
and is equivalent, at least behaviorally, to 10 mg/kg CNO in animals expressing 
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DREADDs, a 10 mg/kg dose of CNO or 0.1 mg/kg dose of clozapine may provide 
a more pronounced effect of DREADD receptor activation in our paradigm. 
Summary, conclusions, and future directions 
In conclusion, the results presented herein do not support the hypothesis that 
augmented PrL cortical or PrL-NAc core neuronal activity during early withdrawal 
is sufficient to suppress cocaine seeking after abstinence. However, we found 
discrete timepoints in the post-abstinence context-induced relapse test as well as 
cue-induced reinstatement when hM3Dq was effective, particularly when control 
lever pressing was elevated. Although it is unknown at exactly what point PrL 
cortical ERK2 phosphorylation normalizes in cocaine self-administering animals, it 
is likely that BDNF provides an enduring normalization during the critical early 
withdrawal period. However, we hypothesize that hM3Dq activation transiently 
elevates neuronal activity in the PrL-NAc core pathway during early withdrawal, 
culminating in a transient reversal of ERK2 dephosphorylation which is not 
sustained during the entire timecourse of early withdrawal from cocaine SA. This 
normalization is likely more transient and not as strong as BDNF, and does not 
prevent STEP activation as is the case of TC-2153 according to data presented in 
Chapter two (Fig. 3.8A). We propose that this ultimately leads to a transient 
attenuation of stimulus-induced drug seeking relative to BDNF or STEP inhibition 
with TC-2153 (Fig. 3.8B), which is differentially regulated by activating the PrL 
cortex or specifically activating the PrL-NAc core pathway. Accordingly, future 
experiments should determine whether hM3Dq activation is sufficient to normalize 
the cocaine-induced dephosphorylation of ERK2 in the PrL cortex during early 
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withdrawal, as well as glutamate release in the NAc core after extinction, as 
previously found for BDNF (Berglind et al., 2009; Whitfield et al., 2011). 
Additionally, future studies should examine dose-dependent effects of clozapine 
or CNO on relapse to cocaine seeking. 
Figure 3.8. Comparison between hM3Dq activation, STEP inhibition, and BDNF 
on ERK activation during early withdrawal and subsequent lever pressing during 
relapse testing. A. Schematic illustrating the hypothesized temporal difference in 
modulation of the cocaine-induced ERK dephosphorylation in the PrL cortex during 
early withdrawal between BDNF, TC-2153, and hM3Dq activation. The horizontal 
dotted line indicates baseline ERK activity, whereas the vertical dotted lines 
indicates timepoint of maximal or minimal ERK activity. B. Schematic illustrating 
the hypothesized behavioral consequences of BDNF, TC-2153, and hM3Dq during 
early withdrawal on relapse testing after abstinence or extinction. 
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Chapter 4: Biphasic effect of abstinence duration 
following cocaine SA on corticostriatal structural 




In contrast to depressed glutamatergic neurotransmission in the PrL cortex during 
early withdrawal, after one week of abstinence from cocaine SA, hyper-
phosphorylation of the PKA targets, CREBS133 and GluA1S845, in the PrL cortex 
and synapsin-1S9 in the NAc core emerge (Sun et al., 2014b; Sun et al., 2014a). 
Inhibition of PKA with intra-PrL Rp-cAMPs normalizes these hyper-
phosphorylation events and prevents context-induced relapse to cocaine seeking 
under extinction conditions (Sun et al., 2014b). GluA1S845 phosphorylation by PKA 
enhances glutamate currents by promoting membrane insertion of AMPA 
receptors (Banke et al., 2000). Further, learning promotes incorporation of GluA1-
containing AMPA receptors in large, mushroom-type dendritic spines (Matsuo et 
al., 2008). In addition, mushroom-type spines, relative to smaller, less stable 
spines, show an augmented AMPA receptor-mediated excitatory current in 
response to glutamate uncaging (Matsuzaki et al., 2001). Thus, cocaine-induced 
adaptations in glutamate transmission are likely associated with altered dendritic 
spine morphology and AMPA receptor expression. However, it is unknown how 
the signaling events occurring in the PrL cortex during these stages of early 
withdrawal and abstinence translate into alterations in spine morphology and/or 
density, changes that have been linked to relapse propensity (Russo et al., 2010; 
Gipson et al., 2013). 
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 Although cocaine-induced alterations in structural plasticity within the NAc 
core are well-documented (Gipson et al., 2013; Stefanik et al., 2016), conflicting 
reports have appeared about modifications in structural plasticity in PrL pyramidal 
neurons after the end of cocaine SA. The earliest report, based on Golgi staining, 
indicated that cocaine SA followed by one month of abstinence increased layer V 
apical spine density (Robinson et al., 2001). More recently, it was reported (also 
with Golgi staining) that synaptic density was significantly reduced, but the density 
of thin dendritic spines was significantly increased, on layer V pyramidal neurons 
in the PrL cortex after one week of abstinence (Rasakham et al., 2014). In contrast, 
using intracellular dye filling, cocaine SA followed by two weeks of abstinence 
reduced layer II/III distal apical spine density, but remaining spines showed 
augmented volume (Radley et al., 2015). Thus, changes in structural plasticity in 
the PrL cortex after cocaine SA may depend on the type of pyramidal neurons 
analyzed, the duration of cocaine abstinence, and the technological strategy used 
to reveal dendritic spine morphology. 
 Various techniques have been used to visualize dendritic spine morphology 
including Golgi-Cox staining, lipophilic dye (i.e. DiI) labeling, intracellular dye filling 
(i.e. lucifer yellow iontophoresis), or transgenic animals expressing YFP driven by 
cell-type specific promoters (i.e. thy1 promoter-driven YFP transgenic mice). 
Although Golgi staining provides sparse and complete labeling of deep-layer 
pyramidal neuron dendritic arbors, it severely underestimates the density of thin 
spines (Shen et al., 2008). In contrast, lipophilic dyes such as DiI provide sparse 
and intense labeling of pyramidal neuronal somas but minimize visualization of the 
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long apical dendrites of deep-layer pyramidal neurons (Trantham-Davidson et al., 
2017). Moreover, intracellular dye filling with fluorescent dyes such as Lucifer 
Yellow allows for investigator-controlled labeling of neurons, but inconsistently 
labels apical dendritic arbors of deep-layer pyramidal neurons in the PFC (Radley 
et al., 2015). Finally, thy1-YFP transgenic mice have been used extensively for 
dendritic spine morphometric analyses (Keifer et al., 2015; Swanson et al., 2017). 
However, their utility is generally restricted to experiments involving mice because 
only one study has described the use of thy1-YFP rats (Magill et al., 2010).   
A recent experiment found that intersectional viral approaches using a cell 
type-specific promoter expressing Cre recombinase in D1 receptor-expressing 
MSNs in the striatum in conjunction with Cre-dependent fluorescent reporters can 
be used to label dendritic spines (Dos Santos et al., 2017). In parallel, we recently 
found that an intersectional viral approach can be used to fully label the dendritic 
trees of deep-layer pyramidal neurons in the PrL cortex with pathway specificity. 
Moreover, this approach can be combined with immunohistochemical detection of 
various proteins of interest in different dendritic subcompartments, allowing for a 
high-throughput analysis of dendritic spine morphology and associated protein 
expression in spines of PrL cortical neurons projecting to the NAc core. In the 
current experiment, we focused our attention specifically on the distal apical tuft of 
layer V neurons in part because chronic stress produces a selective reduction in 
distal apical tuft dendrite length as well as spine density in layer V PrL cortical 
neurons (Liu and Aghajanian, 2008). Additionally, recent evidence indicates a 
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relationship between abstinence from cocaine SA, stress, and prefrontal pyramidal 
neuron apical tuft regressive structural plasticity (Radley et al., 2015). 
Because PrL cortical glutamatergic transmission switches from a putatively 
hypoactive to a hyperactive state as a function of abstinence duration from cocaine 
(Sepulveda-Orengo et al., 2017; Dennis et al., 2018), we hypothesized that activity 
markers and dendritic spine morphometric features would follow a similar trajectory 
in PrL-NAc neurons because this pathway is highly implicated in pathological 
adaptations that promote cocaine seeking (Kalivas et al., 2005). Here we show 
that cocaine SA causes a biphasic alteration in nuclear markers of neuronal activity 
(Fos, p-CREB), structural plasticity, as well as AMPA receptor immunoreactivity in 
dendritic spines of PrL-NAc core neurons after two hours of withdrawal or one 
week of abstinence, changes which are likely important for subsequent relapse to 
cocaine seeking.  
Materials and Methods 
Animal subjects  
Thirty-two adult male Sprague Dawley rats were used in this study (Charles Rivers 
Laboratories; Wilmington, MA). Rats were acclimated to the vivarium and catheter 
surgery was performed identical to methods in Chapters 2 and 3. Following 
catheterization, rats were secured in a stereotaxic apparatus (Kopf Instruments, 
Tujunga, CA) for intra-cranial virus microinjections. 
Viral constructs and stereotaxic surgery 
All viral procedures and constructs used in this study were approved by the 
Medical University of South Carolina Institutional Biosafety Committee. All rats 
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received a single microinjection (0.75 µl/hemisphere) of a canine adeno virus type 
2 expressing a Cre-eGFP (CAV2-Cre-eGFP) fusion protein under the control of a 
CMV promoter (3.6x1012 vg/ml) (gift of E. Kremer, Montpellier Molecular Genetic 
Institute Vector Core, Montpellier, FR) within the NAc core (coordinates: +1.6 mm 
AP from bregma, +/- 2.8 mm ML from bregma, -7.1 mm DV from skull, 10º angle). 
Rats were then microinjected within the PrL cortex (coordinates: +2.8 mm AP from 
bregma, +/- 0.6 mm from bregma, -3.8 DV from skull) with an AAV5-hSyn-DIO-
mCherry (~1.5X1012 vg/ml) obtained from Addgene (Cambridge, MA). Injections 
were performed over a period of 5 minutes (0.15 µl/minute) using a Nanoject II 
(Drummond scientific, Broomall, PA) and injectors were left in place for 10 minutes 
to facilitate diffusion away from the injection site, then slowly retracted. Following 
surgery, bore holes were sealed with dental acrylic, and the incision was sutured 
closed. Rats were allowed at least 5 days of recovery, during which food and water 
were available ad libitum prior to beginning behavioral training.  
Self-administration  
SA procedures, including use of yoked saline controls, were conducted in an 
identical manner to those in Chapter 2.   
Abstinence and perfusions 
In Experiment 1, rats were returned to their homecage for two hours after the final 
cocaine SA session, heavily anesthetized with equithesin (~0.5 ml, i.v.), and 
transcardially perfused with 150 ml of ice-cold 0.1M phosphate buffer (PB) at 60 
ml/minute followed by 200 ml of ice-cold 4% paraformaldehyde (PFA, pH 7.4) in 
0.1M PB. Brains were rapidly removed and immersed in the same fixative for 1 
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hour, then transferred to a 20% sucrose solution prior to sectioning. In Experiment 
2, rats were perfused one week after the final cocaine SA session following forced 
homecage abstinence where food and water were provided ad libitum, and brains 
were post-fixed for 24 hours. To match virus expression duration between 
experiments, rats in Experiment 1 were given an extra week of recovery after 
surgery prior to beginning SA. 
Immunohistochemistry 
Coronal sections (AP +2.52-4.2 mm from bregma) were sliced at 80 µm using a 
Leica cryostat and collected in 0.1M PBS containing 0.01% sodium azide. Sections 
were stored at 4ºC until immunohistochemical processing. Immunohistochemistry 
was performed according to previously published protocols (Scofield et al., 2016b). 
Briefly, sections were blocked with 0.1M phosphate-buffered saline containing 2% 
Triton X-100 (PBST) and 2% normal goat serum (NGS) for two hours at RT 
protected from light. Sections were then incubated in chicken anti-mCherry 
(1:2000; LS Biosciences #LS-C204825, Seattle, WA RRID:AB_2716246), mouse 
anti-GluR2 (2.13 ug/ml; Millipore #MAB397, Billerica, MA RRID:AB_2113875), 
rabbit anti-GluA1 (1:500; Cell Signaling Technology #13185, Danvers, MA), rabbit 
anti-cFos (1:1000, Santa Cruz Biotechnology #sc-52, Dallas, TX 
RRID:AB_2106783), or mouse anti-p-CREB (1:200, Cell Signaling Technology, 
#9196, Danvers, MA RRID:AB_331275) at 4ºC overnight. Sections were washed 
3 X 10 minutes in PBST, and then incubated with species-appropriate Alexa 
Fluor®594 (mCherry), Alexa Fluor®488 (Fos, p-CREB), or Alexa Fluor®647 (GluA1, 
GluA2)-conjugated secondary antisera (1:1000, Abcam, Cambridge, UK) diluted 
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in 2% PBST with 2% NGS for 5 hours at room temperature (RT) protected from 
light. Sections were washed 3 X 10 minutes and then mounted on superfrost plus 
slides using ProLong® gold Antifade (Thermo Fisher Scientific; Waltham, MA). 
Slides were stored at 4ºC until imaging. 
Confocal microscopy 
Fos/p-CREB quantitation. Confocal Z-stack (50 µm) images were captured with 
a Leica SP8 confocal microscope. Fos or p-CREB immunoreactivity (IR) was 
excited using an Optically Pumped Semiconductor Laser (OPSL) 488 nm line 
using a 20X air objective. mCherry IR was excited using an OPSL 552 nm laser 
line. Z-stacks were then imported to Imaris. The spot tool in Imaris was used and 
detection threshold and spot size were empirically determined and maintained 
constant for each measurement. The number of p-CREB-IR or Fos-IR cells was 
counted automatically for each hemisphere and averaged across 1 section per rat. 
The spots colocalization extension in Imaris was used to determine coregistry 
between mCherry+ and Fos/p-CREB+ somas. The number of mCherry-IR neurons 
that were p-CREB or Fos-IR was normalized to the number of total mCherry-IR 
neurons.  
Dendritic Spine Imaging. Confocal Z-series data sets were acquired using a 
Leica SP8 laser-scanning confocal microscope. Dendrites selected for imaging 
had the following characteristics: the apical dendritic segment was 1) visually 
connected to the cell body of origin, 2) after the third branch point, 3) >15 μm below 
the surface of the tissue, and 4) located within 10 µm of the end of the dendrite 
(i.e. approaching the pial surface). Overall imaging parameters including laser 
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power, gain, pinhole, and optical section thickness were set empirically prior to 
imaging and were held constant for the remainder of the experiment. mCherry was 
excited using an OPSL 552 nm laser line, and GluA1/2 were excited using a Diode 
638 nm laser line.  Emitted photons were collected using high-sensitivity hybrid 
detectors (HyD). Images were acquired with a 1024x512 frame size, 3.5X digital 
zoom, and 0.1 um step size generating a voxel size of 52nm X 52nm X 100nm. 
Images were acquired using sub-airy unit pinhole sizes. These parameters were 
selected to obtain optimal deconvolution as recommended by Huygens essential 
deconvolution software (Hilversum, NL). The resulting set of parameters allows for 
a minimum resolution of 150nm XY by 300nm Z in our reconstructions. Four to 
twelve dendritic spine segments were analyzed per animal, each with an 
accompanying GluA1 or GluA2 channel collected.  
Imaris 3D reconstruction, morphological analyses, and colocalization 
Following deconvolution, Z-stacks were imported into BitPlane Imaris (version 9.0) 
for morphological analyses. Z-stacks were cropped in 3D to isolate individual 
dendrites, and a 3D space-filling model was generated to isolate voxels 
corresponding to the mCherry-positive dendrite of interest. The filament module 
was used to semi-manually trace identified dendritic spines as described 
previously (Trantham-Davidson et al., 2017). Dendritic spine head diameter was 
calculated using an automated threshold set by Imaris. To calculate dendritic spine 
density, the number of spines was normalized to the length of the dendrite (in µm). 
Segments were typically 40-50 μm in length.  
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 The “create channel” filament extension was used to generate a channel 
defined by the filament built by Imaris, which was used for colocalization analyses. 
To isolate GluA1/2-IR corresponding to dendritic spine heads relative to total 
dendrite, the “filament analysis” extension was used to mask all GluA1/2-IR not 
corresponding to Imaris-defined dendritic spine heads and shafts. Filament 
analysis uses the predefined boundaries of the spine heads relative to the dendritic 
shaft to isolate specific channels of interest in dendritic subcompartments. 
For colocalization analyses, a region of interest (ROI) containing only the 
mCherry dendrite was used. The colocalization module of Imaris was used to 
perform standard intensity-based colocalization analyses between total mCherry 
signal and total GluA1/2 signal (dendrite shaft and spine heads). The intensity 
value at which a voxel could be considered coregistered was set empirically by a 
blinded investigator for both channels as described previously (Scofield et al., 
2016b). We recorded the percent of signal above threshold to determine whether 
differences in the intensity of signal impacted coregistry analyses for GluA1, 
GluA2, and mCherry. Percent colocalization was calculated by normalizing the 
total volume of GluA1/2-mCherry coregistry to the total volume of mCherry. The 
total colocalization channel was then separated into Imaris-defined spine heads 
and dendritic shaft using the “filament analysis” extension, and a 3D space-filling 
model was generated corresponding to colocalized voxels for a) spine head-
specific colocalization and b) dendritic shaft-specific colocalization. Electron 
microscopy studies indicate that a significant amount of GluA2 expression is 
present in both dendritic shafts and spine heads (Vissavajjhala et al., 1996) and in 
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vitro experiments indicate similar patterns for GluA1 (Szepesi et al., 2014). Thus, 
percent colocalization was determined for total GluA1/2, spine head-specific 
GluA1/2, and dendritic shaft-specific GluA1/2 by normalizing the volume of 
colocalized voxels in each compartment to the volume of the mCherry dendrite. To 
determine specific spine head bins that may account for overall alterations in spine 
head diameter, the number of spines within each bin was normalized to the total 
number of spines and compared between groups. To determine spine head bins 
that show more/less GluA1/2 coregistry in spine heads, the volume of coregistry 
was manually counted in each spine, then averaged for each bin for each segment, 
then across segments for each animal. All analyses were performed by an 
individual blinded to experimental treatment groups. 
Statistical analyses 
Behavioral data were analyzed with a two-way repeated measures (RM) ANOVA 
with treatment (cocaine versus saline) as a between-subjects factor and SA 
session as a within-subjects factor followed by Bonferroni-corrected pairwise 
comparison’s when a significant interaction was observed. A two-tailed t-test with 
or without Welch’s correction was used when two groups were compared for a 
single dependent variable. Binned dendritic spine head and GluA1/2 colocalization 
volume data were analyzed with a two-way RM ANOVA with treatment (cocaine 
versus saline) as a between-subjects factor and bin as a within-subjects factor 
followed by a Bonferroni-corrected pairwise comparison test when a significant 
interaction was observed, as previously performed (Ball et al., 2009). Each 
animal’s dendritic spine or colocalization data points were derived from an average 
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across the analyzed segments. Cumulative frequency distribution data were 
analyzed to determine general shifts in spine head diameter for each group using 
a Kolmogorov-Smirnov non-parametric test. When correlating spine head diameter 
and density with p-CREB-IR, Pearson’s correlation test was used. Statistical 
outliers were detected with Grubbs’ test and were excluded from all analyses as 
discussed in the results. Data are expressed as the mean +/- SEM, and 
significance was determined at p<0.05.  
Results 
Experimental design and cocaine SA 
The timeline for Experiments 1 and 2 are shown in Figure 4.1A. Representative 
CAV2-Cre-eGFP expression in the NAc core and an mCherry-expressing PrL-NAc 
core neuron are shown in Figure 4.1B and C, respectively. Figure 4.1D shows a 
representative PrL-NAc core neuron immunohistochemically processed for GluA2. 
Figure 4.1E shows cocaine SA data. A two-way RM ANOVA revealed a significant 
treatment (cocaine versus saline) by session interaction for active lever presses 
(F(11,264)=2.01, p<0.05) as well as a significant main effect of treatment 
(F(1,24)=38.88, p<0.0001), but not time (F(11,264)=1.69, p>0.05). Bonferroni-
corrected pairwise comparisons indicated a significant difference between cocaine 
and saline on SA sessions 4-12 (all p<0.05). There was no significant treatment 
by SA session interaction for inactive lever presses (F(11,264)=1.19, p>0.05), nor 
was there a significant main effect of time (F(11,264)=0.60, p>0.05). However, there 
was a significant main effect of treatment (F(1,24)=4.31, p<0.05). Thus, yoked saline 
controls pressed the inactive lever more than cocaine SA rats. Additionally, 
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cocaine SA rats showed lever discrimination, as evidenced by a significant main 
effect of lever (active versus inactive) (F(1,24)=60.38, p<0.0001).   
 
 
Figure 4.1. Experimental timeline, virus expression, and cocaine-induced 
alterations in Fos-IR in PrL-NAc core neurons during early withdrawal A. Timeline 
for Experiments 1 and 2. B. Representative CAV2-Cre-eGFP virus expression in 
the NAc core. Dotted lines indicate lateral ventricle (top), anterior commissure (ac, 
center) and border of NAc core and shell. C. Representative mCherry-labeled PrL-
NAc core layer V neuron. Inset corresponds to a representative dendritic spine 
segment taken from the distal apical tuft. D. Representative mCherry-labeled spine 
segment from distal apical tuft of a layer V PrL-NAc core neuron displaying GluA2-
IR (top). Bottom left – GluA2 IR corresponding only to mCherry signal within the 
dendrite. Bottom right – GluA2-mCherry coregistered voxels in dendritic spine 
heads (yellow) and dendritic shaft (white). E. SA data over the last 12 days of SA. 
Sold lines and closed symbols indicate active lever presses and dotted lines with 
open signals indicates inactive lever presses. F-G. Fos+ cells in layer V of the PrL 
cortex (F) and mCherry+Fos+ normalized to total mCherry+ cells (G). H. Top - 
representative images of Fos+ neurons in saline and cocaine SA rats. Bottom - 
Representative Fos+ mCherry+ and Fos+ mCherry- neurons in saline and cocaine 
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SA rats. White arrows indicate Fos+ mCherry+ neurons, yellow arrows indicate Fos+ 
mCherry- neurons. Scale bars = 200 μm (B), 50 μm (C), 5 μm (Inset, C), 2 μm (D), 
40 μm (H). ****p<0.0001 comparing cocaine to saline active lever presses. SA: 
self-administration. dH: spine head diameter. 
 
Effect of cocaine SA on PrL-NAc core structural plasticity, Fos-IR, p-CREB-
IR, and GluA1/2-IR during early withdrawal. 
 
In Experiment 1, rats (N=16) underwent 12-14 days of cocaine SA or received 
yoked-saline infusions and were then transcardially perfused two hours after the 
final SA session. One yoked-saline rat was excluded due to a missed NAc core 
placement. Two cocaine SA animals were excluded due to failed catheters. The 
final sample sizes were n=6 for cocaine and n=7 for yoked saline. First, we 
examined Fos-IR in layer V PrL cortex in a subset of yoked-saline and cocaine SA 
rats (n=4 per group). One section at approximately the same coronal plane was 
analyzed per rat. A two-tailed t-test indicated a non-significant effect of cocaine SA 
on Fos-IR in layer V PrL neurons (t(6)=1.70, p>0.05, Fig. 4.1F). When limiting 
analysis to mCherry+ neurons, a two-tailed t-test revealed a significant reduction in 
the percent of mCherry+ neurons expressing Fos (t(6)=3.31, p<0.05, Fig. 4.1G). 
Representative images of Fos+ mCherry- and Fos+ mCherry+ neurons for saline and 
cocaine SA rats are shown in Figure 4.1H.  
Next, a subset of animals was used to analyze p-CREB-IR in the PrL cortex 
(n=5 per group due to limited number of sections available). One section, at 
approximately the same coronal plane, was analyzed per rat. A two-tailed t-test 
indicated a non-significant effect of cocaine SA on p-CREB-IR in layer V PrL 
neurons (t(8)=1.16, p>0.05, Fig. 4.2A). However, when limiting analysis only to 
mCherry+ PrL-NAc core neurons, a Welch’s-corrected two-tailed t-test showed a 
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significant decrease in the percentage of mCherry+ neurons displaying p-CREB-
IR (t(4.7)=2.94, p<0.05, Fig. 4.2B). There was no difference between groups in the 
average p-CREB signal intensity in all cells that were p-CREB+ (t(8)=0.87, p>0.05, 
Fig. 4.2C) or mCherry+p-CREB+ neurons (t(8)=0.96, p>0.05, Fig. 4.2D). 
Representative images of mCherry- p-CREB+ and mCherry+p-CREB+ neurons from 
yoked-saline and cocaine SA rats are shown in Figure 4.2E.  
We next asked whether the alteration in PrL-NAc core activity markers 
during early withdrawal was associated with altered dendritic spine morphometry 
and AMPA receptor expression. Adjacent sections from the same rats were 
immunostained for mCherry and GluA1 or mCherry and GluA2 in two separate 
runs. Dendritic spine morphometric data from distal tufts of layer V dendrites were 
pooled from both runs. In a minority of instances when sections from individual 
animals showed mCherry neurons labeled for GluA1, but not GluA2, and vice 
versa, due to technical issues, the spine morphometry data for that animal 
consisted of the run in which mCherry neurons were labeled, but the colocalization 
data for that animal for the selected protein was not included. A two-tailed t-test 
indicated that there was a significantly lower spine head diameter average 
(t(11)=3.19, p<0.01, Fig. 4.2F) in cocaine SA rats than in yoked-saline rats but there 
was no difference in spine density between groups (t(10)=1.83, p>0.05, Fig. 4.2G). 
There was no difference between cocaine and saline groups in the average spine 
head center intensity (t(11)=0.53, p>0.05, Fig. 4.2H), indicating that the mCherry 
intensity in dendritic spine heads did not contribute to the observed effects.  
Additional binned analyses revealed that cocaine SA altered the percent of total 
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spines as a function of spine head diameter (in 0.1 µm bins) as evidenced by a 
significant two-way RM ANOVA treatment by spine head diameter bin interaction 
(F(5,55)=6.59, p<0.0001). Bonferroni-corrected pairwise comparisons indicated a  
significant increase in the percent of total spines with head diameters between 0.3-
0.4 µm (p<0.01) and a significant decrease in the percent of total spines with head 
diameters between 0.6-0.7 µm (p<0.05) and above 0.7 µm (p<0.01, Fig. 4.2I) in 
cocaine SA rats. These changes were associated with a general leftward shift in 
spine head diameter after all spines in saline (n=1651) and cocaine SA (n=2159) 
rats were analyzed as shown by a non-parametric Kolmogorov-Smirnov test (K-S 
p<0.0001, Fig. 4.2J). Representative dendrites from yoked-saline and cocaine SA 
rats are shown in Figure 4.2K. Interestingly, there was a positive correlation 
between spine head diameter and p-CREB-IR (r2=0.64, p<0.01, Fig. 4.2L) whereas 
there was a negative correlation between spine density and p-CREB-IR (r2=0.44, 
p<0.05, Fig. 4.2M).  
106 
 
Figure 4.2. Cocaine SA decreased PrL-NAc core p-CREB-IR and dendritic spine 
head diameter during early withdrawal. A-B. p-CREB+ cells in layer V of the PrL 
cortex (A) and mCherry+ p-CREB+ normalized to total mCherry+ cells (B).  C-D. 
There was no difference between groups in p-CREB signal intensity in all p-CREB+ 
neurons (C) or mCherry+ p-CREB+ neurons (D). E. Top-representative images of 
p-CREB+ neurons in yoked-saline and cocaine SA rats. Bottom-representative 
mCherry+ p-CREB+ and mCherry+ p-CREB- neurons in yoked-saline and cocaine 
SA rats. White arrows indicate mCherry+p-CREB+ neurons, yellow arrows indicate 
mCherry+ p-CREB- neurons. F. Cocaine SA decreased spine head diameter 
compared to yoked-saline controls. G. There was no difference in spine density 
between groups. H. The average mCherry signal intensity in the center of the spine 
head was not different between groups. I-J. Cocaine SA rats show a general 
leftward shift in percent of total spines as a function of spine head diameter (I) and 
cumulative frequency (J). K. Representative dendrites from saline and cocaine SA 
rats. L-M. The percentage of mCherry+ neurons that are also p-CREB+ positively 
correlated with dendritic spine head diameter (L), but negatively correlated with 
dendritic spine density (M). *p<0.05, **p<0.01 compared to saline. Scale bars = 40 




Next, a subset of the sections was immunostained for mCherry and GluA1, 
as described above. One saline rat showed no neurons labeled for mCherry in this 
run and was not included in the analysis. Final sample sizes were n=6 for both 
groups. Interestingly, analyses revealed a significant reduction in total GluA1-IR in 
PrL-NAc core dendrites (t(10)=2.39, p<0.05, Fig. 4.3A). This was accounted for by 
a decrease in shaft-specific GluA1-IR (t(10)=2.45, p<0.05, Fig. 4.3B) as well as a 
decrease in spine head-specific GluA1-IR (t(10)=2.30, p<0.05, Fig. 4.3C). When 
analyzing GluA1 volume in spine heads as a function of dendritic spine head 
diameter, a two-way RM ANOVA revealed a significant treatment by spine head 
diameter bin interaction (F(5,50)=4.18, p<0.01). Bonferroni-corrected pairwise 
comparisons indicated that cocaine SA rats showed a specific decrease in GluA1- 
IR in spine heads larger than 0.7 μm (p<0.0001, Fig. 4.3D). Importantly, these 
effects are likely not due to differences in empirical thresholds set for GluA1 
because the percent of signal above threshold was not different between cocaine 
and saline groups (t(10)=1.10, p>0.05, Fig. 4.3E). The percent of mCherry signal 
above threshold was also not different between groups (t(10)=0.73, p>0.05, Fig. 
4.3F). Furthermore, reduced overall GluA1-IR was not accounted for by reduced 
average signal intensity of GluA1 in the mCherry+ dendrites (t(10)=0.29, p>0.05, 
Fig. 4.3G). Representative spine segments are shown in Figure 4.3H. 
Next, sections from all animals were immunostained for GluA2. One yoked- 
saline rat was excluded from analysis due to immunohistochemical detection 
issues leading to profound saturation in each image. Thus, final sample sizes were 
n=6 per group. Unlike GluA1, total GluA2-IR was not altered by cocaine (t(10)=0.51, 
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p>0.05, Fig. 4.3I). Moreover, there was no effect of cocaine on shaft-specific 
GluA2-IR (t(10)=0.22, p>0.05, Fig. 4.3J) but there was a trend towards reduced 
spine head-specific GluA2-IR (t(10)=1.74, p=0.11, Fig. 4.3K). However, like GluA1, 
there was a treatment by spine head diameter bin interaction on GluA2-IR volume 
as a function of spine head diameter (F(5,50)=4.89, p<0.01). A Bonferroni-corrected 
pairwise comparison test indicated a specific reduction in GluA2-IR in spines larger 
than 0.7 μm (p<0.0001, Fig. 4.3L) in the cocaine group. These effects are likely 
not due to differences in the empirical thresholds set for GluA2 because the 
percent of signal above threshold was not different between groups (GluA2: 
t(10)=0.67, p>0.05, Fig. 4.3M; mCherry: t(10)=2.04, p>0.05, Fig. 4.3N). Moreover, 
there was no difference between groups in the average GluA2-IR intensity in 
mCherry+ dendrites (t(10)=0.30, p>0.05, Fig. 4.3O). Representative spine segments 
are shown in Figure 4.3P. 
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 Figure 4.3. Cocaine SA reduced GluA1/2-IR in enlarged mushroom spines of PrL-
NAc core neurons during early withdrawal. A. Total GluA1-IR was decreased in 
PrL-NAc core dendrites. B-C. The decreased total GluA1-IR was accounted for by 
(B) decreased GluA1 in the dendritic shaft and (C) decreased GluA1 in dendritic 
spine heads. D. The decreased GluA1-IR in spine heads was specific to spines 
with head diameters larger than 0.7 μm. E-F. The signal above threshold for GluA1 
(E) and mCherry (F) was not different between groups. G. The average GluA1 
signal intensity in mCherry+ dendrites was not different between groups. H. 
Representative dendrites from saline (left) and cocaine (right) showing mCherry 
(top), mCherry + GluA1 (middle), and shaft-specific versus spine head-specific IR 
(bottom). I. There was no difference between cocaine and saline in total GluA2-IR. 
J-K. There was no difference between cocaine and saline in shaft-specific GluA2- 
IR (J), but a strong trend towards decreased spine head-specific GluA2-IR (K). L. 
Cocaine SA rats showed decreased GluA2-IR only in spines greater than 0.7 μm. 
M-N. The signal above threshold for GluA2 (M) and mCherry (N) was not different 
between groups. O. The average GluA2 signal intensity in the mCherry+ dendrites 
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was not different between groups. P. Representative dendrites showing decreased 
spine head-specific GluA2 (bottom) in cocaine (right) relative to saline controls 
(left). Scale bars = 2 μm. *p<0.05, **p<0.01, ****p<0.0001 compared to saline.  
 
Effect of cocaine SA on PrL-NAc core activity markers, structural plasticity, 
and GluA1/2-IR after one week of abstinence 
 
In Experiment 2, rats (N=16) underwent 12-14 days of cocaine SA or received 
yoked-saline infusions. One yoked-saline rat never finished SA due to stress 
reactions when handled. One yoked-saline rat was removed from analyses 
because of insufficient virus expression and one cocaine SA rat was removed as 
a statistical outlier in colocalization analyses. Final sample sizes were n=6 for 
saline and n=7 for cocaine.  
A subset of animals was used to analyze p-CREB-IR in the PrL cortex (n=3 
per group). One section, at approximately the same coronal plane, was analyzed 
per rat. A two-tailed t-test indicated a non-significant effect of cocaine SA on p-
CREB-IR, although there was a trend towards elevated p-CREB-IR in cocaine SA 
rats (t(4)=2.04, p=0.11, Fig. 4.4A). However, when limiting analysis only to mCherry+ 
PrL-NAc core neurons, a two-tailed t-test showed a significant increase in the 
percentage of mCherry+ neurons displaying p-CREB-IR (t(4)=3.41, p<0.05, Fig. 
4.4B). There was no difference between groups in the average p-CREB signal 
intensity in all cells that were p-CREB+ (t(4)=1.02, p>0.05, Fig. 4.4C) or in cells 
that were mCherry+ p-CREB+ (t(4)=1.18, p>0.05, Fig. 4.4D). Representative 
images of mCherry- p-CREB+ and mCherry+ p-CREB+ neurons in yoked-saline and 
cocaine SA rats are shown in Figure 4.4E.  
Next, we asked whether this increase in p-CREB-IR in PrL-NAc core 
neurons after one week of abstinence was associated with altered spine head 
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diameter of PrL-NAc core neurons. In contrast to early withdrawal, cocaine SA 
followed by one week of abstinence produced a profound increase in spine head 
diameter of PrL-NAc core distal apical tuft dendrites (t(11)=7.44, p<0.0001, Fig. 
4.4F), but an overall reduction in spine density, in cocaine SA compared to yoked-
saline rats (t(11)=4.32, p<0.01, Fig. 4.4G). Akin to Experiment 1, there was no 
difference in the average spine head center intensity between cocaine and saline 
groups (t(11)=1.80, p>0.05, Fig. 4.4H), indicating that the mCherry intensity in 
dendritic spine heads did not contribute to the observed effects. These effects were 
associated with a significant treatment by spine head diameter bin interaction 
(F(5,55)=18.86, p<0.0001). Bonferroni-corrected pairwise comparisons indicated 
that cocaine SA rats showed a reduction in the percent of total spines with head 
diameters between 0.3-0.4 µm (p<0.001), and 0.4-0.5 µm (p<0.01), but an 
increase in the percent of total spines with head diameter above 0.7 µm (p<0.0001, 
Fig. 4.4I). Moreover, these changes were associated with a general rightward shift 
in spine head diameter when analyzing all spines in yoked-saline (n=1907) and 
cocaine SA (n=1642) rats as shown by a Kolmogorov-Smirnov test (K-S p<0.0001, 
Fig. 4.4J). Representative dendrites from a yoked-saline and cocaine SA rat are 
shown to the right in Figure 4.4K. Like early withdrawal, we found that spine head 
diameter and p-CREB-IR showed a positive correlation (r2=0.82, p<0.01, Fig. 
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4.4L), whereas spine density and p-CREB-IR showed a non-significant trend 
towards a negative correlation (r2=0.58, p=0.07, Fig. 4.4M).  
Figure 4.4. Cocaine SA increased PrL-NAc core p-CREB-IR and dendritic spine 
head diameter following one week of abstinence. A-B. p-CREB+ cells in layer V of 
the PrL cortex (A) and mCherry+ p-CREB+ normalized to total mCherry+ cells (B).  
C-D. There was no difference between groups in p-CREB signal intensity in all p-
CREB+ neurons (C) or mCherry+ p-CREB+ neurons (D). E. Top-representative 
images of p-CREB+ neurons in yoked-saline and cocaine SA rats. Bottom-
representative mCherry+ p-CREB+ and mCherry+ p-CREB- neurons in yoked-saline 
and cocaine SA rats. White arrows indicate mCherry+ p-CREB+ neurons, yellow 
arrows indicate mCherry+ p-CREB- neurons. F-G. Cocaine SA increased spine 
head diameter (F), but decreased spine density (G) compared to yoked-saline 
controls. H. The average mCherry signal intensity in the center of the spine head 
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was not different between groups. I-J. Cocaine SA rats showed a general rightward 
shift in percent of total spines as a function of spine head diameter (I) and 
cumulative frequency (J). K. Representative dendrites from saline and cocaine SA 
rats. L-M. The percentage of mCherry+ neurons that are also p-CREB+ positively 
correlated with dendritic spine head diameter (L) and showed a trend toward 
negatively correlating with dendritic spine density (M). *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001 compared to saline. Scale bars = 40 μm (E), 5μm (K). 
 
To determine whether this hypertrophic structural alteration in spine head 
diameter and elevated p-CREB-IR were associated with altered GluA1-IR, we 
performed the same colocalization analyses as described above. However, 
sections from one cocaine animal did not show virus expression in the run 
processed for GluA1 but was included in GluA2 measurements (see below). 
Interestingly, the elevated spine head diameter was associated with an overall 
reduction in total GluA1 coregistry with mCherry in the cocaine group (t(10)=2.79, 
p<0.05, Fig. 4.5A). This effect was associated with reduced dendritic shaft-specific 
GluA1-IR (t(10)=3.55, p<0.01, Fig. 4.5B), but increased spine head-specific GluA1-
IR (t(10)=2.50, p<0.05, Fig. 4.5C). A two-way RM ANOVA revealed a significant 
treatment by spine head diameter bin interaction of GluA1 volume as a function of 
spine head diameter (F(5,50)=11.87, p<0.0001). Bonferroni-corrected pairwise 
comparison tests indicated an increase in GluA1-IR in spines larger than 0.7 μm 
(p<0.0001, Fig. 4.5D) in cocaine SA rats. It is unlikely that differences in empirical 
thresholds set for GluA1 or mCherry accounted for these differences because the 
percent of signal above threshold was not different between cocaine and saline 
groups (GluA1: t(10)=0.53, p>0.05, Fig. 4.5E; mCherry: t(10)=1.13, p>0.05, Fig. 
4.5F). There was also no difference in the average intensity of GluA1-IR in 
114 
 
mCherry+ dendrites between groups (t(10)=1.54, p>0.05, Fig. 4.5G). Representative 
spine segments are shown in Figure 4.5H. 
Next, sections were immunostained for GluA2 and mCherry and 
colocalization analyses were performed as described above. All 13 animals 
showed labeled neurons and thus sample sizes for this experiment were n=6 
(saline) and n=7 (cocaine). Interestingly, in contrast to GluA1, total GluA2-IR was 
unaffected after one week of abstinence from cocaine SA (t(11)=0.97, p>0.05, Fig. 
4.5I). There was no difference between groups in dendritic shaft-specific GluA2-IR 
(t(11)=0.08, p<0.05, Fig. 4.5J), but cocaine SA rats showed elevated spine head-
specific GluA2-IR (t(11)=3.47, p<0.01, Fig. 4.5K). A two-way RM ANOVA revealed 
a significant treatment by spine head diameter bin interaction (F(5,55)=5.58, 
p<0.001). Bonferroni-corrected pairwise comparison tests indicated that the 
elevated spine head-specific GluA2-IR was specific to spines greater than 0.7 μm 
(p<0.0001, Fig. 4.5L). Consistent with our previous findings, these effects were not 
due to differences in thresholds for GluA2 or mCherry because the percent of 
signal above threshold was not different between groups (GluA2: t(11)=0.63, 
p>0.05, Fig. 4.5M; mCherry: t(11)=1.02, p>0.05, Fig. 4.5N). Moreover, the average 
GluA2 signal intensity in mCherry dendrites was not different between groups 




Figure 4.5. Cocaine SA increased GluA1/2-IR in enlarged mushroom spines of 
PrL-NAc core neurons after one week of abstinence. A. Total GluA1-IR was 
decreased in PrL-NAc core dendrites. B-C. This was accounted for by decreased 
GluA1 in dendritic shafts (B), but increased GluA1 in dendritic spine heads (C). D. 
The increased GluA1-IR in spine heads was specific to spines with head diameters 
larger than 0.7 μm. E-F. The signal above threshold for GluA1 (E) and mCherry 
(F) was not different between groups. G. The average GluA1 signal intensity in the 
mCherry-labeled dendrite was not different between groups. H. Representative 
dendrites from saline (left) and cocaine (right) showing mCherry (top), mCherry + 
GluA1 (middle), and shaft-specific versus spine head-specific IR (bottom). I. There 
was no difference between cocaine and saline in total GluA2 IR. J-K. There was 
no difference between cocaine and saline in shaft-specific GluA2-IR (J), but a 
significant increase in spine head-specific GluA2-IR (K). L. Cocaine SA rats 
showed increased GluA2-IR only in spines greater than 0.7 μm. M-N. The signal 
above threshold for GluA2 (M) and mCherry (N) was not different between groups. 
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O. The average GluA2 signal intensity in the mCherry-labeled dendrite was not 
different between groups. P. Representative dendrites showing decreased spine 
head-specific GluA2 (bottom) in cocaine SA (right) relative to yoked-saline controls 
(left). Scale bars = 2 μm. *p<0.05, **p<0.01, ****p<0.0001 compared to saline. 
 
Discussion 
Summary of findings 
Here we show that cocaine SA biphasically alters nuclear activity markers, 
structural plasticity, and AMPA receptor expression in dendritic spines of PrL-NAc 
core neurons depending on the duration of abstinence. We found that two hours 
after cocaine SA, PrL-NAc core neurons showed decreased Fos-IR and p-CREB-
IR, as well as spine head diameter, suggesting diminished neuronal activity in this 
specific pathway. Further, total GluA1-IR was diminished in PrL-NAc core 
dendrites, which was accounted for by reduced GluA1-IR in dendritic shafts and 
spine heads. Interestingly, total GluA2-IR was unaffected by cocaine SA, although 
both GluA1-IR and GluA2-IR were reduced in enlarged, putative mushroom-type 
spines (i.e. head diameter greater than 0.7 μm), which make up a minority of 
overall dendritic spines. In contrast, one week of abstinence was associated with 
augmented spine head diameter and overall attrition of dendritic spines. Like early 
withdrawal, one week of abstinence reduced overall GluA1-IR, but not GluA2-IR, 
in PrL-NAc core neurons; however, both AMPA receptor subunits were elevated 
in dendritic spine heads of PrL-NAc core neurons, an effect driven by increased IR 
in enlarged, putative mushroom-type spines. At this timepoint, GluA1-IR was again 
reduced in the dendritic shaft. Overall, these findings suggest that the PrL-NAc 
core pathway may be in a hypoactive state during early withdrawal from cocaine 
and potentiated following one week of abstinence. 
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Cocaine SA reduced nuclear activity markers in PrL-NAc core neurons 
during early withdrawal 
 
A previous report indicates that a single session of cocaine SA enhances Fos 
expression in the PrL cortex, which is normalized after six daily sessions of cocaine 
SA (Zahm et al., 2010). However, others have found that 10 daily sessions of 
cocaine SA increased c-fos gene expression in the medial prefrontal cortex 
(including PrL and IL cortices), effects which are maintained following 60 days of 
cocaine SA (Gao et al., 2017). Previously, we found decreased p-CREB-IR in the 
PrL cortex during early withdrawal (Whitfield et al., 2011). In our study, we found 
no effect of cocaine SA on global Fos-IR or p-CREB-IR in layer V PrL cortex. Layer 
V predominantly contains cortical efferents innervating subcortical structures 
implicated in motivation, cognition, and motor activation (Gabbott et al., 2005), one 
of these pathways being the PrL-NAc core pathway, which is well-documented to 
be involved in drug seeking after abstinence (Kalivas, 2009; Jasinska et al., 2015). 
Interestingly, when analyzing Fos-IR and p-CREB-IR in this specific pathway 
during early withdrawal, we found a significant decrease in both markers. Thus, 
cocaine SA likely leads to a dampening of PrL-NAc core activity during early 
withdrawal as evidenced by decreased IR of the activity markers, Fos and p-
CREB.  
Cocaine SA reduced dendritic spine head diameter and GluA1/2 spine head 
localization in PrL-NAc core neurons 
 
PrL-NAc core apical spine head diameter was decreased during early withdrawal 
from cocaine SA. This finding positively correlates with reduced global 
dephosphorylation of GluN2A/B-containing NMDA receptors, ERK, and CREB and 
118 
 
the activation of STEP (Whitfield et al., 2011; Sun et al., 2013; Go et al., 2016; 
Barry and McGinty, 2017), as well as reduced nuclear Fos-IR and p-CREB-IR, and 
GluA1/2-IR in dendritic spines of PrL-NAc core neurons in this study. Supporting 
these observations, a recent study found that following a single injection of 
cocaine, Fos+ neurons relative to random NAc core neurons in cocaine and 
vehicle-injected controls showed elevated dendritic spine density and spine head 
volume (Dos Santos et al., 2017). Thus, Fos expression positively correlates with 
spine morphometric features. Here we found that p-CREB-IR positively correlated 
with spine head diameter, but negatively correlated with spine density. Thus, 
animals that showed higher p-CREB-IR in PrL-NAc core neurons tended to have 
higher average spine head diameter, but lower spine density. In contrast, following 
CREB overexpression in the amygdala, there is an increase in dendritic spine 
density (Sargin et al., 2013). This dichotomy likely reflects the difference between 
CREB overexpression and detection of endogenous p-CREB, as well as different 
brain regions investigated, and the effects of cocaine SA.  
Interestingly, we found distinct and overlapping alterations in AMPA 
receptor subunit expression in PrL-NAc core dendritic spines. Total GluA1-IR was 
suppressed in PrL-NAc core neurons but GluA2-IR was only reduced in a specific 
subset of dendritic spines (i.e. enlarged, mushroom-type spines). GluA1 and 
GluA2 differentially regulate spine morphology (Prithviraj et al., 2008), with GluA2 
playing a key role in spine morphogenesis in vitro (Passafaro et al., 2003; Saglietti 
et al., 2007). Moreover, β3 integrins, which play a critical role in regulating spine 
morphology (Shi and Ethell, 2006), interact strongly with GluA2-, but not GluA1, -
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containing AMPA receptors (Pozo et al., 2012). Although the trafficking of AMPA 
receptors involves multiple complex interactions with AMPA receptor-interacting 
proteins through the C-terminal domains of AMPA receptor subunits (Shepherd 
and Huganir, 2007), there is general consensus that GluA1 and GluA2 differentially 
undergo trafficking and recycling (reviewed in (Anggono and Huganir, 2012).  
Previous data from our lab indicate that short-access cocaine SA has no 
effect on total GluA1 or GluA2 expression in the PrL cortex two hours after the final 
SA session (Sun et al., 2013). Others have shown that 16 hours of withdrawal 
reduces GluA2/3, but not GluA1, protein expression in the mPFC (Hemby et al., 
2005). These apparently contrasting findings are likely due to the different 
timepoints analyzed in the two studies. Moreover, phospho-deficient mutations of 
p-CREBS133 leading to CREB inactivation preferentially alter GluA1 synaptic 
incorporation in a basal state, without affecting synaptic levels of GluA2/3, in the 
hippocampus (Middei et al., 2013). Although our findings indicate that cocaine SA 
differentially regulates total GluA1-IR and GluA2-IR specifically in PrL-NAc core 
neurons during early withdrawal, the finding that both subunits were reduced in 
enlarged dendritic spines, which constitute the majority of AMPA receptor 
expression and function (Matsuzaki et al., 2001), suggests that mature spines 
undergo AMPA receptor removal during early withdrawal from cocaine. Future 
studies will address what molecular mechanisms may be responsible for the 





One week of abstinence from cocaine SA increased the head diameter, but 
decreased the density, of PrL-NAc core neuron dendritic spines while 
augmenting GluA1/2 IR in spine heads 
 
Chronic cocaine SA followed by abstinence alters dendritic spine structural 
plasticity within the PrL cortex (Robinson et al., 2001; Rasakham et al., 2014; 
Radley et al., 2015). However, the precise induction of PrL cortical structural 
plasticity is controversial, with some showing hypertrophic spine changes (i.e. 
increased spine density), whereas others have shown hypotrophic spine 
alterations (i.e. decreased spine density).  
We found that cocaine SA followed by one week of abstinence decreased 
the density of PrL-NAc core neuron apical dendritic spines but increased the 
average head diameter. To the best of our knowledge, the only other study 
investigating layer V PrL cortical structural plasticity after one week of abstinence 
from cocaine SA found increased layer V basal thin spine density, but decreased 
synapse number as well as overall dendritic complexity (Rasakham et al., 2014). 
Our results should not be viewed as contradictory to these findings, rather these 
differences underline the importance of investigating pathway-specific structural 
modifications as well as the region of dendrite investigated as inputs to the apical 
tuft (Liu and Aghajanian, 2008) and basal dendrites (Liu et al., 2015) differ in their 
origin.  
One week of abstinence from cocaine SA leads to increased PKA-mediated 
phosphorylation of CREBS133 as well as GluA1S845 in the PrL cortex. Inhibiting PKA 
activity with an intra-PrL microinfusion of the PKA inhibitor, Rp-cAMPs, suppresses 
relapse to cocaine seeking when tested in the absence of conditioned cues (i.e. 
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context-induced relapse) (Sun et al., 2014b). Here we extend these findings by 
showing that elevated p-CREBS133 and GluA1 occurs in PrL-NAc core nuclei and 
spines, respectively. Although it has not been confirmed that this PKA-mediated 
induction of AMPA receptor phosphorylation results in a physiological 
enhancement of PrL cortical glutamate currents, this is not without precedent as it 
has been recently shown that cocaine conditioned place preference (CPP) training 
increases evoked AMPA receptor excitatory transmission in layer V PrL cortical 
neurons (Otis and Mueller, 2017). 
Interestingly, we found decreased total GluA1-IR in PrL-NAc core neurons 
after one week of abstinence which was largely accounted for by decreased 
dendritic shaft-specific GluA1-IR. However, we found increased spine head-
specific GluA1-IR. These findings infer that cocaine SA leads to compartment-
specific changes in GluA1-IR in PrL-NAc core neurons one week after abstinence 
that are distinct from those which occur during early withdrawal. In contrast to early 
withdrawal, GluA-1IR and GluA2-IR were upregulated in spine heads of PrL-NAc 
core neurons after one week of abstinence. Although GluA2-lacking AMPA 
receptors in the NAc play a key role in cocaine seeking after abstinence in long-
access SA paradigms (Conrad et al., 2008), we are likely not detecting such 
receptors in our model because both AMPA receptor subunits were increased in 
dendritic spines of PrL-NAc core neurons after one week of abstinence. However, 
we cannot exclude the involvement of GluA3/4-containing AMPA receptors in the 
effects of cocaine. Thus, it is possible that we are detecting elevated GluA1/3 as 
well as GluA2/3-containing AMPA receptors in PrL-NAc core spine heads. 
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Electrophysiological experiments would be needed to further discern the 
involvement of specific AMPA receptor subunit conformation in the observed 
effects. Regardless, it is likely that increased AMPA receptor expression in 
enlarged dendritic spines disposes these dendritic compartments to be 
hypersensitive to glutamate release because spines with enlarged volume show 
greater AMPA receptor-mediated excitatory transmission (Matsuzaki et al., 2001; 
Matsuzaki et al., 2004). Because we found an overall decrease in spine density, 
but increased spine head diameter, it is intriguing to hypothesize that specific 
inputs to the distal apical tuft of PrL-NAc core neurons may be potentiated whereas 
others are depressed, but this remains to be tested. This is supported by previous 
work showing that spines adjacent to active synapses have an accumulation of 
AMPA receptors leading to a lack of lateral diffusion (i.e. functional trapping at 
synapses), but AMPA receptors within spines adjacent to inactive synapses rapidly 
diffuse away from synaptic sites (Ehlers et al., 2007). 
Overexpression of the GluA2 subunit of AMPA receptors is sufficient to 
increase dendritic spine density and size (Passafaro et al., 2003). Moreover, 
following learning in a fear conditioning paradigm, newly synthesized GluA1-
containing AMPA receptors are incorporated into synapses preferentially in 
mushroom-type spines (Matsuo et al., 2008). Further, GluA1S845 phosphorylation 
by PKA is critical for the induction of synaptic plasticity governing learning and 
memory (Huganir and Nicoll, 2013). Stimulation of the PKA-GluA1 pathway by 
catecholamines lowers the threshold for LTP induction (Hu et al., 2007), indicating 
that GluA1 phosphorylation by PKA primes AMPA receptors for synaptic 
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incorporation, as shown previously with D1-PKA-GluA1 in cultured prefrontal 
cortical neurons (Sun et al., 2005). Thus, the elevated PKA activity and 
phosphorylation state of the PKA substrates described above that drive relapse 
after abstinence (Sun et al., 2014b) in conjunction with the results described here 
suggest that PrL-NAc core neurons likely exist in a hypersensitive glutamate state 
after one week of abstinence which may be maintained by elevated dopamine 
tone. 
Technical considerations 
Although confocal microscopy does not provide adequate resolution to infer 
surface expression of AMPA receptors or trafficking of AMPA receptors, it does 
provide the resolution to discern differences in compartmentalization of AMPA 
receptors (i.e. dendritic shaft versus spine heads). This is important given that 
previous work shows activity-dependent alterations in AMPA receptor 
compartmentalization in spines versus dendritic shafts in vitro (Shi et al., 1999; 
Brown et al., 2007). Moreover, conventional techniques to measure receptor 
surface expression (i.e. immunoblotting) in their current technological state 
occlude the use of pathway-specific measurements. Interestingly, at both 
timepoints, we observed differential expression of GluA1 and GluA2 in PrL-NAc 
core dendrites. It is plausible that this could be due to differential regulation of 
these AMPA receptor subunits by cocaine experience, which is supported by the 
finding that at both time points total GluA1-IR was decreased whereas total GluA2- 
IR was not. However, this interpretation should be viewed with caution because 
the immunostaining for GluA1 and GluA2 in each experiment was done 
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independently. Thus, this difference could be due to variations in the affinity of the 
antibodies for their respective antigens, although both antibodies have been well-
validated for the use of immunohistochemistry (Vissavajjhala et al., 1996; Yap et 
al., 2017). Thus, directly comparing GluA1 and GluA2 findings may not be 
warranted, whereas the comparison between timepoints for each protein target 
may be more valid.  
Moreover, it could be argued that several variables could account for altered 
spine morphology and increased, or decreased, GluA1/2 expression in spine 
heads, including signal intensity. This is extremely unlikely because a) the mCherry 
intensity in spine heads did not differ between groups in either experiment, and b) 
the percent of signal above threshold and the average signal intensity was not 
different between groups for neither GluA1 or GluA2 in either experiment. Thus, it 
is unlikely that differences in signal intensity contributed to our findings, but rather 
that the observed effects are due to cocaine-induced adaptations in the 
compartmentalization of AMPA receptors in these neurons. 
Conclusions 
The PrL cortex represents an important hub for the integration of sensory and 
motivational computations and is a critical node in which encoded information 
engages motor programs. Cocaine-induced structural plasticity in the PrL cortex 
has not been heavily investigated, largely due to experimental obstacles in imaging 
the full length of deep layer pyramidal neurons. The data described herein suggest 
that the previously described biphasic alterations in glutamatergic signaling that 
occur globally in the PrL cortex during early withdrawal and early abstinence are 
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associated with adaptations in the PrL-NAc core pathway. These adaptations 
occur not only at the level of the nucleus, but also at the level of individual dendritic 
spines, leading to differential compartmentalization of AMPA receptors in spines. 
Given that the two timepoints show remarkable dichotomy in PrL-NAc core 
adaptations, it is plausible that the altered structure and presumably diminished 
function of PrL-NAc core neurons during early withdrawal is likely required for the 
subsequent enlargement of dendritic spines, induction of p-CREB, and 
accumulation of AMPA receptors in enlarged spines after one week of abstinence. 
Thus, the abstinence duration-dependent adaptations in PrL-NAc core neurons 
provide a novel way of looking at corticostriatal dysfunction as it relates to relapse 
vulnerability. Future studies should investigate the precise timescale of these 
events as they occur over one week of abstinence. Furthermore, it is not clear 
whether structural and synaptic adaptations in PrL-NAc neurons are required for 
context-induced relapse. Future studies should address this question utilizing 






Chapter 5: General discussion 
Summary of findings 
The data described in this dissertation show that the dephosphorylation of ERK2 
in the PrL cortex during early withdrawal is mediated by cocaine-induced activation 
of STEP that is critical to subsequent relapse to cocaine seeking after abstinence. 
Moreover, stimulation of the PrL cortex or the PrL-NAc core pathway immediately 
after SA leads to a transient suppression of cocaine seeking after abstinence, with 
differential effects depending on the stimuli used to induce cocaine seeking, 
suggesting that the ability to suppress subsequent cocaine seeking by intervening 
during early withdrawal is more complex than merely stimulating PrL output to the 
NAc core. Finally, cocaine SA decreases PrL-NAc core distal apical tuft dendritic 
spine head diameter, nuclear p-CREB and Fos, as well as GluA1/2 AMPA receptor 
expression in specific subsets of dendritic spines during early withdrawal. 
However, one week of abstinence elevated dendritic spine head diameter, but 
decreased density, and elevated GluA1/2 expression in dendritic spine heads and 
p-CREB-IR in the nucleus. Thus, cocaine-induced adaptations in glutamatergic 
transmission in the PrL-NAc core pathway emerge during early withdrawal, and 
induce subsequent circuit remodeling during abstinence, ultimately facilitating 
relapse to cocaine seeking.  
Brain region-specific effects of drug-induced regulation of STEP function 
Relative to several other neuropsychological and neurodegenerative disorders, far 
less is known about the involvement of STEP in addiction-related disorders. The 
little that is known clearly shows that STEP activation plays different roles in 
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regulation of psychostimulant-induced synaptic transmission and glutamatergic 
signaling depending on the brain region investigated, whether investigators 
measure acute versus chronic effects of drugs of abuse, and whether drug 
administration is contingent or non-contingent (Valjent et al., 2000).  
Acute cocaine and amphetamine are well-documented to engage ERK2 
phosphorylation in the ventral striatum, which is important for the expression of 
behavioral sensitization, through concomitant activation of dopamine D1 and 
NMDA receptors. The effect is complex, involving augmented dopamine 
interactions with ambient glutamate, PKA-mediated phosphorylation of DARRP-
32, activation of PP1, dephosphorylation (inactivation) of STEP, elevations in 
dendritic spine density, and Src Family Kinase (SFK)-mediated augmentation of 
GluN2B-containing NMDA receptors  (Zhang et al., 2001; Valjent et al., 2005; 
Girault et al., 2007; Pascoli et al., 2011; Cahill et al., 2014; Dos Santos et al., 2017).  
Although reinstatement/relapse following chronic cocaine SA and the 
expression of locomotor sensitization to cocaine share some overlapping 
characteristics (Kalivas et al., 1998), there are also clear differences between the 
two paradigms pertaining to the operant conditioning nature of cocaine SA. 
Remarkably, it is unknown how chronic cocaine SA alters STEP activity in the NAc 
following cocaine SA. However, ERK phosphorylation is elevated in the NAc core 
of cocaine SA animals following three weeks of withdrawal, which is not present 
after one day of withdrawal, when reintroduced into the cocaine-paired context 
(Edwards et al., 2011). This finding suggests that STEP activity in the NAc core 
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may undergo abstinence duration-dependent inhibition of activity to drive relapse, 
although other ERK phosphatases, such as MKP3, may be involved. 
In the prefrontal cortex, a rather different picture emerges and, in general, 
far less is known. In contrast to the NAc, acute cocaine-induced elevations in ERK 
phosphorylation do not require PKA-mediated phosphorylation of DAARP-32 
(Valjent et al., 2005), suggesting alternative pathways are involved. We have 
previously found that cocaine SA leads to ERK, GluN2A/B-containing NMDA 
receptor, and CREB dephosphorylation in the PrL cortex during early withdrawal 
(Whitfield et al., 2011; Sun et al., 2013; Barry and McGinty, 2017). These changes 
are associated with dephosphorylation and activation of STEP (Sun et al., 2013). 
BDNF-mediated attenuation of cocaine seeking requires normalization of ERK 
phosphorylation (Whitfield et al., 2011). The results presented herein posit that 
STEP mediates the cocaine-induced dephosphorylation of ERK and plays a role 
in relapse after abstinence and extinction training depending on whether STEP is 
inhibited globally or specifically within the PrL cortex during early withdrawal. Thus, 
STEP-mediated ERK dephosphorylation in the PrL cortex is a critical regulator of 
cocaine-induced plasticity during early withdrawal that may ultimately facilitate 
dysfuntional corticostriatal glutamate transmission that drives relapse, perhaps 
through dysregulated gene expression.  
Divergent prelimbic cortical pathways and their encoding of reward-
predictive stimuli 
 
The PrL cortex is a highly organized structure that contains heterogenous 
pyramidal neurons that project to multiple diverse subcortical targets. Layer II/III 
pyramidal neurons are generally believed to be made up of projection neurons 
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innervating the contralateral medial prefrontal cortex. In addition, a small number 
of neurons project to subcortical structures implicated in assignment of stimulus 
valence, such as the NAc and BLA (Gabbott et al., 2005; Little and Carter, 2013). 
A few layer V projection neurons also project to contralateral mPFC, but the 
majority of layer V neurons project to subcortical structures implicated in 
reinforcement learning and conditioned reward seeking, including the NAc core 
(Gabbott et al., 2005). Finally layer VI neurons encompass corticothalamic neurons 
innervating the mediodorsal nucleus of the thalamus as well as midline thalamic 
nuclei, such as the PVT (Otis et al., 2017). These glutamatergic projection neurons 
are fundamentally regulated by an array of GABAergic inhibitory interneurons and 
disruptions in this regulation have been implicated in numerous neuropsychiatric 
disorders (Lodge et al., 2009; Hervig et al., 2016).  
Recent evidence indicates that layer V corticostriatal neurons (including the 
PrL-NAc core pathway) and layer VI neurons projecting to the midline thalamus, 
particularly the PVT, produce dichotomous encoding of reward-related information 
following learning (Otis et al., 2017). Moreover, recent data from our lab indicate 
that chemogenetic-mediated inhibition of the PrL cortex immediately following SA 
provides an enduring reduction in cocaine-seeking after abstinence or extinction 
training. Specifically, selectively inhibiting the PrL-NAc core pathway during early 
withdrawal had no effect on relapse to cocaine seeking whereas selective inhibition 
of the PrL-PVT pathway replicated the suppression of cocaine seeking following 
global PrL output inhibition (Giannotti et al., submitted).  
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STEP mRNA is expressed in all layers of the PrL cortex (Lein et al., 2007). 
Thus it is likely that intra-PrL STEP inhibition during early withdrawal from cocaine 
SA inhibits STEP activity in the majority of pyramidal neurons in the PrL cortex. 
However, it is unknown to what degree STEP is expressed in a pathway-specific 
manner. It would be interesting to examine whether the effect of intra-PrL STEP 
inhibition during early withdrawal is dependent on inhibiting STEP activity 
specifically in the PrL efferents projecting to the NAc core. 
In the experiments presented herein, we found that global chemogenetic 
activation of the PrL cortex during early withdrawal transiently suppressed cue-
induced reinstatement after extinction. In contrast, selective activation of the PrL-
NAc core pathway transiently suppressed post-abstinence context-induced 
relapse but not cue-, or cocaine prime-, induced reinstatement. The relatively low 
dose of CNO used may account for the transient suppression in each case 
although alternative explanations, as discussed in Chapter 3, are possible. 
However, the differential, transient, suppression of relapse depending on the 
stimulus used to induce cocaine seeking after non-selective vs. pathway-specific 
activation of PrL cortex may be because global chemogenetic activation of the PrL 
cortex activates pyramidal neurons in all layers of the PrL cortex whereas selective 
activation of the PrL-NAc core pathway is preferentially infecting layer V PrL 
neurons projecting to the NAc core. Although PrL cortical STEP inhibition and Gq-
DREADD activation showed vastly different behavioral effects, it can be postulated 
that the two interventions combined may provide a more enduring normalization of 
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ERK phosphorylation in the PrL cortex during early withdrawal more akin to BDNF, 
allowing hM3Dq to provide a sustained suppression of relapse (Fig. 5.1). 
Figure 5.1. TC-2153 and Gq-DREADD interact at the level of ERK. The cocaine-
induced dephosphorylation of ERK by STEP represents a critical adaptation that 
facilitates relapse. The synergistic action of the two to drive ERK phosphorylation 
may provide a more enduring suppression of relapse behavior in cocaine SA 
animals. 
 
Cyotoarchitecture of layer V pyramidal neurons: Implications for activity-
dependent structural remodeling 
 
Pyramidal neurons make up the majority of glutamatergic projection neurons and 
are characterized by two distinct dendritic domains: basal and apical dendrites. 
Layer V-VI pyramidal neurons have a distinct primary apical dendrite that extends 
~ 600 μm towards the pial surface, passing through layer III before bifurcating and 
ultimately producing a tuft of apical dendrites in layers II and layer I. Importantly, 
the apical tuft receives inputs from different origins relative to the proximal apical 
or basal dendrites (Spruston, 2008). For example, serotonin application to medial 
prefrontal cortical layer V distal apical tufts, but not basal dendrites, increases 
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excitatory post synaptic currents (EPSCs-(Aghajanian and Marek, 1997). 
Moreover, orexin (hypocretin) inputs to thalamocortical projection neuron axon 
boutons arising from intralaminar and midline thalamic nuclei elicits glutamate 
release onto distal apical tuft dendritic spines of layer V pyramidal neurons in the 
prefrontal cortex. Interestingly, this was associated with large Ca2+ transients in 
only a subset of dendritic spines (Lambe and Aghajanian, 2003). Stimulation of  
α4β2 nicotinic acetylcholine receptors (nAchRs) also induces glutamate release 
onto layer V prefrontal cortical pyramidal neurons due to actions at axon terminals 
of the same thalamocortical neurons (Lambe et al., 2003). Thus, it is possible that 
altered glutamatergic neurotransmission arising from thalamic neurons and 
regulated by orexinergic, serotonergic, or cholinergic inputs may induce altered 
glutamatergic plasticity in layer V PrL-NAc core neurons. Ultimately, this may lead 
to circuit level remodeling and sensitivity of these neurons to glutamate inputs that 
may drive relapse after abstinence. 
It is well known that layer I-III of mPFC contains massive innervation by TH+ 
(presumably dopaminergic) fibers, at least in the primate PFC (Goldman-Rakic et 
al., 1989). Moreover, dendritic spines of distal apical tufts of layer V pyramidal 
neurons show an abundance of hyperpolarization-activated cyclic nucleotide-
gated channel (HCN) immunoreactivity, which colocalize with D1 receptors 
preferentially on long thin spines (Paspalas et al., 2013). Thus, although it has not 
been definitively shown, the latter finding suggests that, in addition to serotonergic 
and orexinergic inputs, layer V prefrontal cortical distal apical tufts also receive 
dopaminergic inputs, presumably arising from the VTA. In contrast, glutamatergic 
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inputs arising from the BLA preferentially innervate basal dendrites of layer V PrL 
cortical pyramidal neurons (Liu et al., 2015). Furthermore, during development, 
proximal apical dendrites of layer V prefrontal cortical neurons undergo a 
transformational shift in NMDA receptor-dependent excitatory neurotransmission 
characterized by an emergence of GluN2B-containing NMDA receptors, which 
requires PKA and D1 activity. Such an emergence provides sustained plasticity in 
response to ventral hippocampal, but not BLA, inputs (Flores-Barrera et al., 2014). 
These findings provide insight into the potential anatomical inputs onto layer V PrL 
cortical distal apical tufts which may undergo plasticity following chronic cocaine 
SA, ultimately driving post synaptic alterations in form (structural plasticity) and 
function (glutamatergic signaling).  
In the context of psychopathology, chronic mild stress paradigms have been 
shown to reduce the percentage of mushroom-type spines of distal apical 
dendrites, but not basal dendrites, in both the CA3 region of the hippocampus as 
well as the mPFC (Bessa et al., 2009). Moreover, distal apical tufts of layer V 
pyramidal neurons undergo hypotrophic structural plasticity (i.e. loss of dendritic 
spines) following chronic stress, which is associated with a loss of orexin and 
sertonin-induced EPSCs (Liu and Aghajanian, 2008). Chronic stress also 
decreases the surface expression of GluA1 and GluA2 subunits of AMPA 
receptors in the mPFC, effects which occur through activation of glucocorticoid 
receptors (Yuen et al., 2012). Finally, layer II/III PrL cortical neurons show reduced 
spine density, but increased spine volume, following two weeks of abstinence; 
alterations which are associated with heightened corticosterone as well as working 
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memory deficits following cocaine SA (Radley et al., 2015). This latter finding has 
also been shown following chronic stress (Radley et al., 2006), suggesting that 
cocaine SA and chronic stress induce similar neuroadaptations, perhaps ultimately 
leading to a shared inability of top-down control of behavior. Thus, it is possible 
that acute cocaine withdrawal following chronic SA may engage the rodent stress 
response which sensitizes during more prolonoged abstinence, ultimately leading 
to prefrontal cortical impairments and dysregulation of downstream structures such 
as the NAc core.  
Time-dependent regulation of structural plasticity: Role of experience-
dependent circuit remodeling 
 
The majority of mature dendritic spines in various brain regions are relatively stable 
during adulthoood (Trachtenberg et al., 2002). However, several experiments have 
shown that structural remodeling of neurons occurs following learning. In the 
hippocampus, contextual fear conditioning alters morphological plasticity 24 hours 
after learning, specifically in neurons activated during fear conditioning relative to 
neurons that were inactive during fear conditioning (Sanders et al., 2012). 
Moreover, contextual fear conditioning leads to a hippocampal-dependent 
progressive reorganization of anterior cingulate neuron apical dendritic spine 
density characterized by elevated density 36 days, but not 24 hours, after 
conditioning. Lesions of the hippocampus immediately after conditioning prevent 
this elevated spine density weeks after conditioning (Restivo et al., 2009). In the 
barrel cortex, dendritic spine formation and pruning occurs following paradigms 
that induce functional reorganization, such as contralateral whisker trimming. 
Specifically, whisker trimming destablizaes nascent spines, while stabilizing spines 
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that were persistent during repeated two-photon imaging (Holtmaat et al., 2006). 
It is therefore plausbile that the initial spine head shrinkage observed in PrL-NAc 
core neurons during early withdrawal, and the subsequent enlargement of spines 
coupled with the elimination of spines after one week of abstinence, may lead to 
stabilization of synapses that have a greater influence on PrL-NAc core 
transmission, leading to heightened encoding of cocaine-paired stimuli. 
What might be the molecular substrates of activity-dependent structural 
remodeling? Several lines of evidence point to altered gene transcription in 
structural remodeling following associative learning. For example, prolonged 
whisker trimming elevates the proportion of thin spines in the contralateral barrel 
cortex in wild type, but not CREB-knockout mice. Moreover, in the ipsilateral barrel 
cortex, there is a CREB-dependent enlargement of dendritic spines (Pignataro et 
al., 2015). Furthermore, in the CA1 field of the hippocampus, CREB inhibition 
impairs contextual fear conditioning and leads to actin depolymerization resulting 
in the collapse of dendritic spines (Middei et al., 2012). BDNF has been recognized 
as a major upstream regulator of CREB-mediated gene transcription and spine 
morphogenesis. In the mPFC, BDNF mice containing the knockin Val66Met 
polymorphism, that hinders intracellular BDNF transport and secretion (Chen et 
al., 2004) show distal apical dendrite atrophy of layer V neurons, characterized by 
decreased density and spine head width. They also display decrements in evoked 
EPSCs, which is consistent with the above-mentioned effects of stress on apical 
dendrites of layer V mPFC neurons (Liu et al., 2012). Thus, it is likely that BDNF 
and CREB act in concert to regulate time-dependent changes in structural 
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plasticity. Moreover, these two signaling molecules likely exist as core tenants of 
activity-dependent structural remodeling, ultimately resulting in a stabilization of 
newly formed synapses, and perhaps the coordinated and parallel pruning of other 
synapses.  
Potential cellular mechanisms mediating PrL-NAc core apical dendrite 
structural plasticity: Role of STEP and BDNF 
 
It is possible that the cocaine-induced activation of STEP in the PrL cortex during 
early withdrawal serves as a potential mediator of dendritic spine changes in PrL-
NAc core neurons. Previous work indicates that activation of STEP leads to the 
dephosphorylation and inactivation of a key inhibitor of cofilin-mediated actin 
depolymerization, SPIN 90, in cultured neurons (Cho et al., 2013), although this is 
yet to be demonstrated in vivo. This agrees with findings that STEP suppresses 
LTP induction (Pelkey et al., 2002), which is generally associated with enlargement 
of dendritic spine heads (Huganir and Nicoll, 2013). Importantly, chronic inhibition 
of STEP ameliorates dendritic spine adaptations in a Fmr1 knockout mouse model 
of Fragile X syndrome (Chatterjee et al., 2018). Moreover, chronic inhibition of the 
upstream activator of STEP, PP2B (calcineurin), has been shown to increase 
dendritic branching and spine density in naïve mouse neocortex (Spires-Jones et 
al., 2011), although this effect could be due to alterations in other systems 
downstream of PP2B, and not necessarily at the level of STEP. Regarding 
regulation of AMPA receptors, STEP dephosphorylates tyrosine residues in the 
intracellular C-terminal domain of GluA2, promoting endocytosis (Zhang et al., 
2008). Finally, STEP knock-out mice crossed with Tg2576 Alzheimer’s disease 
transgenic mice show an attenuation of Amyloidβ-mediated GluA1/2 endocytosis 
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in cortical tissue normally present in Tg2576 mice alone (Zhang et al., 2011). 
These findings suggest the possible involvement of STEP activation in cocaine-
induced structural plasticity and AMPA receptor alterations in PrL-NAc core 
neurons. Given the role of STEP-mediated dephosphorylation of p-ERK2 in the 
PrL cortex during early withdrawal, leading to subsequent relapse, it would be 
interesting to examine whether transient inhibition of STEP specifically in PrL-NAc 
core neurons immediately after SA is sufficient to suppress relapse after 
abstinence. 
Acute stimulation of neuronal cultures in vitro with BDNF leads to a 
sustained incorporation of synaptic AMPA receptors through increased association 
of GluA2 with Glutamate Receptor-Interacting Protein 1 (GRIP1) and GluA1 with 
synapse-associated protein 97 (SAP97) (Jourdi and Kabbaj, 2013). Moreover, 
BDNF promotes actin polymerization and dendritic spine growth (Horch et al., 
1999; Tanaka et al., 2008; Bennett and Lagopoulos, 2014). Because the 
suppressive effect of intra-PrL BDNF on cocaine seeking is ERK dependent 
(Whitfield et al., 2011) and AMPA receptor exocytosis and lateral diffusion into 
stimulated synapses during LTP induction is ERK-dependent (Patterson et al., 
2010), it is plausible that one mechanism of action by which an intra-PrL BDNF 
microinfusion suppresses relapse is through increased incorporation of AMPA 
receptors in dendritic spines of PrL-NAc core neurons during early withdrawal as 
has been demonstrated in the NAc (Li and Wolf, 2011). Future studies should 
investigate whether this intervention normalizes the cocaine-induced depression 
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of dendritic spine head size as well as GluA-IR in large spines of PrL-NAc core 
neurons.  
Are all PrL-NAc core neurons created equal? 
The PrL-NAc core pathway represents a critical node in regulating cocaine-
seeking, as discussed in detail above. Using a rabies monosynaptic tracing 
technique, it was found that the NAc receives input from ~50 different brain 
regions. Cortical inputs (including cingulate, orbitofrontal, PrL, IL, insular, 
perirhinal, entorhinal, and motor cortices) were found to constitute ~25% of brain-
wide inputs to the NAc core. PrL cortical neurons innervating the NAc core project 
evenly to D1 and D2 MSN’s, whereas medial orbitofrontal cortical neurons 
innervate a significantly greater proportion of D1 relative to D2 MSNs (Barrientos 
et al., 2018).  Both D1 and D2-expressing MSNs innervate the ventral pallidum 
(Kupchik et al., 2015), and D1 versus D2 activation differentially regulates cocaine-
seeking (Lobo et al., 2010) via actions in the ventral pallidum (Heinsbroek et al., 
2017).  
Thus, it is plausible that hM3Dq-mediated PrL-NAc core activation 
immediately after SA is activating both PrL-NAc core neurons innervating D1-
expressing MSNs as well as D2-expressing MSNs. Because these accumbens 
neurons have different effects on cocaine-seeking when stimulated or inhibited, it 
is possible that the overall lack of effect of hM3Dq activation on cocaine-seeking 
may be due to differential effects on these divergent NAc MSN subtypes. This 
differential activation is further supported by the finding that the majority of hM3Dq-
expressing PrL-NAc core neurons were Fos activated, indicating that PrL-NAc core 
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neurons innervating both D1 and D2 expressing MSNs were likely to be activated 
by CNO during early withdrawal. Furthermore, the experiments performed by 
Barrientos and colleagues demonstrated that PrL-NAc core neurons innervating 
D1 MSNs preferentially showed reduced apical dendrite spine density following 
14, but not 5, days of withdrawal from daily non-contingent cocaine injections. 
Thus, our findings that PrL-NAc core neurons show decreased spine density 
following one week of abstinence from cocaine SA agree and suggest that our 
effects may be specific to PrL neurons innervating D1-expressing MSNs, a subject 
for future investigation. Moreover, because Barrientos and colleagues found 
structural alterations after 14, but not 5 days, implies that these changes occur as 
a result of abstinence duration and not necessarily because of the pharmacological 
effect of daily cocaine injections. 
Conclusions 
Pyramidal neurons within the mPFC are well-positioned to integrate multiple 
sensory and neuromodulatory inputs that guide motivated behavior to ensure 
survival of a given species. In naïve animals, it could be postulated that the mPFC 
acts as a gate that allows for stimuli to induce adaptive, or inhibit maladaptive, 
behaviors that facilitate behavioral activation in response to cues that predict 
rewards, likely through innervation of the NAc core. The ability to adapt to an ever-
changing environment likely involves transient alterations in structural plasticity, 
glutamatergic signaling, and ultimately gene transcription in PrL neurons 
innervating limbic regions that interact with motor programs, such as the NAc core 





























Figure 5.2.  Schematic illustrating “normal” PrL-NAc core neuronal activity. Layer 
V PrL cortical neurons’ distal apical tufts receive input from various excitatory and 
neuromodulatory regions, facilitating activity-dependent synaptic and structural 
remodeling in response to these inputs. These changes may be both upstream 
and downstream of transcriptional activity in the nucleus. Specifically, PrL neurons 
projecting to the NAc core may undergo activity-dependent alterations in response 
to stimuli associated with rewards, ultimately facilitating motor activation via 
interactions with D1 and D2-expressing MSNs in the NAc core. 
 
However, following chronic cocaine SA, the PrL-NAc core pathway 
undergoes maladaptive plasticity within the first few hours of withdrawal. This is 
characterized by decreased CREB phosphorylation, decreased nuclear Fos 
expression, as well as decreased GluA1/2 expression in mature dendritic spines 
of PrL-NAc core neurons. These neurons may also make up a proportion of those 
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that show elevated STEP activity, leading to decreased phosphorylation of ERK2 
and GluN2A/B-containing NMDA receptors. It is likely that these effects rely on 
altered glutamatergic inputs to PrL-NAc core neurons that may also undergo 




Figure 5.3. Schematic illustrating dysfuntional PrL-NAc core transmission during 
early withdrawal. Chronic cocaine exposure may alter the excitatory and 
modulatory inputs to PrL-NAc core distal apical tufts. These inputs result in 
hypotrophic structural alterations, which may be due to an imbalance in kinase-
phosphatase activity (i.e. increased STEP). Ultimately, this may facilitate 







Moreover, the altered plasticity in PrL-NAc core neurons is time-dependent, 
such that after one week of abstinence (i.e. immediately prior to a context-induced 
relapse test), PrL-NAc core neurons may exist in a state of hyper-responsiveness 
to glutamate inputs, characterized by elevated GluA1/2 expression in dendritic 
spines, as well as increased nuclear p-CREB (Fig. 5.4). Ultimately, this chain of 
maladaptive plasticity likely facilitates preferential encoding of drug-associated 
stimuli, facilitating the seeking for cocaine, perhaps at the expense of natural 




















Figure 5.4. Schematic illustrating dysfuntional PrL-NAc core transmission after 
one week of abstinence. Chronic cocaine SA may alter encoding of cocaine-
related stimuli by layer V PrL cortical neurons via hypertrophic enlargements in 
spine heads and AMPA receptor accumulation in spine heads, as well as elevated 
p-CREB-dependent transcription of plasticity-related genes. This likely facilitates 
increased PrL-NAc core glutamate transmission, perhaps preferentially in PrL 





Most of the experiments described herein have taken advantage of traditional 
behavioral pharmacology and biochemical techniques, as well as the recent 
advent of pathway-specific viral vector techniques and high-resolution confocal 
microscopy. However, the findings from these experiments would be greatly 
enhanced by electrophysiological and Ca2+ imaging experiments that would further 
reveal mechanisms involved in producing the transient and enduring PrL 
adaptations following chronic cocaine exposure, as well as providing a 
physiological readout of activity. Moreover, the precise mechanisms mediating 
these adaptive effects are unknown. As described above, it is possible that STEP 
activation during early withdrawal is involved in these adaptations. Furthermore, it 
is probable that one mechanism of action of the suppressive effect of BDNF on 
cocaine seeking involves normalizing structural and glutamate signaling 
adaptations in PrL-NAc core neurons. Furthermore, future studies should examine 
whether the spine changes are positively correlated with p-CREB-IR using two-
photon imaging in behaving animals.  
 An often-underappreciated aspect of glutamate transmission is the 
involvement of astroglial cells. Astrocytes play a critical role in glutamate uptake at 
synapses through the actions of the high-affinity glutamate transporter GLT1 
(Anderson and Swanson, 2000; Shen et al., 2014b), and cocaine-induced 
alterations in the proximity of astrocytes to synapses in the NAc core has been 
suggested to play a role in altered glutamate transmission implicated in relapse to 
various drugs of abuse (Scofield et al., 2016a; Scofield et al., 2016b). Indeed, 
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drugs that have shown promise in the treatment of addiction-related disorders, 
such as N-acetyl-cysteine, exert most of their effects on astrocytes, particularly by 
normalizing drug-induced downregulation in GLT1 (Reissner et al., 2015). 
Emerging evidence indicates that perisynaptic astrocytic processes (PAPs) 
interdigitate with individual dendritic spines where they regulate the fidelity of 
neuronal communication and ensheathe synapses in response to bouts of high 
activity (Bernardinelli et al., 2014). An advantage of our pathway-specific labeling 
of dendritic spines is that viruses used to label neurons can be co-injected with 
viruses that label the fine membrane of astrocytes. Indeed, using this multi-viral 
labeling technique, we can observe the degree to which astrocytes associate with 
neurons at the level of individual dendritic spines (Fig. 5.5).  
Figure 5.5.  Representative PAP association with 
PrL-NAc core dendrite. A. PrL-NAc core mCherry-
labeled neuron (red) surrounded by field of GFAP-
Lck-GFP which preferentially labels asrocytic plasma 
membranes (green). B. High magnification inset of 
boxed region in A. Note the dense array of dendritic 
spine heads surrounded by astrocyte PAPs. 
Instances where astrocyte PAPs are within 150 nm of 
the dendritic shaft and spines are shown in white. 
Scale bars = 50 μm (A), 3 μm (B). 
Thus, future experiments should determine whether a) STEP inhibition alters 
astrocyte-neuron interactions at spines of PrL-NAc core neurons during early 
withdrawal, b) hM3Dq-mediated activation of PrL-NAc core neurons is associated 
with altered astrocyte contact, and c) whether PrL-NAc core neuron structural 
plasticity and dendritic AMPA receptor expression is associated with altered 
astrocyte contact, particularly at enlarged mushroom-type spines. Ultimately, 
these experiments would synergize with those presented within this dissertation 
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by providing a greater understanding of how drug-induced adaptations in synaptic 
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